QUARTERLY REPORT

Q2 2022 — Quarterly report (Form 10-Q)

Q2 2022PDF · 121 pages1.6 MB
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
OR
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________
Commission file number: 001-38855
___________________________________
Nasdaq, Inc.
(Exact name of registrant as specified in its charter)
Delaware 	52-1165937
(State or Other Jurisdiction of Incorporation or Organization) 	(I.R.S. Employer Identification No.)
151 W. 42nd Street, New York, New York 	10036
(Address of Principal Executive Offices) 	(Zip Code)
Registrant’s telephone number, including area code: +1 212 401 8700
No Changes
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.01 par value per share 	NDAQ 	The Nasdaq Stock Market
0.900% Senior Notes due 2033 	NDAQ33 	The Nasdaq Stock Market
0.875% Senior Notes due 2030 	NDAQ30 	The Nasdaq Stock Market
1.75% Senior Notes due 2029 	NDAQ29 	The Nasdaq Stock Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of
this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class 	Outstanding at July 26, 2022
Common Stock, $0.01 par value per share 	163,742,074 shares

-- 1 of 121 --

Nasdaq, Inc.
Page
Part I. FINANCIAL INFORMATION
Item 1. 	Financial Statements 	1
Condensed Consolidated Balance Sheets - June 30, 2022 (unaudited) and December 31, 2021 	1
Condensed Consolidated Statements of Income - Three and Six Months Ended June 30, 2022 and 2021 (unaudited) 	2
Condensed Consolidated Statements of Comprehensive Income - Three and Six Months Ended June 30, 2022 and 2021 (unaudited) 	3
Condensed Consolidated Statements of Changes in Stockholders' Equity - Three and Six Months Ended June 30, 2022 and 2021
(unaudited) 	4
Condensed Consolidated Statements of Cash Flows - Six Months Ended June 30, 2022 and 2021 (unaudited) 	5
Notes to Condensed Consolidated Financial Statements (unaudited) 	6
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	32
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	49
Item 4. 	Controls and Procedures 	51
Part II. OTHER INFORMATION
Item 1. 	Legal Proceedings 	52
Item 1A. Risk Factors 	52
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	52
Item 3. 	Defaults Upon Senior Securities 	52
Item 4. 	Mine Safety Disclosures 	52
Item 5. 	Other Information 	52
Item 6. 	Exhibits 	53
SIGNATURES 	53
i

-- 2 of 121 --

About this Form 10-Q
Throughout this Form 10-Q, unless otherwise specified:
• “Nasdaq,” “we,” “us” and “our” refer to Nasdaq, Inc.
• “Nasdaq Baltic” refers to collectively, Nasdaq Tallinn AS, Nasdaq
Riga, AS, and AB Nasdaq Vilnius.
• “Nasdaq BX” refers to the cash equity exchange operated by Nasdaq
BX, Inc.
• “Nasdaq BX Options” refers to the options exchange operated by
Nasdaq BX, Inc.
• “Nasdaq Clearing” refers to the clearing operations conducted by
Nasdaq Clearing AB.
• “Nasdaq CXC” and “Nasdaq CX2” refer to the Canadian cash equity
trading books operated by Nasdaq CXC Limited.
• “Nasdaq First North” refers to our alternative marketplaces for smaller
companies and growth companies in the Nordic and Baltic regions.
• “Nasdaq GEMX” refers to the options exchange operated by Nasdaq
GEMX, LLC.
• “Nasdaq ISE” refers to the options exchange operated by Nasdaq ISE,
LLC.
• “Nasdaq MRX” refers to the options exchange operated by Nasdaq
MRX, LLC.
• “Nasdaq Nordic” refers to collectively, Nasdaq Clearing AB, Nasdaq
Stockholm AB, Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd, and
Nasdaq Iceland hf.
• “Nasdaq PHLX” refers to the options exchange operated by Nasdaq
PHLX LLC.
• “Nasdaq PSX” refers to the cash equity exchange operated by Nasdaq
PHLX LLC.
• “The Nasdaq Options Market” refers to the options exchange operated
by The Nasdaq Stock Market LLC.
• “The Nasdaq Stock Market” refers to the cash equity exchange and
listing venue operated by The Nasdaq Stock Market LLC.
Nasdaq also provides as a tool for the reader the following list of
abbreviations and acronyms that are used throughout this Quarterly Report
on Form 10-Q.
401(k) Plan: Voluntary Defined Contribution Savings Plan
2020 Credit Facility: $1.25 billion senior unsecured revolving credit
facility, which matures on December 22, 2025
2022 Notes: $600 million aggregate principal amount of 0.445% senior
unsecured notes due December 21, 2022
2024 Notes: $500 million aggregate principal amount of 4.25% senior
unsecured notes, repaid in full and terminated in April 2022
2026 Notes: $500 million aggregate principal amount of 3.85% senior
unsecured notes due June 30, 2026
2029 Notes: €600 million aggregate principal amount of 1.75% senior
unsecured notes due March 28, 2029
2030 Notes: €600 million aggregate principal amount of 0.875% senior
unsecured notes due February 13, 2030
2031 Notes: $650 million aggregate principal amount of 1.650% senior
unsecured notes due January 15, 2031
2033 Notes: €615 million aggregate principal amount of 0.900% senior
unsecured notes due July 30, 2033
2040 Notes: $650 million aggregate principal amount of 2.500% senior
unsecured notes due December 21, 2040
2050 Notes: $500 million aggregate principal amount of 3.25% senior
unsecured notes due April 28, 2050
2052 Notes: $550 million aggregate principal amount of 3.950% senior
unsecured notes due March 7, 2052
ARR: Annualized Recurring Revenue
ASR: Accelerated Share Repurchase
AUM: Assets Under Management
CCP: Central Counterparty
CFTC: Commodity Futures Trading Commission
EMIR: European Market Infrastructure Regulation
Equity Plan: Nasdaq Equity Incentive Plan
ESG: Environmental, Social and Governance
ESPP: Nasdaq Employee Stock Purchase Plan
ETF: Exchange Traded Fund
ETP: Exchange Traded Product
Exchange Act: Securities Exchange Act of 1934, as amended
FICC: Fixed Income and Commodities Trading and Clearing
FINRA: Financial Industry Regulatory Authority
IPO: Initial Public Offering
LIBOR: London Interbank Offered Rate
NFF: Nasdaq Financial Framework; Nasdaq's end-to-end technology
solutions for market infrastructure operators, buy-side firms, sell-side
firms and other non-financial markets
NPM: The NASDAQ Private Market, LLC
NSCC: National Securities Clearing Corporation
OCC: The Options Clearing Corporation
OTC: Over-the-Counter
PSU: Performance Share Unit
Reg NMS: Regulation National Market System
SaaS: Software as a Service
ii

-- 3 of 121 --

SEC: U.S. Securities and Exchange Commission
SERP: Supplemental Executive Retirement Plan
SFSA: Swedish Financial Supervisory Authority
S&P: Standard & Poor’s
S&P 500: S&P 500 Stock Index
SPAC: Special Purpose Acquisition Company
TSR: Total Shareholder Return
U.S. GAAP: U.S. Generally Accepted Accounting Principles
NASDAQ, the NASDAQ logos, and other brand, service or product names
or marks referred to in this report are trademarks or service marks,
registered or otherwise, of Nasdaq, Inc. and/or its subsidiaries. FINRA and
Trade Reporting Facility are registered trademarks of FINRA.
This Quarterly Report on Form 10-Q includes market share and industry
data that we obtained from industry publications and surveys, reports of
governmental agencies and internal company surveys. Industry
publications and surveys generally state that the information they contain
has been obtained from sources believed to be reliable, but we cannot
assure you that this information is accurate or complete. We have not
independently verified any of the data from third-party sources nor have
we ascertained the underlying economic assumptions relied upon therein.
Statements as to
our market position are based on the most currently available market data.
For market comparison purposes, The Nasdaq Stock Market data in this
Quarterly Report on Form 10-Q for IPOs is based on data generated
internally by us; therefore, the data may not be comparable to other
publicly-available IPO data. Data in this Quarterly Report on Form 10-Q
for new listings of equity securities on The Nasdaq Stock Market is based
on data generated internally by us, which includes issuers that switched
from other listing venues, closed-end funds and ETPs. Data in this
Quarterly Report on Form 10-Q for IPOs and new listings of equity
securities on the Nasdaq Nordic and Nasdaq Baltic exchanges and Nasdaq
First North also is based on data generated internally by us. IPOs and new
listings data is presented as of period end. While we are not aware of any
misstatements regarding industry data presented herein, our estimates
involve risks and uncertainties and are subject to change based on various
factors. We refer you to the “Risk Factors” section in our Quarterly Report
on Form 10-Q for the quarter ended March 31, 2022 that was filed with the
SEC on May 4, 2022 and the "Risk Factors" section in our Form 10-K for
the fiscal year ended December 31, 2021 that was filed with the SEC on
February 23, 2022.
Nasdaq intends to use its website, ir.nasdaq.com, as a means for disclosing
material non-public information and for complying with SEC Regulation
FD and other disclosure obligations.
iii

-- 4 of 121 --

Forward-Looking Statements
The SEC encourages companies to disclose forward-looking information
so that investors can better understand a company’s future prospects and
make informed investment decisions. This Quarterly Report on Form 10-Q
contains these types of statements. Words such as “may,” “will,” “could,”
“should,” “anticipates,” “envisions,” “estimates,” “expects,” “projects,”
“intends,” “plans,” “believes” and words or terms of similar substance
used in connection with any discussion of future expectations as to
industry and regulatory developments or business initiatives and
strategies, future operating results or financial performance, and other
future developments are intended to identify forward-looking statements.
These include, among others, statements relating to:
• our strategic direction;
• the integration of acquired businesses, including accounting decisions
relating thereto;
• the scope, nature or impact of acquisitions, divestitures, investments,
joint ventures or other transactional activities;
• the effective dates for, and expected benefits of, ongoing initiatives,
including transactional activities and other strategic, restructuring,
technology, de-leveraging and capital return initiatives, including our
stock split;
• our products and services;
• the impact of pricing changes;
• tax matters;
• the cost and availability of liquidity and capital;
• any litigation, or any regulatory or government investigation or action,
to which we are or could become a party or which may affect us; and
• the ongoing impact of the COVID-19 pandemic on our business,
operations, results of operations, financial condition and workforce.
Forward-looking statements involve risks and uncertainties. Factors that
could cause actual results to differ materially from those contemplated by
the forward-looking statements include, among others, the following:
• our operating results may be lower than expected;
• our ability to successfully integrate acquired businesses or divest sold
businesses or assets, including the fact that any integration or transition
may be more difficult, time consuming or costly than expected, and we
may be unable to realize synergies from business combinations,
acquisitions, divestitures or other transactional activities;
• loss of significant trading and clearing volumes or values, fees, market
share, listed companies, market data customers or other customers;
• our ability to develop and grow our non-trading businesses, including
our technology and analytics offerings;
• our ability to keep up with rapid technological advances and adequately
address cybersecurity risks;
• economic, political and market conditions and fluctuations, including
inflation, interest rate and foreign currency risk, inherent in U.S. and
international operations, and geopolitical instability arising from the
Russian invasion of Ukraine;
• the performance and reliability of our technology and technology of
third parties on which we rely;
• any significant error in our operational processes;
• our ability to continue to generate cash and manage our indebtedness;
and
• adverse changes that may occur in the litigation or regulatory areas, or
in the securities markets generally, or increased regulatory oversight
domestically or internationally.
Most of these factors are difficult to predict accurately and are generally
beyond our control. You should consider the uncertainty and any risk
related to forward-looking statements that we make. These risk factors are
more fully described in our "Risk Factors" section in our Form 10-K that
was filed with the SEC on February 23, 2022, and supplemented in the
“Risk Factors” section in our Quarterly Report on Form 10-Q for the
quarter ended March 31, 2022 that was filed with the SEC on May 4,
2022. You are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date of this report. You
should carefully read this entire Quarterly Report on Form 10-Q,
including “Part I, Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations” and the condensed
consolidated financial statements and the related notes. Except as required
by the federal securities laws, we undertake no obligation to update any
forward-looking statement, release publicly any revisions to any forward-
looking statements or report the occurrence of unanticipated events. For
any forward-looking statements contained in any document, we claim the
protection of the safe harbor for forward-looking statements contained in
the Private Securities Litigation Reform Act of 1995.
iv

-- 5 of 121 --

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Nasdaq, Inc.
Condensed Consolidated Balance Sheets
(in millions, except share and par value amounts)
June 30, 2022 	December 31, 2021
Assets 	(unaudited)
Current assets:
Cash and cash equivalents 	$ 	454 $ 	393
Restricted cash and cash equivalents 	30 	29
Default funds and margin deposits (including restricted cash and cash equivalents of $7,769 and $5,074,
respectively) 	8,688 	5,911
Financial investments 	161 	208
Receivables, net 	652 	588
Other current assets 	233 	294
Total current assets 	10,218 	7,423
Property and equipment, net 	514 	509
Goodwill 	8,151 	8,433
Intangible assets, net 	2,670 	2,813
Operating lease assets 	462 	366
Other non-current assets 	581 	571
Total assets 	$ 	22,596 $ 	20,115
Liabilities
Current liabilities:
Accounts payable and accrued expenses 	$ 	175 $ 	185
Section 31 fees payable to SEC 	175 	62
Accrued personnel costs 	161 	252
Deferred revenue 	512 	329
Other current liabilities 	140 	115
Default funds and margin deposits 	8,688 	5,911
Short-term debt 	1,020 	1,018
Total current liabilities 	10,871 	7,872
Long-term debt 	4,696 	4,812
Deferred tax liabilities, net 	464 	406
Operating lease liabilities 	470 	386
Other non-current liabilities 	244 	234
Total liabilities 	16,745 	13,710
Commitments and contingencies
Equity
Nasdaq stockholders’ equity:
Common stock, $0.01 par value, 300,000,000 shares authorized, shares issued: 170,888,738 at June 30, 2022
and 173,418,939 at December 31, 2021; shares outstanding: 163,734,534 at June 30, 2022 and 166,679,635
at December 31, 2021 	2 	2
Additional paid-in capital 	1,385 	1,952
Common stock in treasury, at cost: 7,154,204 shares at June 30, 2022 and 6,739,304 shares at December 31,
2021 	(509) 	(437)
Accumulated other comprehensive loss 	(1,905) 	(1,587)
Retained earnings 	6,869 	6,465
Total Nasdaq stockholders’ equity 	5,842 	6,395
Noncontrolling interests 	9 	10
Total equity 	5,851 	6,405
Total liabilities and equity 	$ 	22,596 $ 	20,115
See accompanying notes to condensed consolidated financial statements.
1

-- 6 of 121 --

Nasdaq, Inc.
Condensed Consolidated Statements of Income
(Unaudited)
(in millions, except per share amounts)
Three Months Ended June 30, 	Six Months Ended June 30,
2022 	2021 	2022 	2021
Revenues:
Market Technology 	$ 	131 $ 	117 $ 	255 $ 	217
Investment Intelligence 	283 	261 	567 	516
Corporate Platforms 	168 	149 	336 	296
Market Services 	969 	874 	1,927 	2,010
Other revenues 	1 	11 	2 	24
Total revenues 	1,552 	1,412 	3,087 	3,063
Transaction-based expenses:
Transaction rebates 	(529) 	(517) 	(1,111) 	(1,170)
Brokerage, clearance and exchange fees 	(130) 	(49) 	(191) 	(196)
Revenues less transaction-based expenses 	893 	846 	1,785 	1,697
Operating expenses:
Compensation and benefits 	247 	231 	501 	470
Professional and contract services 	29 	38 	64 	65
Computer operations and data communications 	50 	46 	101 	90
Occupancy 	25 	26 	52 	55
General, administrative and other 	34 	12 	55 	24
Marketing and advertising 	11 	9 	21 	19
Depreciation and amortization 	65 	68 	132 	131
Regulatory 	8 	7 	15 	14
Merger and strategic initiatives 	12 	12 	27 	57
Restructuring charges 	— 	21 	— 	31
Total operating expenses 	481 	470 	968 	956
Operating income 	412 	376 	817 	741
Interest income 	— 	— 	1 	1
Interest expense 	(32) 	(33) 	(64) 	(62)
Net gain on divestiture of business 	— 	84 	— 	84
Other income 	8 	— 	2 	1
Net income from unconsolidated investees 	9 	27 	15 	84
Income before income taxes 	397 	454 	771 	849
Income tax provision 	90 	113 	182 	210
Net income 	307 	341 	589 	639
Net loss attributable to noncontrolling interests 	— 	— 	1 	—
Net income attributable to Nasdaq 	$ 	307 $ 	341 $ 	590 $ 	639
Per share information:
Basic earnings per share 	$ 	1.87 $ 	2.08 $ 	3.59 $ 	3.89
Diluted earnings per share 	$ 	1.85 $ 	2.05 $ 	3.55 $ 	3.83
Cash dividends declared per common share 	$ 	0.60 $ 	0.54 $ 	1.14 $ 	1.03
See accompanying notes to condensed consolidated financial statements.
2

-- 7 of 121 --

Nasdaq, Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
(in millions)
Three Months Ended June 30, 	Six Months Ended June 30,
2022 	2021 	2022 	2021
Net income 	$ 	307 $ 	341 $ 	589 $ 	639
Other comprehensive income (loss):
Foreign currency translation gains (losses) 	(206) 	47 	(273) 	(67)
Income tax benefit (expense) 	(29) 	6 	(45) 	(17)
Foreign currency translation, net 	(235) 	53 	(318) 	(84)
Comprehensive income 	72 	394 	271 	555
Comprehensive loss attributable to noncontrolling interests 	— 	— 	1 	—
Comprehensive income attributable to Nasdaq 	$ 	72 $ 	394 $ 	272 $ 	555
____________
Primarily relates to the tax effect of unrealized gains and losses on Euro denominated notes.
See accompanying notes to condensed consolidated financial statements.
(1)
(1)
3

-- 8 of 121 --

Nasdaq, Inc.
Condensed Consolidated Statements of Changes in Stockholders' Equity
(Unaudited)
(in millions)
Three Months Ended June 30, 	Six Months Ended June 30,
2022 	2021 	2022 	2021
Shares 	$ 	Shares 	$ 	Shares 	$ 	Shares 	$
Common stock 	165 	2 	164 	2 	167 	2 	165 	2
Additional paid-in capital
Beginning balance 	1,510 	2,405 	1,952 	2,547
Share repurchase program 	(1) 	(166) 	(2) 	(248) 	(2) 	(308) 	(3) 	(410)
ASR agreement 	— 	— 	— 	— 	(2) 	(325) 	— 	—
Share-based compensation 	— 	25 	1 	24 	1 	49 	1 	43
Stock option exercises, net 	— 	— 	— 	— 	— 	— 	— 	1
Other issuances of common stock, net 	— 	16 	6 	254 	— 	17 	6 	254
Ending balance 	1,385 	2,435 	1,385 	2,435
Common stock in treasury, at cost
Beginning balance 	(489) 	(415) 	(437) 	(376)
Other employee stock activity 	— 	(20) 	— 	(8) 	— 	(72) 	— 	(47)
Ending balance 	(509) 	(423) 	(509) 	(423)
Accumulated other comprehensive loss
Beginning balance 	(1,670) 	(1,505) 	(1,587) 	(1,368)
Other comprehensive income (loss) 	(235) 	53 	(318) 	(84)
Ending balance 	(1,905) 	(1,452) 	(1,905) 	(1,452)
Retained earnings
Beginning balance 	6,660 	5,845 	6,465 	5,628
Net income attributable to Nasdaq 	307 	341 	590 	639
Cash dividends declared per common share 	(98) 	(88) 	(186) 	(169)
Ending balance 	6,869 	6,098 	6,869 	6,098
Total Nasdaq stockholders’ equity 	5,842 	6,660 	5,842 	6,660
Noncontrolling interests
Beginning balance 	9 	2 	10 	3
Net activity related to noncontrolling interests 	— 	9 	(1) 	8
Ending balance 	9 	11 	9 	11
Total Equity 	164 $ 5,851 	169 $ 6,671 	164 $ 5,851 	169 $ 	6,671
____________
See “ASR Agreement,” of Note 11, “Nasdaq Stockholders’ Equity,” for further discussion.
In 2021, other issuances of common stock primarily related to shares accelerated and issued upon the sale of our U.S. Fixed Income business.
See accompanying notes to condensed consolidated financial statements.
(1)
(2)
(1)
(2)
4

-- 9 of 121 --

Nasdaq, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in millions)
Six Months Ended June 30,
2022 	2021
Cash flows from operating activities:
Net income 	$ 	589 $ 	639
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 	132 	131
Share-based compensation 	49 	43
Deferred income taxes 	35 	55
Extinguishment of debt 	16 	—
Net gain on divestiture of business 	— 	(84)
Net income from unconsolidated investees 	(15) 	(84)
Other reconciling items included in net income 	4 	10
Net change in operating assets and liabilities, net of effects of acquisitions:
Receivables, net 	(75) 	24
Other assets 	25 	(87)
Accounts payable and accrued expenses 	6 	(9)
Section 31 fees payable to SEC 	113 	(52)
Accrued personnel costs 	(83) 	(56)
Deferred revenue 	195 	195
Other liabilities 	(11) 	(258)
Net cash provided by operating activities 	980 	467
Cash flows from investing activities:
Purchases of securities 	(201) 	(207)
Proceeds from sales and redemptions of securities 	222 	160
Proceeds from divestiture of business, net of cash divested 	— 	190
Acquisition of businesses, net of cash and cash equivalents acquired 	(41) 	(2,430)
Purchases of property and equipment 	(77) 	(81)
Investments related to default funds and margin deposits, net 	(202) 	(90)
Other investing activities 	55 	(67)
Net cash used in investing activities 	(244) 	(2,525)
Cash flows from financing activities:
Proceeds from (repayments of) commercial paper, net 	(1) 	221
Repayments of borrowings under our credit commitment 	(499) 	(100)
Payment of debt extinguishment cost 	(16) 	—
Proceeds from issuances of debt, net of issuance costs and utilization of credit commitment 	541 	100
Repurchases of common stock 	(308) 	(410)
ASR agreement 	(325) 	—
Dividends paid 	(186) 	(169)
Proceeds received from employee stock activity and other issuances 	17 	17
Payments related to employee shares withheld for taxes 	(72) 	(47)
Default funds and margin deposits 	3,554 	(229)
Other financing activities 	(2) 	8
Net cash provided by (used in) financing activities 	2,703 	(609)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents 	(682) 	(108)
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents 	2,757 	(2,775)
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period 	5,496 	5,979
Cash and cash equivalents, restricted cash and cash equivalents at end of period 	$ 	8,253 $ 	3,204
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents
Cash and cash equivalents 	$ 	454 $ 	390
Restricted cash and cash equivalents 	30 	40
Restricted cash and cash equivalents (default funds and margin deposits) 	7,769 	2,774
Total 	$ 	8,253 $ 	3,204
Supplemental Disclosure Cash Flow Information
Interest paid 	$ 	60 $ 	70
Income taxes paid, net of refund 	$ 	133 $ 	393
__________________________
Includes payment of an acquired tax liability in the second quarter of 2021 related to the Verafin acquisition. See “2021 Acquisition,” of Note 4, “Acquisitions and Divestiture,”
for further discussion.
Includes purchases and proceeds from sales and redemptions related to the default funds and margin deposits of our clearing operations. For further information, see "Default
Fund Contributions and Margin Deposits," within Note 14, "Clearing Operations."
See accompanying notes to condensed consolidated financial statements.
(1)
(2)
(1)
(1)
(2)
5

-- 10 of 121 --

Nasdaq, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. ORGANIZATION AND NATURE OF OPERATIONS
Nasdaq is a global technology company serving the capital markets and
other industries. Our diverse offerings of data, analytics, software and
services enable clients to optimize and execute their business vision with
confidence.
We manage, operate and provide our products and services in four
business segments: Market Technology, Investment Intelligence, Corporate
Platforms, and Market Services.
Market Technology
Our Market Technology segment is a leading global technology solutions
provider and partner to exchanges, clearing organizations, central
securities depositories, regulators, banks, brokers, buy-side firms and
corporate businesses. Our solutions are utilized by leading markets in the
U.S., Europe and Asia as well as emerging markets in the Middle East,
Latin America, and Africa. The Market Technology segment includes our
Anti Financial Crime Technology business and our Marketplace
Infrastructure Technology business.
Our Anti Financial Crime Technology business includes Nasdaq Trade
Surveillance, a SaaS solution designed for brokers and other market
participants, and Market Surveillance, a solution for market infrastructure
operators. Both solutions are designed to assist in complying with market
rules, regulations and internal market surveillance policies. Our Verafin
business is a SaaS anti-financial crime management solution that offers a
cloud-based platform to help detect, investigate, and report money
laundering and fraud. Verafin also has targeted sanctions screening
solutions that help banks manage sanctions, including those imposed
against Russia. Verafin is further expanding this product to detect new
means of evasion-based typologies. In the first quarter of 2022, we
reclassified Nasdaq Risk Platform revenues from Anti Financial Crime
Technology to Marketplace Infrastructure Technology. Total Market
Technology segment revenues were unchanged.
Our Marketplace Infrastructure Technology business powers market
infrastructure operators and new market clients globally and handles a
wide array of assets, including but not limited to cash equities, equity
derivatives, currencies, various interest-bearing securities, commodities,
energy products and digital currencies. Our solutions can also be used in
the creation of new asset classes, and non-capital markets customers,
including those in insurance liabilities securitization, cryptocurrencies and
sports wagering.
Investment Intelligence
Our Investment Intelligence segment includes our Market Data, Index and
Analytics businesses.
Our Market Data business sells and distributes historical and real-time
market data to the sell-side, the institutional investing community, retail
online brokers, proprietary trading shops, other venues, internet portals and
data distributors. Our market data products can enhance transparency of
market activity within our exchanges and provide critical information to
professional and non-professional investors globally. Additionally, our
Nasdaq Cloud Data Service provided on our Data Link data dissemination
platform provides a flexible and efficient method of delivery for real-time
exchange data and other financial information.
Our Index business develops and licenses Nasdaq-branded indexes. We
also license cash-settled options, futures and options on futures on our
indexes. As of June 30, 2022, 374 ETPs listed on 29 exchanges in over 20
countries tracked a Nasdaq index and accounted for $321 billion in AUM.
Our Analytics business provides asset managers, investment consultants
and institutional asset owners with information and analytics to make data-
driven investment decisions and deploy their resources more productively.
We also provide liquidity solutions for private funds. Through our
eVestment offerings, we provide a suite of cloud-based solutions that help
institutional investors and consultants conduct pre-investment due
diligence, and monitor their portfolios post-investment. The eVestment
platform also enables asset managers to efficiently distribute information
about their firms and funds to asset owners and consultants worldwide.
Through the Solovis platform, endowments, foundations, pensions and
family offices transform how they collect and aggregate investment data,
analyze portfolio performance, model and predict future outcomes, and
share meaningful portfolio insights with key stakeholders. The Nasdaq
Fund Network and Nasdaq Data Link are additional platforms in our suite
of investment data analytics offerings and data management tools. The
Nasdaq Fund Network offers fund data services that deliver transparency
to investable products through the collection and dissemination of
performance, net asset value, valuation, and strategy-level reference data.
Nasdaq Data Link strengthens our position as a leading source for
financial, economic, and alternative datasets. For investment management
firms, investment banks and other investors, the platform powers data-
driven decision-making for users across the globe via universal application
programming interfaces, and provides for highly efficient data discovery
and delivery.
6

-- 11 of 121 --

Corporate Platforms
Our Corporate Platforms segment includes our Listing Services and IR &
ESG Services businesses. These businesses deliver critical capital market
and ESG solutions across the lifecycle of public and private companies.
Our Listing Services business includes our U.S. and European Listing
Services businesses. We operate a variety of listing platforms around the
world to provide multiple global capital raising solutions for public
companies. Our main listing markets are The Nasdaq Stock Market and the
Nasdaq Nordic and Nasdaq Baltic exchanges. Through Nasdaq First
North, our Nordic and Baltic operations also offer alternative marketplaces
for smaller companies and growth companies. In July 2021, we
contributed our NPM business, which was included in our Listing Services
business, to a standalone, independent company, of which we own the
largest minority interest, together with a consortium of third-party
financial institutions. The NPM business provides liquidity solutions for
private companies to enable employees, investors, and companies to
execute transactions.
As of June 30, 2022, there were 4,269 total listings on The Nasdaq Stock
Market, including 465 ETPs. The combined market capitalization was
approximately $20.3 trillion. In Europe, the Nasdaq Nordic and Nasdaq
Baltic exchanges, together with Nasdaq First North, were home to 1,260
listed companies with a combined market capitalization of approximately
$1.8 trillion.
We also operate a U.S. Corporate Bond exchange for the listing of
corporate bonds. This exchange operates pursuant to The Nasdaq Stock
Market exchange license and is powered by the NFF. As of June 30, 2022,
102 corporate bonds were listed on the Corporate Bond exchange. We
continue to develop the Nasdaq Sustainable Bond Network, a platform for
increased transparency in the global sustainable bond markets.
Our IR & ESG Services include our portfolio of products and services that
support corporations’ investor relations and ESG functions. Our clients
include both public and private companies and organizations. Our public
company clients can be companies listed on our exchanges or other U.S.
and global exchanges. Our private company clients include a diverse group
of organizations ranging from family owned companies, government
organizations, law firms, privately held entities, various non-profit
organizations to hospitals and health care systems. We help organizations
enhance their ability to understand and expand their global shareholder
base, improve corporate governance, and navigate the evolving ESG
landscape through our suite of advanced technology, analytics, reporting
and consultative services. In June 2022, we acquired Metrio Software Inc.,
or Metrio, a provider of ESG data collection, analytics and reporting
services based in Montreal, Canada. We plan to integrate Metrio’s SaaS
platform into our suite of ESG solutions.
Market Services
Our Market Services segment includes our Equity Derivative Trading and
Clearing, Cash Equity Trading, FICC and Trade Management Services
businesses. We operate multiple exchanges and other marketplace facilities
across several asset classes, including derivatives, commodities, cash
equity, debt, structured products and ETPs. In addition, in certain countries
where we operate exchanges, we also provide clearing, settlement and
central depository services. In June 2022, we completed the wind-down of
our Nordic broker services business.
Our transaction-based platforms provide market participants with the
ability to access, process, display and integrate orders and quotes. The
platforms allow the routing and execution of buy and sell orders as well as
the reporting of transactions, providing fee-based revenues.
In the U.S., we operate six options exchanges and three cash equity
exchanges. The Nasdaq Stock Market, the largest of our cash equities
exchanges, is the largest single venue of liquidity for trading U.S.-listed
cash equities.
In Canada, we operate an exchange with three independent markets for the
trading of Canadian-listed securities: Nasdaq Canada CXC, Nasdaq
Canada CX2 and Nasdaq Canada CXD.
In Europe, we operate exchanges in Stockholm (Sweden), Copenhagen
(Denmark), Helsinki (Finland), and Reykjavik (Iceland), as well as the
clearing operations of Nasdaq Clearing, as Nasdaq Nordic. We also
operate exchanges in Tallinn (Estonia), Riga (Latvia) and Vilnius
(Lithuania) as Nasdaq Baltic. Collectively, Nasdaq Nordic and Nasdaq
Baltic offer trading in cash equities, depository receipts, warrants,
convertibles, rights, fund units and ETFs, as well as trading and clearing of
equity derivatives, fixed income and commodity products. We also own a
majority stake in Puro.earth, a Finnish-based leading marketplace for
carbon removal.
Nasdaq Fixed Income provides a wide range of products and services, such
as trading and clearing, for fixed income products in Sweden, Denmark,
Finland, Iceland, Estonia, Lithuania and Latvia.
Nasdaq Commodities is the brand name for Nasdaq’s European
commodity-related products and services. Nasdaq Commodities’ offerings
include derivatives in power, natural gas and carbon emission markets,
seafood, electricity certificates and clearing services. These products are
listed on Nasdaq Oslo ASA, except for seafood, which is listed on
Fishpool, a third-party platform.
In June 2021, we sold our U.S. Fixed Income business, which included an
electronic platform for the trading of U.S. Treasuries. See “2021
Divestiture” of Note 4, “Acquisitions and Divestiture,” for further
discussion.
7

-- 12 of 121 --

Through our Trade Management Services business, we provide market
participants with a wide variety of alternatives for connecting to and
accessing our markets. Our marketplaces may be accessed via a number of
different protocols used for quoting, order entry, trade reporting, and
connectivity to various data feeds. In 2021, we launched WorkX, an
upgraded version of Nasdaq Workstation, a browser-based, front-end
interface that allows market participants to report OTC transactions,
monitor trade compliance and clear securities subject to Reg NMS. WorkX
enables a seamless workflow and enhanced trade intelligence. In the
Nordics we provide a similar browser based trading application called
Nasdaq Nordic Trader. In addition, we offer a variety of add-on
compliance tools to help firms comply with regulatory requirements.
We provide colocation services to market participants, whereby we offer
firms cabinet space and power to house their own equipment and servers
within our data centers. Additionally, we offer a number of wireless
connectivity offerings between select data centers using millimeter wave
and microwave technology.
2. BASIS OF PRESENTATION AND PRINCIPLES OF
CONSOLIDATION
The condensed consolidated financial statements are prepared in
accordance with U.S. GAAP and include the accounts of Nasdaq, its
wholly-owned subsidiaries and other entities in which Nasdaq has a
controlling financial interest. When we do not have a controlling interest in
an entity, but exercise significant influence over the entity’s operating and
financial policies, such investment is accounted for under the equity
method of accounting. We recognize our share of earnings or losses of an
equity method investee based on our ownership percentage. See “Equity
Method Investments,” of Note 6, “Investments,” for further discussion of
our equity method investments.
The accompanying condensed consolidated financial statements reflect all
adjustments which are, in the opinion of management, necessary for a fair
statement of the results. These adjustments are of a normal recurring
nature. All significant intercompany accounts and transactions have been
eliminated in consolidation.
As permitted under U.S. GAAP, certain footnotes or other financial
information can be condensed or omitted in the interim condensed
consolidated financial statements. The information included in this
Quarterly Report on Form 10-Q should be read in conjunction with the
consolidated financial statements and accompanying notes included in
Nasdaq’s Form 10-K. The year-end condensed balance sheet data was
derived from the audited financial statements, but does not include all
disclosures required by U.S. GAAP.
Certain prior year amounts have been reclassified to conform
to the current year presentation.
During the fourth quarter of 2021, we began adjusting the presentation of
cash and cash equivalents held within default funds and margin deposits on
the condensed consolidated statement of cash flows from operating
activities, to present them as restricted cash and cash equivalents with the
associated changes being included within cash flows from investing and
financing activities. These balances cannot be used to satisfy operating or
other liabilities. See Note 14, “Clearing Operations,” for further discussion
of the default funds and margin deposits.
Prior period amounts have also been adjusted to conform to current period
presentation. This immaterial adjustment had no impact on our previously
reported Condensed Consolidated Balance Sheets, Condensed
Consolidated Statements of Income, or Condensed Consolidated
Statements of Comprehensive Income. The table below presents a
summary of the as reported and adjusted amounts relating to the
Condensed Consolidated Statement of Cash Flows for the six months
ended June 30, 2021.
Six Months Ended June 30, 2021
As Reported 	Adjustment 	Adjusted
(in millions)
Net cash provided by operating activities $ 	467 $ 	— $ 	467
Net cash used in investing activities 	(2,435) 	(90) 	(2,525)
Net cash used in financing activities 	(380) 	(229) 	(609)
Effect of exchange rate changes on cash,
cash equivalents, restricted cash and
cash equivalents 	(4) 	(104) 	(108)
Net decrease in cash, cash equivalents,
restricted cash and cash equivalents 	(2,352) 	(423) 	(2,775)
Cash, cash equivalents, restricted cash
and cash equivalents at beginning of
period 	2,782 	3,197 	5,979
Cash, cash equivalents, restricted cash
and cash equivalents at end of period $ 	430 $ 	2,774 $ 	3,204
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash
Equivalents
Cash and cash equivalents 	$ 	390 $ 	— $ 	390
Restricted cash and cash equivalents 	40 	— 	40
Restricted cash and cash equivalents
(Default funds and margin deposits) 	— 	2,774 	2,774
Total 	$ 	430 $ 	2,774 $ 	3,204
Accounting Estimates
In preparing our condensed consolidated financial statements, we make
assumptions, judgments and estimates that can have a significant impact
on our revenue, operating income and net income, as well as on the value
of certain assets and liabilities in our condensed consolidated balance
sheets. At least quarterly, we evaluate our assumptions, judgments and
estimates, and make changes as deemed necessary.
8

-- 13 of 121 --

Subsequent Event
We have evaluated subsequent events through the issuance date of this
Quarterly Report on Form 10-Q. In July 2022, we amended and restated
our certificate of incorporation to increase our authorized shares to
930,000,000, consisting of 30,000,000 shares of preferred stock, par value
$0.01 per share and 900,000,000 shares of common stock, par value $0.01
per share, in order to effect a stock split in the form of a stock dividend.
For discussion of our 3-for-1 stock split in the form of a stock dividend,
see "Stock Split," of Note 11, “Nasdaq Stockholders' Equity.”
3. REVENUE FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue
The following tables summarize the disaggregation of revenue by major
product and service and by segment for the three and six months ended
June 30, 2022 and 2021:
Three Months Ended June 30,
2022 	2021
(in millions)
Market Technology
Anti Financial Crime Technology 	$ 	75 $ 	58
Marketplace Infrastructure Technology 	56 	59
Investment Intelligence
Market data 	105 	104
Index 	124 	107
Analytics 	54 	50
Corporate Platforms
Listing services 	107 	93
IR & ESG Services 	61 	56
Market Services
Transaction-based trading and clearing,
net 	223 	227
Trade management services 	87 	81
Other revenues 	1 	11
Revenues less transaction-based
expenses 	$ 	893 $ 	846
Substantially all revenues from the Market Technology, Investment
Intelligence and Corporate Platforms segments were recognized over time
for the three months ended June 30, 2022 and 2021. For the three months
ended June 30, 2022 and 2021 approximately 69.2% and 70.8%,
respectively, of Market Services revenues were recognized at a point in
time and 30.8% and 29.2%, respectively, were recognized over time.
Six Months Ended June 30,
2022 	2021
(in millions)
Market Technology
Anti Financial Crime Technology 	$ 	147 $ 	101
Marketplace Infrastructure Technology 	108 	116
Investment Intelligence
Market data 	213 	209
Index 	246 	209
Analytics 	108 	98
Corporate Platforms
Listing services 	214 	184
IR & ESG Services 	122 	112
Market Services
Transaction-based trading and clearing,
net 	454 	483
Trade management services 	171 	161
Other revenues 	2 	24
Revenues less transaction-based
expenses 	$ 	1,785 $ 	1,697
Substantially all revenues from the Market Technology, Investment
Intelligence and Corporate Platforms segments were recognized over time
for the six months ended June 30, 2022 and 2021. For the six months
ended June 30, 2022 and 2021 approximately 69.8% and 72.0%,
respectively, of Market Services revenues were recognized at a point in
time and 30.2% and 28.0%, respectively, were recognized over time.
Contract Balances
Substantially all of our revenues are considered to be revenues from
contracts with customers. The related accounts receivable balances are
recorded in our Condensed Consolidated Balance Sheets as receivables,
which are net of allowance for doubtful accounts of $15 million as of June
30, 2022 and $17 million as of December 31, 2021. The changes in the
balance between periods were immaterial. We do not have obligations for
warranties, returns or refunds to customers.
For the majority of our contracts with customers, except for our
marketplace infrastructure technology and listings services contracts, our
performance obligations range from three months to three years and there
is no significant variable consideration.
Deferred revenue is the only significant contract asset or liability as of
June 30, 2022. Deferred revenue represents consideration received that is
yet to be recognized as revenue for unsatisfied performance obligations.
Deferred revenue primarily represents our contract liabilities related to our
fees for Market Technology, Investment Intelligence, Annual and Initial
Listings, and IR & ESG Services contracts. See Note 7, “Deferred
Revenue,” for our discussion on deferred revenue balances, activity, and
expected timing of recognition.
9

-- 14 of 121 --

We do not have a material amount of revenue recognized from
performance obligations that were satisfied in prior periods. We do not
provide disclosures about transaction price allocated to unsatisfied
performance obligations if contract durations are less than one year. For
our initial listings the transaction price allocated to remaining performance
obligations is included in deferred revenue. For our Market Technology,
Analytics, and IR & ESG contracts, the portion of transaction price
allocated to unsatisfied performance obligations is presented in the table
below. To the extent consideration has been received, unsatisfied
performance obligations would be included in the table below as well as
deferred revenue.
The following table summarizes the amount of the transaction price
allocated to performance obligations that are unsatisfied, for contract
durations greater than one year, as of June 30, 2022:
Market
Technology 	Analytics
IR & ESG
Services 	Total
(in millions)
Remainder of 2022 $ 	269 $ 	34 $ 	35 $ 	338
2023 	461 	52 	47 	560
2024 	218 	27 	17 	262
2025 	137 	10 	3 	150
2026 	84 	7 	— 	91
2027+ 	137 	5 	— 	142
Total 	$ 	1,306 $ 	135 $ 	102 $ 1,543
4. ACQUISITIONS AND DIVESTITURE
We completed the following acquisitions and divestiture in 2022 and 2021.
Financial results of each transaction are included in our condensed
consolidated financial statements from the date of each acquisition.
2022 Acquisition
In June 2022, we acquired Metrio, a provider of ESG data collection,
analytics and reporting services based in Montreal, Canada. We plan to
integrate Metrio’s SaaS platform into our suite of ESG solutions. Metrio is
part of our IR & ESG business in our Corporate Platforms segment.
2021 Divestiture
In June 2021, we sold our U.S. Fixed Income business, which was part of
our FICC business within our Market Services segment, to Tradeweb
Markets Inc. We recognized a pre-tax gain on the sale of $84 million, net
of disposal costs. The pre-tax gain was included in net gain on divestiture
of business in the Condensed Consolidated Statements of Income.
In connection with this sale, we issued approximately 6.2 million shares of
Nasdaq common stock. Nasdaq used the proceeds from the sale, available
tax benefits and working and clearing capital of this business, as well as
other sources of cash, to repurchase shares of Nasdaq common stock to
reduce the impact on earnings per share dilution from the sale. To facilitate
these repurchases, in June 2021, the board of directors authorized an
increase to the share repurchase program. These repurchases were
completed during the second quarter of 2022. See “Share Repurchase
Program,” of Note 11, “Nasdaq Stockholders' Equity,” for further
discussion.
2021 Acquisition
Acquisition of Verafin
In February 2021, we completed the acquisition of Verafin, a SaaS
technology provider of anti-financial crime management solutions that
provides a cloud-based platform to help detect, investigate, and report
money laundering and fraud, for an aggregate purchase price of $2.75
billion, subject to certain adjustments. The $2.75 billion purchase price
includes a cash payment of $102 million, reflected in cash from operating
activities in our Condensed Consolidated Statements of Cash Flows, the
release of which is subject to certain employment-related conditions over
three years following the closing of the transaction. This payment was
recorded as a prepaid expense and is recorded in other current and non-
current assets in our Condensed Consolidated Balance Sheets and will be
amortized to merger and strategic initiatives expense on a straight-line
basis over a three-year period. Verafin is part of our Market Technology
segment.
The amounts in the table below represent the final allocation of the
purchase price. The allocation of the purchase price was subject to revision
during the measurement period, a period not to exceed 12 months from the
acquisition date. Adjustments to the provisional values, which may include
tax and other estimates, during the measurement period are recorded in the
reporting period in which the adjustment amounts are determined. In 2021,
we recorded a measurement period adjustment of $9 million. This
adjustment resulted in an increase to both total net liabilities acquired and
goodwill. This adjustment did not result in an impact to our Condensed
Consolidated Statements of Income. The allocation of the purchase price
for Verafin was finalized in the first quarter of 2022.
(in millions)
Goodwill 	$ 	1,882
Acquired Intangible Assets 	815
Total Net Liabilities Acquired 	(46)
Purchase Consideration 	$ 	2,651
10

-- 15 of 121 --

Intangible Assets
The following table presents the details of acquired intangible assets for
Verafin at the date of acquisition. Acquired intangible assets with finite
lives are amortized using the straight-line method.
Customer
Relationships 	Technology
Trade
Name
Total Acquired
Intangible
Assets
Intangible asset value
(in millions) 	$ 	532 $ 	246 $ 	37 $ 	815
Discount rate used 	7.5 % 	7.5 % 	7.5 %
Estimated average
useful life 	22 years 	7 years 	20 years
Customer Relationships
Customer relationships represent the non-contractual and contractual
relationships with customers.
Methodology
Customer relationships were valued using the income approach,
specifically an excess earnings method. The excess earnings method
examines the economic returns contributed by the identified tangible and
intangible assets of a company, and then isolates the excess return that is
attributable to the intangible asset being valued.
Discount Rate
The discount rate used reflects the amount of risk associated with the
hypothetical cash flows for the customer relationships relative to the
overall business. In developing a discount rate for the customer
relationships, we estimated a weighted-average cost of capital for the
overall business and we utilized this rate as an input when discounting the
cash flows. The resulting discounted cash flows were then tax-effected at
the applicable statutory rate.
For our acquisition of Verafin, a discounted tax amortization benefit was
added to the fair value of the assets under the assumption that the customer
relationships would be amortized for tax purposes over a period of 20
years.
Estimated Useful Life
We estimate the useful life based on the historical behavior of the
customers and a parallel analysis of the customers using the excess
earnings method.
Technology
As part of our acquisition of Verafin, we acquired developed technology.
Methodology
The developed technology was valued using the income approach,
specifically the relief-from-royalty method, or RFRM. The RFRM is used
to estimate the cost savings that accrue to the owner of an intangible asset
who would otherwise have to pay royalties or license fees on revenues
earned through the use of the asset. The royalty rate is applied to the
projected revenue over the expected remaining life of the intangible asset
to estimate royalty savings. The net after-tax royalty savings are calculated
for each year in the remaining economic life of the technology and
discounted to present value.
Discount Rate
The discount rates used reflect the amount of risk associated with the
hypothetical cash flows for the developed technology relative to the
overall business as discussed above in “Customer Relationships.”
Estimated Useful Life
We have estimated the useful life of the Verafin technology to be 7 years.
Trade Name
As part of our acquisition of Verafin, we acquired a trade name. The trade
name is recognized in the industry and carries a reputation for quality. As
such, the reputation and positive recognition embodied in the trade name is
a valuable asset to Nasdaq.
Methodology
The Verafin trade name was valued using the income approach,
specifically the RFRM as discussed above in “Technology.”
Discount Rate
The discount rate used reflects the amount of risk associated with the
hypothetical cash flows for the trade name relative to the overall business
as discussed above in “Customer Relationships.”
Estimated Useful Life
We have estimated the useful life of the Verafin trade name to be 20 years
and our intention is to continue to use it in the branding of products.
Pro Forma Results and Acquisition-Related Costs
The condensed consolidated financial statements for the three and six
months ended June 30, 2022 and 2021 include the financial results of the
above acquisitions from the date of the acquisitions. Pro forma financial
results have not been presented since these acquisitions were not material
to our financial results.
Acquisition-related costs for the transactions described above
were expensed as incurred and are included in merger and strategic
initiatives expense in the Condensed Consolidated Statements of Income.
11

-- 16 of 121 --

5. GOODWILL AND ACQUIRED INTANGIBLE ASSETS
Goodwill
The following table presents the changes in goodwill by business segment
during the six months ended June 30, 2022:
(in millions)
Market Technology
Balance at December 31, 2021 	$ 	2,171
Foreign currency translation adjustments 	(28)
Balance at June 30, 2022 	$ 	2,143
Investment Intelligence
Balance at December 31, 2021 	$ 	2,428
Foreign currency translation adjustments 	(107)
Balance at June 30, 2022 	$ 	2,321
Corporate Platforms
Balance at December 31, 2021 	$ 	469
Goodwill acquired 	40
Foreign currency translation adjustments 	(22)
Balance at June 30, 2022 	$ 	487
Market Services
Balance at December 31, 2021 	$ 	3,365
Foreign currency translation adjustments 	(165)
Balance at June 30, 2022 	$ 	3,200
Total
Balance at December 31, 2021 	$ 	8,433
Goodwill acquired 	40
Foreign currency translation adjustments 	(322)
Balance at June 30, 2022 	$ 	8,151
As of June 30, 2022, the amount of goodwill that is expected
to be deductible for tax purposes in future periods is $40 million.
Goodwill represents the excess of purchase price over the value assigned
to the net assets, including identifiable intangible assets, of a business
acquired. Goodwill is allocated to our reporting units based on the
assignment of the fair values of each reporting unit of the acquired
company. We test goodwill for impairment at the reporting unit level
annually, or in interim periods if certain events occur indicating that the
carrying amount may be impaired, such as changes in the business climate,
poor indicators of operating performance or the sale or disposition of a
significant portion of a reporting unit. There was no impairment of
goodwill for the three and six months ended June 30, 2022 and 2021;
however, events such as prolonged economic weakness or unexpected
significant declines in operating results of any of our reporting units or
businesses, may result in goodwill impairment charges in the future.
Acquired Intangible Assets
The following table presents details of our total acquired intangible assets,
both finite- and indefinite-lived:
June 30, 2022 December 31, 2021
Finite-Lived Intangible Assets 	(in millions)
Gross Amount
Technology 	$ 	305 $ 	295
Customer relationships 	2,009 	2,050
Trade names and other 	60 	60
Foreign currency translation adjustment 	(199) 	(143)
Total gross amount 	$ 	2,175 $ 	2,262
Accumulated Amortization
Technology 	$ 	(75) $ 	(54)
Customer relationships 	(727) 	(711)
Trade names and other 	(14) 	(11)
Foreign currency translation adjustment 	111 	81
Total accumulated amortization 	$ 	(705) $ 	(695)
Net Amount
Technology 	$ 	230 $ 	241
Customer relationships 	1,282 	1,339
Trade names and other 	46 	49
Foreign currency translation adjustment 	(88) 	(62)
Total finite-lived intangible assets 	$ 	1,470 $ 	1,567
Indefinite-Lived Intangible Assets
Exchange and clearing registrations 	$ 	1,257 $ 	1,257
Trade names 	121 	121
Licenses 	52 	52
Foreign currency translation adjustment 	(230) 	(184)
Total indefinite-lived intangible assets $ 	1,200 $ 	1,246
Total intangible assets, net 	$ 	2,670 $ 	2,813
There was no impairment of indefinite-lived intangible assets for the three
and six months ended June 30, 2022 and 2021.
12

-- 17 of 121 --

The following table presents our amortization expense for acquired finite-
lived intangible assets:
Three Months Ended June 30,
2022 	2021
(in millions)
Amortization expense 	$ 	39 $ 	40
Six Months Ended June 30,
2022 	2021
(in millions)
Amortization expense 	$ 	78 $ 	76
The table below presents the estimated future amortization expense
(excluding the impact of foreign currency translation adjustments of $88
million as of June 30, 2022) of acquired finite-lived intangible assets as of
June 30, 2022:
(in millions)
Remainder of 2022 	$ 	80
2023 	159
2024 	153
2025 	151
2026 	148
2027+ 	867
Total 	$ 	1,558
6. INVESTMENTS
The following table presents the details of our investments:
June 30, 2022 	December 31, 2021
(in millions)
Financial investments 	$ 	161 $ 	208
Equity method investments 	$ 	377 $ 	363
Equity securities 	$ 	63 $ 	67
Financial Investments
Financial investments are comprised of trading securities, primarily highly
rated European government debt securities, of which $147 million as of
June 30, 2022 and $162 million as of December 31, 2021, are assets
primarily utilized to meet regulatory capital requirements, mainly for our
clearing operations at Nasdaq Clearing.
Equity Method Investments
We record our estimated pro-rata share of earnings or losses each reporting
period and record any dividends as a reduction in the investment balance.
As of June 30, 2022 and 2021, our equity method investments primarily
included our 40.0% equity interest in OCC.
The carrying amounts of our equity method investments are included in
other non-current assets in the Condensed Consolidated Balance Sheets.
No material impairments were recorded for the three and six months end
June 30, 2022 and 2021.
Net income recognized from our equity interest in the earnings and losses
of these equity method investments, primarily OCC, was $9 million for the
three months ended June 30, 2022, $27 million for the three months ended
June 30, 2021, $15 million for the six months ended June 30, 2022 and
$84 million for the six months ended June 30, 2021. For the three and six
months ended June 30, 2022, lower equity interest in the earnings of OCC,
as compared to 2021, was primarily driven by a reduction in the clearing
fee rate that OCC charges its customers, partially offset by elevated U.S.
industry trading volumes.
Equity Securities
The carrying amounts of our equity securities are included in other non-
current assets in the Condensed Consolidated Balance Sheets. We elected
the measurement alternative for substantially all of our equity securities as
they do not have a readily determinable fair value. No material
adjustments were made to the carrying value of our equity securities for
the three and six months ended June 30, 2022 and 2021. As of June 30,
2022 and December 31, 2021, our equity securities primarily represent
various strategic investments made through our corporate venture program
as well as investments acquired through various acquisitions.
7. DEFERRED REVENUE
Deferred revenue represents consideration received that is yet to be
recognized as revenue. The changes in our deferred revenue during the six
months ended June 30, 2022 are reflected in the following table:
Balance at
December 31, 2021 Additions Revenue
Recognized 	Adjustments Balance at June
30, 2022
(in millions)
Market
Technology $ 	117 $ 	87 $ 	(84) $ 	(5) $ 	115
Investment
Intelligence 	106 	82 	(70) 	— 	118
Corporate Platforms:
Initial Listing 	145 	20 	(30) 	(2) 	133
Annual Listings 	2 	180 	(1) 	(1) 	180
IR & ESG
Services 	57 	45 	(39) 	(1) 	62
Other 	21 	7 	(6) 	(2) 	20
Total 	$ 	448 $ 421 $ 	(230) $ 	(11) $ 	628
In the above table:
• Additions primarily reflect deferred revenue billed in the current period,
net of recognition.
• Revenue recognized includes revenue recognized during the current
period that was included in the beginning balance.
• Adjustments reflect foreign currency translation adjustments.
• Other primarily includes deferred revenue from non-U.S. listing of
additional shares fees. Listing of additional shares fees are included in
our Listing Services business.
13

-- 18 of 121 --

As of June 30, 2022, we estimate that our deferred revenue will be
recognized in the following years:
Fiscal year
ended: 	2022 	2023 	2024 	2025 	2026 	2027+ 	Total
(in millions)
Market
Technology $ 87 $ 27 $ 	1 $ — $ — $ — $ 115
Investment
Intelligence 	87 	31 	— 	— 	— 	— 	118
Corporate Platforms:
Initial Listings 	24 	38 	28 	19 	16 	8 	133
Annual Listings 	180 	— 	— 	— 	— 	— 	180
IR & ESG
Services 	50 	12 	— 	— 	— 	— 	62
Other 	6 	6 	5 	2 	1 	— 	20
Total 	$ 434 $ 114 $ 34 $ 21 $ 17 $ 	8 $ 628
In the above table, 2022 represents the remaining six months of 2022.
The timing of recognition of deferred revenue related to certain
marketplace infrastructure technology contracts is primarily dependent
upon the completion of customization and any significant modifications
made pursuant to existing market technology contracts. As such, as it
relates to market technology revenues, the timing represents our best
estimate.
8. DEBT OBLIGATIONS
The following table presents the changes in the carrying amount of our
debt obligations during the six months ended June 30, 2022:
December 31,
2021 	Additions
Payments,
Foreign
Currency
Translation and
Accretion 	June 30, 2022
(in millions)
Short-term debt:
Commercial
paper 	$ 	420 $ 2,485 $ (2,484) $ 	421
2022 Notes 	598 	— 	1 	599
2024 Notes 	499 	— 	(499) 	—
Total short-term
debt 	$ 	1,517 $ 2,485 $ (2,982) $ 	1,020
Long-term debt - senior unsecured notes:
2026 Notes 	498 	— 	— 	498
2029 Notes 	676 	— 	(53) 	623
2030 Notes 	676 	— 	(53) 	623
2050 Notes 	486 	— 	— 	486
2031 Notes 	643 	— 	1 	644
2040 Notes 	644 	— 	— 	644
2033 Notes 	694 	— 	(54) 	640
2052 Notes 	— 	541 	— 	541
2020 Credit
Facility 	(4) 	— 	1 	(3)
Total long-term
debt 	$ 	4,313 $ 	541 $ 	(158) $ 	4,696
Total debt
obligations 	$ 	5,830 $ 3,026 $ (3,140) $ 	5,716
In the table above, the 2024 Notes were reclassified to short-term debt as
of March 31, 2022.
The long-term debt senior unsecured notes in the table above, and
discussion below, are listed based on their issuance date.
Commercial Paper Program
Our U.S. dollar commercial paper program is supported by our 2020
Credit Facility which provides liquidity support for the repayment of
commercial paper issued through this program. See “2020 Credit Facility”
below for further discussion. The effective interest rate of commercial
paper issuances fluctuates as short term interest rates and demand
fluctuate. The fluctuation of these rates may impact our interest expense.
In January 2022, we issued commercial paper to partially fund our ASR
agreement. See “ASR Agreement,” of Note 11, “Nasdaq Stockholders'
Equity." As of June 30, 2022, we had $421 million outstanding under our
commercial paper program.
14

-- 19 of 121 --

Senior Unsecured Notes
Our 2022 and 2040 Notes were issued at par. All of our other outstanding
senior unsecured notes were issued at a discount. As a result of the
discount, the proceeds received from each issuance were less than the
aggregate principal amount. As of June 30, 2022, the amounts in the table
above reflect the aggregate principal amount, less the unamortized debt
discount and the unamortized debt issuance costs, which are being
accreted through interest expense over the life of the applicable notes. For
our Euro denominated notes, the “Payments, Foreign Currency Translation
and Accretion” column also includes the impact of foreign currency
translation. Our senior unsecured notes are general unsecured obligations
which rank equally with all of our existing and future unsubordinated
obligations and are not guaranteed by any of our subsidiaries. The senior
unsecured notes were issued under indentures that, among other things,
limit our ability to consolidate, merge or sell all or substantially all of our
assets, create liens, and enter into sale and leaseback transactions. The
senior unsecured notes may be redeemed by Nasdaq at any time, subject to
a make-whole amount.
Upon a change of control triggering event (as defined in the various
supplemental indentures governing the applicable notes), the terms require
us to repurchase all or part of each holder’s notes for cash equal to 101%
of the aggregate principal amount purchased plus accrued and unpaid
interest, if any.
Early Extinguishment of 2024 Notes
In May 2014, Nasdaq issued the 2024 Notes, which paid interest
semiannually at a rate of 4.25% per annum. In April 2022, we primarily
used the net proceeds from the 2052 Notes to repay in full and redeem our
2024 Notes. For further discussion see “2052 Notes” below. In connection
with the early extinguishment of the 2024 Notes, in April 2022 we
recorded a pre-tax charge of $16 million, which primarily includes a make-
whole redemption price premium.
2026 Notes
In June 2016, Nasdaq issued the 2026 Notes, which pay interest semi-
annually at a rate of 3.85% per annum until June 30, 2026. Such interest
rate may vary with Nasdaq’s debt rating, to the extent Nasdaq is
downgraded below investment grade, up to a rate not to exceed 5.85%.
2029 Notes
In April 2019, Nasdaq issued the 2029 Notes, which pay interest annually
at a rate of 1.75% per annum until March 28, 2029. Such interest rate may
vary with Nasdaq’s debt rating, to the extent Nasdaq is downgraded below
investment grade, up to a rate not to exceed 3.75%.
The 2029 Notes have been designated as a hedge of our net investment in
certain foreign subsidiaries to mitigate the foreign exchange risk
associated with certain investments in these subsidiaries. The decrease in
the carrying amount of $53 million noted in the “Payments, Foreign
Currency Translation and Accretion” column in the table above primarily
reflects the remeasurement of the 2029 Notes into U.S. dollars and is
recorded in accumulated other comprehensive loss within Nasdaq's
stockholders’ equity in the Condensed Consolidated Balance Sheets as of
June 30, 2022.
2030 Notes
In February 2020, Nasdaq issued the 2030 Notes, which pay interest
annually at a rate of 0.875% in arrears, which began on February 13, 2021.
The 2030 Notes were designated as a hedge of our net investment in
certain foreign subsidiaries to mitigate the foreign exchange risk
associated with certain investments in these subsidiaries. The decrease in
the carrying amount of $53 million noted in the “Payments, Foreign
Currency Translation and Accretion” column in the table above primarily
reflects the remeasurement of the 2030 Notes into U.S. dollars and is
recorded in accumulated other comprehensive loss within Nasdaq's
stockholders’ equity in the Condensed Consolidated Balance Sheets as of
June 30, 2022.
2050 Notes
In April 2020, Nasdaq issued the 2050 Notes, which pay interest semi-
annually at a rate of 3.25% per annum until April 28, 2050. Such rate may
vary with Nasdaq's debt rating, to the extent Nasdaq is downgraded below
investment grade, up to a rate not to exceed 5.25%.
2022, 2031 and 2040 Notes
In December 2020, Nasdaq issued the 2022, 2031 and 2040 Notes. The net
proceeds were used to partially fund the acquisition of Verafin. For further
discussion of the acquisition of Verafin, see “2021 Acquisition,” of Note 4,
“Acquisitions and Divestiture.”
2022 Notes
The 2022 Notes pay interest semi-annually in arrears, which began on June
21, 2021. The interest rate of 0.445% may vary with Nasdaq's debt rating,
to the extent Nasdaq is downgraded below investment grade, up to a rate
not to exceed 2.445%.
2031 Notes
The 2031 Notes pay interest semi-annually in arrears, which began on
January 15, 2021. The interest rate of 1.650% may vary with Nasdaq's debt
rating, to the extent Nasdaq is downgraded below investment grade, up to
a rate not to exceed 3.65%.
15

-- 20 of 121 --

2040 Notes
The 2040 Notes pay interest semi-annually in arrears, which began on June
21, 2021. The interest rate of 2.500% may vary with Nasdaq's debt rating,
to the extent Nasdaq is downgraded below investment grade, up to a rate
not to exceed 4.50%.
2033 Notes
In July 2021, Nasdaq issued the 2033 Notes, which pay interest annually in
arrears, at a rate of 0.900%, beginning on July 30, 2022.
The 2033 Notes have been designated as a hedge of our net investment in
certain foreign subsidiaries to mitigate the foreign exchange risk
associated with certain investments in these subsidiaries. The decrease in
the carrying amount of $54 million noted in the “Payments, Foreign
Currency Translation and Accretion” column in the table above primarily
reflects the remeasurement of the 2033 Notes into U.S. dollars and is
recorded in accumulated other comprehensive loss within Nasdaq
stockholders’ equity in the Condensed Consolidated Balance Sheets as of
June 30, 2022.
2052 Notes
In March 2022, Nasdaq issued $550 million aggregate principal amount of
3.950% senior notes due in 2052, which pay interest semi-annually in
arrears, beginning on September 7, 2022. The interest rate of 3.950% may
vary with Nasdaq's debt rating, to the extent Nasdaq is downgraded below
investment grade, up to a rate not to exceed 5.950%. The net proceeds
from the 2052 Notes were approximately $541 million after deducting the
underwriting discount and expenses of the offering. We used the net
proceeds from the 2052 Notes to redeem all of the 2024 Notes in April
2022.
Credit Facilities
2020 Credit Facility
In December 2020, Nasdaq entered into the 2020 Credit Facility, which
replaced a former credit facility and consists of a $1.25 billion five-year
revolving credit facility (with sublimits for non-dollar borrowings,
swingline borrowings and letters of credit). Nasdaq intends to use funds
available under the 2020 Credit Facility for general corporate purposes and
to provide liquidity support for the repayment of commercial paper issued
through the commercial paper program. Nasdaq is permitted to repay
borrowings under our 2020 Credit Facility at any time in whole or in part,
without penalty.
As of June 30, 2022, no amounts were outstanding on the 2020 Credit
Facility. The $(3) million balance represents unamortized debt issuance
costs which are being accreted through interest expense over the life of the
credit facility.
Borrowings under the revolving credit facility and swingline borrowings
bear interest on the principal amount outstanding at a variable interest rate
based on either the LIBOR (or a successor rate to LIBOR), the base rate
(as defined in the credit agreement), or other applicable rate with respect to
non-dollar borrowings, plus an applicable margin that varies with Nasdaq’s
debt rating. We are charged commitment fees of 0.125% to 0.350%,
depending on our credit rating, whether or not amounts have been
borrowed. These commitment fees are included in interest expense and
were not material for the three and six months ended June 30, 2022 and
2021.
The 2020 Credit Facility contains financial and operating covenants.
Financial covenants include a maximum leverage ratio. Operating
covenants include, among other things, limitations on Nasdaq’s ability to
incur additional indebtedness, grant liens on assets, dispose of assets and
make certain restricted payments. The facility also contains customary
affirmative covenants, including access to financial statements, notice of
defaults and certain other material events, maintenance of properties and
insurance, and customary events of default, including cross-defaults to our
material indebtedness.
The 2020 Credit Facility includes an option for Nasdaq to increase the
available aggregate amount by up to $625 million, subject to the consent
of the lenders funding the increase and certain other conditions.
Other Credit Facilities
Certain of our European subsidiaries have several other credit facilities,
which are available in multiple currencies, primarily to support our Nasdaq
Clearing operations in Europe, as well as to provide a cash pool credit line
for one subsidiary. These credit facilities, in aggregate, totaled $188
million as of June 30, 2022 and $212 million as of December 31, 2021 in
available liquidity, none of which was utilized. Generally, these facilities
each have a one year term. The amounts borrowed under these various
credit facilities bear interest on the principal amount outstanding at a
variable interest rate based on a base rate (as defined in the applicable
credit agreement), plus an applicable margin. We are charged commitment
fees (as defined in the applicable credit agreement), whether or not
amounts have been borrowed. These commitment fees are included in
interest expense and were not material for the three and six months ended
June 30, 2022 and 2021.
These facilities include customary affirmative and negative operating
covenants and events of default.
Debt Covenants
As of June 30, 2022, we were in compliance with the covenants of all of
our debt obligations.
16

-- 21 of 121 --

9. RETIREMENT PLANS
Defined Contribution Savings Plan
We sponsor a 401(k) Plan for U.S. employees. Employees are immediately
eligible to make contributions to the plan and are also eligible for an
employer contribution match at an amount equal to 100.0% of the first
6.0% of eligible employee contributions. Savings plan expense included in
compensation and benefits expense in the Condensed Consolidated
Statements of Income was $4 million for the three months ended June 30,
2022, $3 million for the three months ended June 30, 2021, and $8 million
for the six months ended June 30, 2022 and $7 million for the six months
ended June 30, 2021.
Pension and Supplemental Executive Retirement Plans
We maintain non-contributory, defined-benefit pension plans, non-
qualified SERPs for certain senior executives and other post-retirement
benefit plans for eligible employees in the U.S. Our pension plans and
SERPs are frozen. Future service and salary for all participants do not
count toward an accrual of benefits under the pension plans and SERPs.
Most employees outside the U.S. are covered by local retirement plans or
by applicable social laws. Benefits under social laws are generally
expensed in the periods in which the costs are incurred. The total expense
for these plans is included in compensation and benefits expense in the
Condensed Consolidated Statements of Income and was $6 million for the
three months ended June 30, 2022, $7 million for the three months ended
June 30, 2021, $12 million for the six months ended June 30, 2022 and
$13 million for the six months ended June 30, 2021.
Deferred Compensation Plan
In June 2022, we established the Nasdaq, Inc. Deferred Compensation
Plan. This plan provides certain eligible employees with the opportunity to
defer a portion of their annual salary and bonus up to certain approval
limits. All deferrals and associated earnings are our general unsecured
obligations.
10. SHARE-BASED COMPENSATION
We have a share-based compensation program for employees and non-
employee directors. Share-based awards granted under this program
include restricted stock (consisting of restricted stock units), PSUs and
stock options. For accounting purposes, we consider PSUs to be a form of
restricted stock.
Summary of Share-Based Compensation Expense
The following table presents the total share-based compensation expense
resulting from equity awards and the 15.0% discount for the ESPP for the
three and six months ended June 30, 2022 and 2021, which is included in
compensation and benefits expense in the Condensed Consolidated
Statements of Income:
Three Months Ended June 30, Six Months Ended June 30,
2022 	2021 	2022 	2021
(in millions)
Share-based
compensation expense
before income taxes 	$ 	25 $ 	24 $ 	49 $ 	43
Common Shares Available Under Our Equity Plan
As of June 30, 2022, we had approximately 8.9 million shares of common
stock authorized for future issuance under our Equity Plan.
Restricted Stock
We grant restricted stock to most employees. The grant date fair value of
restricted stock awards is based on the closing stock price at the date of
grant less the present value of future cash dividends. Restricted stock
awards granted to employees below the manager level generally vest
33.3% on the first anniversary of the grant date, 33.3% on the second
anniversary of the grant date, and 33.3% on the third anniversary of the
grant date. Restricted stock awards granted to employees at or above the
manager level generally vest 33.3% on the second anniversary of the grant
date, 33.3% on the third anniversary of the grant date, and 33.3% on the
fourth anniversary of the grant date.
Summary of Restricted Stock Activity
The following table summarizes our restricted stock activity for the six
months ended June 30, 2022:
Restricted Stock
Number of Awards
Weighted-Average Grant
Date Fair Value
Unvested at January 1, 2022 	1,466,340 $ 	106.16
Granted 	465,704 	175.98
Vested 	(464,316) 	89.80
Forfeited 	(48,415) 	119.80
Unvested at June 30, 2022 	1,419,313 $ 	133.96
As of June 30, 2022, $121 million of total unrecognized compensation cost
related to restricted stock is expected to be recognized over a weighted-
average period of 1.9 years.
17

-- 22 of 121 --

PSUs
PSUs are based on performance measures that impact the amount of shares
that each recipient will receive upon vesting. Prior to April 1, 2020, we
had two performance-based PSU programs for certain officers, a one-year
performance-based program and a three-year cumulative performance-
based program that focuses on TSR. Effective April 1, 2020, to better align
the equity programs for eligible officers, the one-year performance-based
program was eliminated and all eligible officers now participate in the
three-year cumulative performance-based program. While the performance
periods are complete for all PSUs granted under the one-year performance-
based program, some shares underlying these PSUs have not vested.
One-Year PSU Program
The grant date fair value of PSUs under the one-year performance-based
program was based on the closing stock price at the date of grant less the
present value of future cash dividends. Under this program, an eligible
employee received a target grant of PSUs, but could have received from
0.0% to 150.0% of the target amount granted, depending on the
achievement of performance measures. These awards vest ratably on an
annual basis over a three-year period commencing with the end of the one-
year performance period. Compensation cost is recognized over the
performance period and the three-year vesting period based on the
probability that such performance measures will be achieved, taking into
account an estimated forfeiture rate.
Three-Year PSU Program
Under the three-year performance-based program, each eligible individual
receives PSUs, subject to market conditions, with a three-year cumulative
performance period that vest at the end of the performance period.
Compensation cost is recognized over the three-year performance period,
taking into account an estimated forfeiture rate, regardless of whether the
market condition is satisfied, provided that the requisite service period has
been completed. Performance will be determined by comparing Nasdaq’s
TSR to two peer groups, each weighted 50.0%. The first peer group
consists of exchange companies, and the second peer group consists of all
companies in the S&P 500. Nasdaq’s relative performance ranking against
each of these groups will determine the final number of shares delivered to
each individual under the program. The award issuance under this program
will be between 0.0% and 200.0% of the number of PSUs granted and will
be determined by Nasdaq’s overall performance against both peer groups.
However, if Nasdaq’s TSR is negative for the three-year performance
period, regardless of TSR ranking, the award issuance will not exceed
100.0% of the number of PSUs granted. We estimate the fair value of
PSUs granted under the three-year PSU program using the Monte Carlo
simulation model, as these awards contain a market condition.
Grants of PSUs that were issued in 2019 with a three-year performance
period exceeded the applicable performance parameters. As a result, an
additional 289,307 units above the original target were granted in the first
quarter of 2022 and were fully vested upon issuance.
The following weighted-average assumptions were used to determine the
weighted-average fair values of the PSU awards granted under the three-
year PSU program for the six months ended June 30, 2022 and 2021:
June 30, 2022 	June 30, 2021
Weighted-average risk free interest
rate 	2.55 % 	0.31 %
Expected volatility 	30.33 % 	30.11 %
Weighted-average grant date share
price 	$ 	181.92 	$ 	150.85
Weighted-average fair value at grant
date 	$ 	190.51 	$ 	206.17
In the table above, the risk-free interest rate for periods within the
expected life of the award is based on the U.S. Treasury yield curve in
effect at the time of grant; and we use historic volatility for PSU awards
issued under the three-year PSU program, as implied volatility data could
not be obtained for all the companies in the peer groups used for relative
performance measurement within the program.
In addition, the annual dividend assumption utilized in the Monte Carlo
simulation model is based on Nasdaq’s dividend yield at the date of grant.
Summary of PSU Activity
The following table summarizes our PSU activity for the six months ended
June 30, 2022:
PSUs
One-Year Program 	Three-Year Program
Number of
Awards
Weighted-
Average Grant
Date Fair
Value 	Number of Awards
Weighted-
Average Grant
Date Fair Value
Unvested at
January 1,
2022 	49,734 $ 84.03 	764,124 $ 135.04
Granted 	— 	— 	490,364 	135.88
Vested 	(2,075) 	84.18 	(578,614) 	97.70
Forfeited 	(759) 	84.18 	(23,067) 	149.66
Unvested at
June 30, 2022 	46,900 $ 84.02 	652,807 $ 168.25
In the table above, the granted amount under the three year program
reflects additional awards granted based on overachievement of
performance parameters.
18

-- 23 of 121 --

As of June 30, 2022, $1 million of total unrecognized compensation cost
related to the one-year PSU program is expected to be recognized over a
weighted-average period of 1.0 year. For the three-year PSU program, $62
million of total unrecognized compensation cost is expected to be
recognized over a weighted-average period of 1.5 years.
Stock Options
In January 2022, in connection with a new five year employment
agreement, our President and Chief Executive Officer received an
aggregate of 204,624 performance-based non-qualified stock options,
which will vest as follows:
• 50% will vest contingent upon the achievement of certain performance
conditions; and
• 50% will vest five years after the grant date, subject to continued
employment through such date.
The fair value of stock options are estimated using the Black-Scholes
option-pricing model. These options expire 10 years after the date of grant.
There were no stock option awards granted for the six months ended June
30, 2021.
A summary of stock option activity for the six months ended June 30,
2022 is as follows:
Number of
Stock Options
Weighted-
Average Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (in
years)
Aggregate
Intrinsic
Value (in
millions)
Outstanding at December 31,
2021 	268,817 $ 	66.68 	5.0 $ 	39
Granted 	204,624 	202.46
Outstanding at June 30, 2022 	473,441 $ 125.36 	6.7 $ 	23
Exercisable at June 30, 2022 	268,817 $ 	66.68 	4.5 $ 	23
The net cash proceeds from the exercise of 24,409 stock options for the six
months ended June 30, 2021 was $1 million.
As of June 30, 2022, the aggregate pre-tax intrinsic value of the
outstanding and exercisable stock options in the above table was $23
million and represents the difference between our closing stock price on
June 30, 2022 of $152.54 and the exercise price, times the number of
shares that would have been received by the option holders had the option
holders exercised their stock options on that date. This amount can change
based on the fair market value of our common stock. As of June 30, 2021,
0.3 million outstanding stock options were exercisable and the weighted-
average exercise price was $66.68.
The total pre-tax intrinsic value of stock options exercised was $3 million
for the six months ended June 30, 2021.
ESPP
We have an ESPP under which approximately 4.1 million shares of our
common stock were available for future issuance as of June 30, 2022.
Under our ESPP, employees may purchase shares having a value not
exceeding 10.0% of their annual compensation, subject to applicable
annual Internal Revenue Service limitations. We record compensation
expense related to the 15.0% discount that is given to our employees,
which totaled $3 million for both the three months ended June 30, 2022
and 2021 and $5 million for both the six months ended June 30, 2022 and
2021.
11. NASDAQ STOCKHOLDERS' EQUITY
Common Stock
As of June 30, 2022, 300,000,000 shares of our common stock were
authorized, 170,888,738 shares were issued and 163,734,534 shares were
outstanding. As of December 31, 2021, 300,000,000 shares of our
common stock were authorized, 173,418,939 shares were issued and
166,679,635 shares were outstanding. The holders of common stock are
entitled to one vote per share, except that our certificate of incorporation
limits the ability of any shareholder to vote in excess of 5.0% of the then-
outstanding shares of Nasdaq common stock.
Common Stock in Treasury, at Cost
We account for the purchase of treasury stock under the cost method with
the shares of stock repurchased reflected as a reduction to Nasdaq
stockholders’ equity and included in common stock in treasury, at cost in
the Condensed Consolidated Balance Sheets. Shares repurchased under
our share repurchase program are currently retired and canceled and are
therefore not included in the common stock in treasury balance. If treasury
shares are reissued, they are recorded at the average cost of the treasury
shares acquired. We held 7,154,204 shares of common stock in treasury as
of June 30, 2022 and 6,739,304 shares as of December 31, 2021, most of
which are related to shares of our common stock withheld for the
settlement of employee tax withholding obligations arising from the
vesting of restricted stock and PSUs.
Share Repurchase Program
As discussed in “2021 Divestiture,” of Note 4, “Acquisitions and
Divestiture,” in June 2021, our board of directors authorized an increase to
our share repurchase program to an aggregate authorized amount of $1.5
billion. As of June 30, 2022, the remaining aggregate authorized amount
under the existing share repurchase program was $293 million.
These repurchases may be made from time to time at prevailing market
prices in open market purchases, privately-negotiated transactions, block
purchase techniques, an accelerated share repurchase program or
otherwise, as determined by our management. The repurchases are
primarily funded from existing cash balances. The share repurchase
program may be suspended, modified or discontinued at any time, and has
no defined expiration date.
19

-- 24 of 121 --

The following is a summary of our share repurchase activity, excluding the
repurchases done through our ASR agreement described below, reported
based on settlement date, for the six months ended June 30, 2022:
Six Months Ended June 30,
2022
Number of shares of common stock repurchased 	1,821,865
Average price paid per share 	$ 	168.78
Total purchase price (in millions) 	$ 	308
In the table above, the number of shares of common stock repurchased
excludes an aggregate of 414,900 shares withheld upon the vesting of
restricted stock and PSUs for the six months ended June 30, 2022.
As discussed above in “Common Stock in Treasury, at Cost,” shares
repurchased under our share repurchase program are currently retired and
cancelled.
ASR Agreement
In January 2022, we entered into an ASR agreement to repurchase $325
million of common stock. We received a total delivery of 1,876,387 shares
of common stock and completed the ASR program during the first quarter
of 2022.
Preferred Stock
Our certificate of incorporation authorizes the issuance of 30,000,000
shares of preferred stock, par value $0.01 per share, issuable from time to
time in one or more series. As of June 30, 2022 and December 31, 2021,
no shares of preferred stock were issued or outstanding.
Stock Split
In April 2022, we announced our plan to seek shareholder and SEC
approval for an increase in the number of authorized shares of common
stock in order to effect a 3-for-1 stock split of the Company’s common
stock in the form of a stock dividend. In June 2022, we received the
necessary approvals. In July 2022, our board of directors approved and
declared the stock split in the form of a stock dividend. The record date for
the stock dividend is August 12, 2022, with a distribution date of August
26, 2022 and we expect trading to begin on a split-adjusted basis on
August 29, 2022.
Cash Dividends on Common Stock
During the first six months of 2022, our board of directors declared and
paid the following cash dividends:
Declaration Date
Dividend Per
Common
Share 	Record Date
Total Amount
Paid 	Payment Date
(in millions)
January 26, 2022 	$ 	0.54
March 11,
2022 	$ 	88
March 25,
2022
April 20, 2022 	0.60 June 10,
2022 	98 June 24,
2022
$ 	186
The total amount paid of $186 million was recorded in retained earnings
within Nasdaq's stockholders' equity in the Condensed Consolidated
Balance Sheets at June 30, 2022.
In July 2022, the board of directors approved a regular quarterly cash
dividend of $0.20 per share on our outstanding common stock. On a split-
adjusted basis, the dividend is economically equivalent to the pre-split
quarterly dividend of $0.60 per share on our outstanding common stock
paid in the preceding quarter. The dividend is payable on September 30,
2022 to shareholders of record at the close of business on September 16,
2022. The estimated amount of this dividend is $98 million. Future
declarations of quarterly dividends and the establishment of future record
and payment dates are subject to approval by the board of directors.
The board of directors maintains a dividend policy with the intention to
provide stockholders with regular and increasing dividends as earnings and
cash flows increase.
20

-- 25 of 121 --

12. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted
earnings per share:
Three Months Ended June 30,
2022 	2021
Numerator: (in millions, except share and per share
amounts)
Net income attributable to common
shareholders 	$ 	307 $ 	341
Denominator:
Weighted-average common shares
outstanding for basic earnings per share 	164,078,459 	164,085,819
Weighted-average effect of dilutive securities:
Employee equity awards 	1,448,250 	2,352,338
Weighted-average common shares
outstanding for diluted earnings per share 	165,526,709 	166,438,157
Basic and diluted earnings per share:
Basic earnings per share 	$ 	1.87 $ 	2.08
Diluted earnings per share 	$ 	1.85 $ 	2.05
Six Months Ended June 30,
2022 	2021
Numerator: (in millions, except share and per share
amounts)
Net income attributable to common
shareholders 	$ 	590 $ 	639
Denominator:
Weighted-average common shares
outstanding for basic earnings per share 	164,560,607 	164,395,991
Weighted-average effect of dilutive securities:
Employee equity awards 	1,824,138 	2,367,405
Weighted-average common shares
outstanding for diluted earnings per share 	166,384,745 	166,763,396
Basic and diluted earnings per share:
Basic earnings per share 	$ 	3.59 $ 	3.89
Diluted earnings per share 	$ 	3.55 $ 	3.83
In the table above, employee equity awards from our PSU program, which
are considered contingently issuable, are included in the computation of
dilutive earnings per share on a weighted average basis when management
determines that the applicable performance criteria would have been met if
the performance period ended as of the date of the relevant computation.
Securities that were not included in the computation of diluted earnings
per share because their effect was antidilutive were immaterial for both the
three and six months ended June 30, 2022 and 2021.
13. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following tables present our financial assets and financial liabilities
that were measured at fair value on a recurring basis as of June 30, 2022
and December 31, 2021.
June 30, 2022
Total 	Level 1 	Level 2 	Level 3
(in millions)
European government
debt securities $ 	132 $ 	132 $ 	— $ 	—
Swedish mortgage
bonds 20 	— 	20 	—
Commercial paper 	9 	— 	9 	—
Total assets at fair
value 	$ 	161 $ 	132 $ 	29 $ 	—
December 31, 2021
Total 	Level 1 	Level 2 	Level 3
(in millions)
European government
debt securities $ 	144 $ 	144 $ 	— $ 	—
Corporate debt
securities 20 	— 	20 	—
State-owned
enterprises and
municipal securities 11 	— 	11 	—
Swedish mortgage
bonds 21 	— 	21 	—
Time deposits 	12 	— 	12 	—
Total assets at fair
value 	$ 	208 $ 	144 $ 	64 $ 	—
Financial Instruments Not Measured at Fair Value on a Recurring
Basis
Some of our financial instruments are not measured at fair value on a
recurring basis but are recorded at amounts that approximate fair value due
to their liquid or short-term nature. Such financial assets and financial
liabilities include: cash and cash equivalents, restricted cash and cash
equivalents, receivables, net, certain other current assets, accounts payable
and accrued expenses, Section 31 fees payable to SEC, accrued personnel
costs, commercial paper and certain other current liabilities.
Our investment in OCC is accounted for under the equity method of
accounting. We have elected the measurement alternative for the majority
of our equity securities, which primarily represent various strategic
investments made through our corporate venture program. See “Equity
Method Investments,” and “Equity Securities,” of Note 6, “Investments,”
for further discussion.
21

-- 26 of 121 --

We also consider our debt obligations to be financial instruments. As of
June 30, 2022, the majority of our debt obligations were fixed-rate
obligations. We are exposed to changes in interest rates as a result of
borrowings under our 2020 Credit Facility, as the interest rates on this
facility have a variable rate depending on the maturity of the borrowing
and the implied underlying reference rate. As of June 30, 2022, we had no
outstanding borrowings under our 2020 Credit Facility. We are also
exposed to changes in interest rates as a result of the amounts outstanding
from the sale of commercial paper under our commercial paper program.
As of June 30, 2022, we had $421 million outstanding under our
commercial paper program. The fair value of our debt obligations utilizing
discounted cash flow analyses for our floating rate debt, and prevailing
market rates for our fixed rate debt was $4.8 billion as of June 30, 2022
and $5.9 billion as of December 31, 2021. The discounted cash flow
analyses are based on borrowing rates currently available to us for debt
with similar terms and maturities. The fair value of our commercial paper
as of June 30, 2022 approximated the carrying value since the rates of
interest on this short-term debt approximated market rates. Our
commercial paper and our fixed rate and floating rate debt are categorized
as Level 2 in the fair value hierarchy.
For further discussion of our debt obligations, see Note 8, “Debt
Obligations.”
Non-Financial Assets Measured at Fair Value on a Non-Recurring
Basis
Our non-financial assets, which include goodwill, intangible assets, and
other long-lived assets, are not required to be carried at fair value on a
recurring basis. Fair value measures of non-financial assets are primarily
used in the impairment analysis of these assets. Any resulting asset
impairment would require that the non-financial asset be recorded at its
fair value. Nasdaq uses Level 3 inputs to measure the fair value of the
above assets on a non-recurring basis. As of June 30, 2022 and December
31, 2021, there were no non-financial assets measured at fair value on a
non-recurring basis.
14. CLEARING OPERATIONS
Nasdaq Clearing
Nasdaq Clearing is authorized and supervised under EMIR as a multi-asset
clearinghouse by the SFSA. Such authorization is effective for all member
states of the European Union and certain other non-member states that are
part of the European Economic Area, including Norway. The
clearinghouse acts as the CCP for exchange and OTC trades in equity
derivatives, fixed income derivatives, resale and repurchase contracts,
power derivatives, emission allowance derivatives, and seafood
derivatives.
Through our clearing operations in the financial markets, which include
the resale and repurchase market, the commodities markets, and the
seafood market, Nasdaq Clearing is the legal counterparty for, and
guarantees the fulfillment of, each contract cleared. These contracts are not
used by Nasdaq Clearing for the purpose of trading on its
own behalf. As the legal counterparty of each transaction, Nasdaq Clearing
bears the counterparty risk between the purchaser and seller in the
contract. In its guarantor role, Nasdaq Clearing has precisely equal and
offsetting claims to and from clearing members on opposite sides of each
contract, standing as the CCP on every contract cleared. In accordance
with the rules and regulations of Nasdaq Clearing, default fund and margin
collateral requirements are calculated for each clearing member’s positions
in accounts with the CCP. See “Default Fund Contributions and Margin
Deposits” below for further discussion of Nasdaq Clearing’s default fund
and margin requirements.
Nasdaq Clearing maintains three member sponsored default funds: one
related to financial markets, one related to commodities markets and one
related to the seafood market. Under this structure, Nasdaq Clearing and
its clearing members must contribute to the total regulatory capital related
to the clearing operations of Nasdaq Clearing. This structure applies an
initial separation of default fund contributions for the financial,
commodities and seafood markets in order to create a buffer for each
market’s counterparty risks. See “Default Fund Contributions” below for
further discussion of Nasdaq Clearing’s default fund. A power of
assessment and a liability waterfall have also been implemented to further
align risk between Nasdaq Clearing and its clearing members. See “Power
of Assessment” and “Liability Waterfall” below for further discussion.
Nasdaq Commodities Clearing Default
In September 2018, a member of the Nasdaq Clearing commodities market
defaulted due to the inability to post sufficient collateral to cover increased
margin requirements for the positions of the relevant member, which had
experienced losses due to sharp adverse movements in the Nordic -
German power market spread. Nasdaq Clearing followed default
procedures and offset the future market risk on the defaulting member’s
positions.
Immediately following the event, Nasdaq Clearing launched a
comprehensive enhancement program to strengthen the resilience and
robustness of the clearinghouse.
In December 2018, the SFSA initiated a review of Nasdaq Clearing. In
January 2021, the SFSA issued a warning combined with an administrative
fine of approximately $29 million (SEK 300 million) to Nasdaq Clearing
based on its review. Nasdaq Clearing appealed the SFSA´s decision to the
Administrative Court. In December 2021, the court rejected Nasdaq
Clearing’s appeal and upheld the decision of the SFSA. In January 2022,
Nasdaq Clearing appealed this decision to the Administrative Court of
Appeal, with the next hearing date set for October 2022. While we
continue to firmly believe in the merit of our appeal, due to the recent
decision by the Administrative Court, we have determined it is appropriate
to record an accrual for the full amount of the administrative fine issued by
the SFSA. The charge was included in regulatory expense in our
Consolidated Statements of Income for the year ended December 31, 2021.
22

-- 27 of 121 --

Default Fund Contributions and Margin Deposits
As of June 30, 2022, clearing member default fund contributions and
margin deposits were as follows:
June 30, 2022
Cash Contributions
Non-Cash
Contributions 	Total Contributions
(in millions)
Default fund
contributions 	$ 	763 $ 	115 $ 	878
Margin deposits 	7,925 	8,063 	15,988
Total 	$ 	8,688 $ 	8,178 $ 	16,866
Of the total default fund contributions of $878 million, Nasdaq Clearing
can utilize $782 million as capital resources in the event of a counterparty
default. The remaining balance of $96 million pertains to member posted
surplus balances.
Our clearinghouse holds material amounts of clearing member cash
deposits which are held or invested primarily to provide security of capital
while minimizing credit, market and liquidity risks. While we seek to
achieve a reasonable rate of return, we are primarily concerned with
preservation of capital and managing the risks associated with these
deposits.
Clearing member cash contributions are maintained in demand deposits
held at central banks and large, highly rated financial institutions or
secured through direct investments, primarily central bank certificates and
highly rated European government debt securities with original maturities
primarily 1 year or less, reverse repurchase agreements and multilateral
development bank debt securities. Investments in reverse repurchase
agreements range in maturity from 1 day to 15 days and are secured with
highly rated government securities and multilateral development banks.
The carrying value of these securities approximates their fair value due to
the short-term nature of the instruments and reverse repurchase
agreements.
Nasdaq Clearing has invested the total cash contributions of $8,688
million as of June 30, 2022 and $5,911 million as of December 31, 2021,
in accordance with its investment policy as follows:
June 30, 2022 	December 31, 2021
(in millions)
Demand deposits 	$ 	6,869 $ 	3,061
Central bank certificates 	900 	2,013
Restricted cash and cash
equivalents 	$ 	7,769 $ 	5,074
European government debt securities 	447 	414
Reverse repurchase agreements 	282 	152
Multilateral development bank debt
securities 	190 	271
Investments 	$ 	919 $ 	837
Total 	$ 	8,688 $ 	5,911
In the preceding table, the change from December 31, 2021 to June 30,
2022 includes currency translation adjustments of $657 million for
restricted cash and cash equivalents and $120 million for investments.
For the six months ended June 30, 2022 and 2021 investments related to
default funds and margin deposits, net includes purchases of investment
securities of $17,539 million and $20,419 million, respectively, and
proceeds from sales and redemptions of investment securities of $17,337
million and $20,329 million, respectively.
In the investment activity related to default fund and margin contributions,
we are exposed to counterparty risk related to reverse repurchase
agreement transactions, which reflect the risk that the counterparty might
become insolvent and, thus, fail to meet its obligations to Nasdaq Clearing.
We mitigate this risk by only engaging in transactions with high credit
quality reverse repurchase agreement counterparties and by limiting the
acceptable collateral under the reverse repurchase agreement to high
quality issuers, primarily government securities and other securities
explicitly guaranteed by a government. The value of the underlying
security is monitored during the lifetime of the contract, and in the event
the market value of the underlying security falls below the reverse
repurchase amount, our clearinghouse may require additional collateral or
a reset of the contract.
Default Fund Contributions
Required contributions to the default funds are proportional to the
exposures of each clearing member. When a clearing member is active in
more than one market, contributions must be made to all markets’ default
funds in which the member is active. Clearing members’ eligible
contributions may include cash and non-cash contributions. Cash
contributions received are maintained in demand deposits held at central
banks and large, highly rated financial institutions or invested by Nasdaq
Clearing, in accordance with its investment policy, either in central bank
certificates, highly rated government debt securities, reverse repurchase
agreements with highly rated government debt securities as collateral, or
multilateral development bank debt securities. Nasdaq Clearing maintains
and manages all cash deposits related to margin collateral. All risks and
rewards of collateral ownership, including interest, belong to Nasdaq
Clearing. Clearing members’ cash contributions are included in default
funds and margin deposits in the Condensed Consolidated Balance Sheets
as both a current asset and a current liability. Non-cash contributions
include highly rated government debt securities that must meet specific
criteria approved by Nasdaq Clearing. Non-cash contributions are pledged
assets that are not recorded in the Condensed Consolidated Balance Sheets
as Nasdaq Clearing does not take legal ownership of these assets and the
risks and rewards remain with the clearing members. These balances may
fluctuate over time due to changes in the amount of deposits required and
whether members choose to provide cash or non-cash contributions. Assets
pledged are held at a nominee account in Nasdaq Clearing’s name for the
benefit of the clearing members and are immediately accessible by Nasdaq
23

-- 28 of 121 --

Clearing in the event of a default. In addition to clearing members’
required contributions to the liability waterfall, Nasdaq Clearing is also
required to contribute capital to the liability waterfall and overall
regulatory capital as specified under its clearinghouse rules. As of June 30,
2022, Nasdaq Clearing committed capital totaling $123 million to the
liability waterfall and overall regulatory capital, in the form of government
debt securities, which are recorded as financial investments in the
Condensed Consolidated Balance Sheets. The combined regulatory capital
of the clearing members and Nasdaq Clearing is intended to secure the
obligations of a clearing member exceeding such member’s own margin
and default fund deposits and may be used to cover losses sustained by a
clearing member in the event of a default.
Margin Deposits
Nasdaq Clearing requires all clearing members to provide collateral, which
may consist of cash and non-cash contributions, to guarantee performance
on the clearing members’ open positions, or initial margin. In addition,
clearing members must also provide collateral to cover the daily margin
call if needed. See “Default Fund Contributions” above for further
discussion of cash and non-cash contributions.
Similar to default fund contributions, Nasdaq Clearing maintains and
manages all cash deposits related to margin collateral. All risks and
rewards of collateral ownership, including interest, belong to Nasdaq
Clearing and are recorded in revenues. These cash deposits are recorded in
default funds and margin deposits in the Condensed Consolidated Balance
Sheets as both a current asset and a current liability. Pledged margin
collateral is not recorded in our Condensed Consolidated Balance Sheets
as all risks and rewards of collateral ownership, including interest, belong
to the counterparty. Assets pledged are held at a nominee account in
Nasdaq Clearing’s name for the benefit of the clearing members and are
immediately accessible by Nasdaq Clearing in the event of a default.
Nasdaq Clearing marks to market all outstanding contracts and requires
payment from clearing members whose positions have lost value. The
mark-to-market process helps identify any clearing members that may not
be able to satisfy their financial obligations in a timely manner allowing
Nasdaq Clearing the ability to mitigate the risk of a clearing member
defaulting due to exceptionally large losses. In the event of a default,
Nasdaq Clearing can access the defaulting member’s margin and default
fund deposits to cover the defaulting member’s losses.
Regulatory Capital and Risk Management Calculations
Nasdaq Clearing manages risk through a comprehensive counterparty risk
management framework, which is comprised of policies, procedures,
standards and financial resources. The level of regulatory capital is
determined in accordance with Nasdaq Clearing’s regulatory capital and
default fund policy, as approved by the SFSA. Regulatory capital
calculations are continuously updated through a proprietary capital-at-risk
calculation model that establishes the appropriate level of capital.
As mentioned above, Nasdaq Clearing is the legal counterparty for each
contract cleared and thereby guarantees the fulfillment of each contract.
Nasdaq Clearing accounts for this guarantee as a performance guarantee.
We determine the fair value of the performance guarantee by considering
daily settlement of contracts and other margining and default fund
requirements, the risk management program, historical evidence of default
payments, and the estimated probability of potential default payouts. The
calculation is determined using proprietary risk management software that
simulates gains and losses based on historical market prices, extreme but
plausible market scenarios, volatility and other factors present at that point
in time for those particular unsettled contracts. Based on this analysis,
excluding any liability related to the Nasdaq commodities clearing default
(see discussion above), the estimated liability was nominal and no liability
was recorded as of June 30, 2022.
Power of Assessment
To further strengthen the contingent financial resources of the
clearinghouse, Nasdaq Clearing has power of assessment that provides the
ability to collect additional funds from its clearing members to cover a
defaulting member’s remaining obligations up to the limits established
under the terms of the clearinghouse rules. The power of assessment
corresponds to 230.0% of the clearing member’s aggregate contribution to
the financial, commodities and seafood markets’ default funds.
Liability Waterfall
The liability waterfall is the priority order in which the capital resources
would be utilized in the event of a default where the defaulting clearing
member’s collateral and default fund contribution would not be sufficient
to cover the cost to settle its portfolio. If a default occurs and the
defaulting clearing member’s collateral, including cash deposits and
pledged assets, is depleted, then capital is utilized in the following amount
and order:
• junior capital contributed by Nasdaq Clearing, which totaled $40 million
as of June 30, 2022;
• a loss-sharing pool related only to the financial market that is
contributed to by clearing members and only applies if the defaulting
member’s portfolio includes interest rate swap products;
• specific market default fund where the loss occurred (i.e., the financial,
commodities, or seafood market), which includes capital contributions
of the clearing members on a pro-rata basis; and
24

-- 29 of 121 --

• fully segregated senior capital for each specific market contributed by
Nasdaq Clearing, calculated in accordance with clearinghouse rules,
which totaled $21 million as of June 30, 2022.
If additional funds are needed after utilization of the liability waterfall, or
if part of the waterfall has been utilized and needs to be replenished, then
Nasdaq Clearing will utilize its power of assessment and additional capital
contributions will be required by non-defaulting members up to the limits
established under the terms of the clearinghouse rules.
In addition to the capital held to withstand counterparty defaults described
above, Nasdaq Clearing also has committed capital of $62 million to
ensure that it can handle an orderly wind-down of its operation, and that it
is adequately protected against investment, operational, legal, and business
risks.
Market Value of Derivative Contracts Outstanding
The following table presents the market value of derivative contracts
outstanding prior to netting:
June 30, 2022
(in millions)
Commodity and seafood options, futures and
forwards 	$ 	1,097
Fixed-income options and futures 	1,969
Stock options and futures 	226
Index options and futures 	74
Total 	$ 	3,366
In the table above:
• We determined the fair value of our option contracts using standard
valuation models that were based on market-based observable inputs
including implied volatility, interest rates and the spot price of the
underlying instrument.
• We determined the fair value of our futures contracts based upon quoted
market prices and average quoted market yields.
• We determined the fair value of our forward contracts using standard
valuation models that were based on market-based observable inputs
including benchmark rates and the spot price of the underlying
instrument.
Derivative Contracts Cleared
The following table presents the total number of derivative contracts
cleared through Nasdaq Clearing for the six months ended June 30, 2022
and 2021:
Six Months Ended June 30,
2022 	2021
Commodity and seafood options,
futures and forwards 	182,341 	312,002
Fixed-income options and futures 	12,287,280 	12,185,338
Stock options and futures 	8,980,694 	10,607,666
Index options and futures 	23,463,638 	17,970,912
Total 	44,913,953 	41,075,918
In the table above, the total volume in cleared power related to commodity
contracts was 250 Terawatt hours (TWh) and 456 TWh for the six months
ended June 30, 2022 and 2021, respectively.
Resale and Repurchase Agreements Contracts Outstanding and
Cleared
The outstanding contract value of resale and repurchase agreements was
$3.0 billion as of June 30, 2022 and the total number of resale and
repurchase agreements contracts cleared was 3,117,583 for the six months
ended June 30, 2022.
15. LEASES
We have operating leases which are primarily real estate leases
predominantly for our U.S. and European headquarters, data centers and
for general office space. The following table provides supplemental
balance sheet information related to Nasdaq's operating leases:
Leases
Balance Sheet
Classification 	June 30, 2022 	December 31, 2021
(in millions)
Assets:
Operating lease
assets
Operating lease
assets 	$ 	462 $ 	366
Liabilities:
Current lease
liabilities
Other current
liabilities 	$ 	56 $ 	37
Non-current lease
liabilities
Operating lease
liabilities 	470 	386
Total lease
liabilities 	$ 	526 $ 	423
25

-- 30 of 121 --

The following table summarizes Nasdaq's lease cost:
Three Months Ended June
30, 	Six Months Ended June 30,
2022 	2021 	2022 	2021
(in millions)
Operating lease cost 	$ 	19 $ 	21 $ 	38 $ 	44
Variable lease cost 	8 	6 	16 	13
Sublease income 	(1) 	(1) 	(2) 	(2)
Total lease cost 	$ 	26 $ 	26 $ 	52 $ 	55
In the table above, operating lease costs include short-term lease cost,
which was immaterial.
The following table reconciles the undiscounted cash flows for each of the
first five years and total of the remaining years to the operating lease
liabilities recorded in our Condensed Consolidated Balance Sheets.
June 30, 2022
(in millions)
Remainder of 2022 	$ 	37
2023 	70
2024 	68
2025 	54
2026 	51
2027+ 	359
Total lease payments 	639
Less: interest 	(113)
Present value of lease liabilities 	$ 	526
In the table above, interest is calculated using the interest rate for each
lease. Present value of lease liabilities include the current portion of $56
million.
Total lease payments in the table above exclude $44 million of legally
binding minimum lease payments for a lease signed but not yet
commenced.
The following table provides information related to Nasdaq's lease term
and discount rate:
June 30, 2022
Weighted-average remaining lease term (in
years) 	10.9
Weighted-average discount rate 	3.5 %
The following table provides supplemental cash flow information related
to Nasdaq's operating leases:
Six Months Ended June 30,
2022 	2021
(in millions)
Cash paid for amounts included in the
measurement of operating lease
liabilities 	$ 	28 $ 	37
Lease assets obtained in exchange for
operating lease liabilities 	$ 	126 $ 	35
16. INCOME TAXES
Income Tax Provision
The following table presents our income tax provision and effective tax
rate:
Three Months Ended
June 30, 2022 	June 30, 2021
(in millions)
Income tax provision 	$ 	90 	$ 	113
Effective tax rate 	22.7 % 	24.9 %
Six Months Ended
June 30, 2022 	June 30, 2021
(in millions)
Income tax provision 	$ 	182 	$ 	210
Effective tax rate 	23.6 % 	24.7 %
The lower effective tax rate for both the three and six months ended June
30, 2022 was primarily due to the income tax effect on geographic mix of
earnings and higher tax benefit from vested share-based awards in the U.S.
The effective tax rate may vary from period to period depending on,
among other factors, the geographic and business mix of earnings and
losses. These same and other factors, including history of pre-tax earnings
and losses, are taken into account in assessing the ability to realize
deferred tax assets.
Tax Audits
Nasdaq and its eligible subsidiaries file a consolidated U.S. federal income
tax return, applicable state and local income tax returns and non-U.S.
income tax returns. We are subject to examination by federal, state and
local, and foreign tax authorities. Our Federal income tax returns for the
years 2018 through 2020 are subject to examination by the Internal
Revenue Service. Several state tax returns are currently under examination
by the respective tax authorities for the years 2012 through 2018, while
2019 and 2020 are subject to examination. Non-U.S. tax returns are subject
to examination by the respective tax authorities for the years 2015 through
2020.
We regularly assess the likelihood of additional assessments by each
jurisdiction and have established tax reserves that we believe are adequate
in relation to the potential for additional assessments. Examination
outcomes and the timing of examination settlements are subject to
uncertainty. Although the results of such examinations may have an impact
on our unrecognized tax benefits, we do not anticipate that such impact
will be material to our condensed consolidated financial position or results
of operations, but may be material to our operating results for a particular
period and the effective tax rate for that period. We do not expect the
settlement of any tax audits to be material in the next twelve months.
26

-- 31 of 121 --

17. COMMITMENTS, CONTINGENCIES AND GUARANTEES
Guarantees Issued and Credit Facilities Available
In addition to the default fund contributions and margin collateral pledged
by clearing members discussed in Note 14, “Clearing Operations,” we
have obtained financial guarantees and credit facilities, which are
guaranteed by us through counter indemnities, to provide further liquidity
related to our clearing businesses. Financial guarantees issued to us totaled
$4 million as of June 30, 2022 and $5 million December 31, 2021. As
discussed in “Other Credit Facilities,” of Note 8, “Debt Obligations,” we
also have credit facilities primarily related to our Nasdaq Clearing
operations, which are available in multiple currencies, and totaled $188
million as of June 30, 2022 and $212 million as of December 31, 2021 in
available liquidity, none of which was utilized.
Other Guarantees
Through our clearing operations in the financial markets, Nasdaq Clearing
is the legal counterparty for, and guarantees the performance of, its
clearing members. See Note 14, “Clearing Operations,” for further
discussion of Nasdaq Clearing performance guarantees.
We have provided a guarantee related to lease obligations for The Nasdaq
Entrepreneurial Center, Inc., which is a not-for-profit organization
designed to convene, connect and engage aspiring and current
entrepreneurs. This entity is not included in the condensed consolidated
financial statements of Nasdaq.
We believe that the potential for us to be required to make payments under
these arrangements is unlikely. Accordingly, no contingent liability is
recorded in the Condensed Consolidated Balance Sheets for the above
guarantees.
Routing Brokerage Activities
One of our broker-dealer subsidiaries, Nasdaq Execution Services,
provides a guarantee to securities clearinghouses and exchanges under its
standard membership agreements, which require members to guarantee the
performance of other members. If a member becomes unable to satisfy its
obligations to a clearinghouse or exchange, other members would be
required to meet its shortfalls. To mitigate these performance risks, the
exchanges and clearinghouses often require members to post collateral, as
well as meet certain minimum financial standards. Nasdaq Execution
Services’ maximum potential liability under these arrangements cannot be
quantified. However, we believe that the potential for Nasdaq Execution
Services to be required to make payments under these arrangements is
unlikely. Accordingly, no contingent liability is recorded in the Condensed
Consolidated Balance Sheets for these arrangements.
Legal and Regulatory Matters
Armenian Stock Exchange Investigation
As disclosed in our prior filings with the SEC, a former non-U.S.
subsidiary of Nasdaq, NASDAQ OMX Armenia OJSC, operated the
Armenian Stock Exchange and the Central Depository of Armenia, which
are regulated by the Central Bank of Armenia under Armenian law. In
accordance with the requirements of Armenian law, Mellat Bank SB
CJSC, an Armenian entity that is designated under Executive Order 13382,
was a market participant on the Armenian Stock Exchange and, as a result,
paid participation and transaction fees to the Armenian Stock Exchange
during the period from 2012-2014. In 2014, we voluntarily self-disclosed
this matter to the U.S. Department of Treasury’s Office of Foreign Assets
Control, or OFAC, and received authorization from OFAC to continue, if
necessary, certain activities pertaining to Mellat Bank SB CJSC in
Armenia in a limited manner. In 2015, Nasdaq sold a majority of its
ownership of Nasdaq OMX Armenia OJSC, with the remaining minority
interest sold in 2018.
OFAC has been conducting an inquiry into the Armenian Stock Exchange
matter described above and in our prior filings since 2016, and during the
first quarter of 2021, we were advised that OFAC is considering a civil
monetary penalty in connection with that matter. We are currently in
discussions with OFAC.
While we believe our decision to voluntarily self-report this issue and our
continued cooperation with OFAC, along with the permit we received from
OFAC in connection with our transactions involving the Armenian Stock
Exchange, will be mitigating factors with respect to the matter, any
monetary fines or restrictions may nonetheless be material to our financial
results in the period in which they are imposed. We cannot currently
predict when our discussions with OFAC will conclude or the amount of
any potential penalties imposed. Accordingly, we are unable to reasonably
estimate any potential loss or range of loss and we have not accrued for a
loss contingency.
27

-- 32 of 121 --

CFTC Matter
In June 2022, NASDAQ Futures, Inc. (“NFX”), a non-operational, wholly-
owned subsidiary of Nasdaq, received a telephonic “Wells Notice” from
the staff of the CFTC relating to certain alleged potential violations by
NFX of provisions of the Commodity Exchange Act and CFTC rules
thereunder during the period beginning July 2015 through October 2018.
The Wells Notice informed NFX that the CFTC staff has made, subject to
consideration of NFX’s response, a preliminary determination to
recommend that the CFTC authorize an enforcement action against NFX
in connection with its former futures exchange business. Nasdaq sold
NFX’s futures exchange business to a third-party in November 2019,
including the portfolio of open interest in NFX contracts. During 2020, all
remaining open interest in NFX contracts was migrated to other exchanges
and NFX ceased operation. NFX plans to contest the staff’s positions in its
response to the Wells Notice. A Wells Notice is neither a formal charge of
wrongdoing nor a final determination that the recipient has violated any
law. Accordingly, we are unable to reasonably estimate any potential loss
or range of loss, and therefore, we have not accrued for a loss contingency.
Nasdaq Commodities Clearing Default
In December 2021, we recorded a charge related to an administrative fine
issued by the SFSA associated with the default which occurred in 2018.
The charge was included in regulatory expense in our Consolidated
Statements of Income for the year ended December 31, 2021. See “Nasdaq
Commodities Clearing Default,” of Note 14, “Clearing Operations,” for
further information.
Other Matters
Except as disclosed above and in prior reports filed under the Exchange
Act, we are not currently a party to any litigation or proceeding that we
believe could have a material adverse effect on our business, consolidated
financial condition, or operating results. However, from time to time, we
have been threatened with, or named as a defendant in, lawsuits or
involved in regulatory proceedings.
In the normal course of business, Nasdaq discusses matters with its
regulators raised during regulatory examinations or otherwise subject to
their inquiries. Management believes that censures, fines, penalties or
other sanctions that could result from any ongoing examinations or
inquiries will not have a material impact on its consolidated financial
position or results of operations. However, we are unable to predict the
outcome or the timing of the ultimate resolution of these matters, or the
potential fines, penalties or injunctive or other equitable relief, if any, that
may result from these matters.
Tax Audits
We are engaged in ongoing discussions and audits with taxing authorities
on various tax matters, the resolutions of which are uncertain. Currently,
there are matters that may lead to assessments, some of which may not be
resolved for several years. Based on currently available information, we
believe we have adequately provided for any assessments that could result
from those proceedings where it is more likely than not that we will be
assessed. We review our positions on these matters as they progress. See
“Tax Audits,” of Note 16, “Income Taxes,” for further discussion.
18. BUSINESS SEGMENTS
We manage, operate and provide our products and services in four
business segments: Market Technology, Investment Intelligence, Corporate
Platforms and Market Services. See Note 1, “Organization and Nature of
Operations,” for further discussion of our reportable segments.
Our management allocates resources, assesses performance and manages
these businesses as four separate segments. We evaluate the performance
of our segments based on several factors, of which the primary financial
measure is operating income. Results of individual businesses are
presented based on our management accounting practices and structure.
Our chief operating decision maker does not review total assets or
statements of income below operating income by segments as key
performance metrics; therefore, such information is not presented below.
28

-- 33 of 121 --

The following table presents certain information regarding our business
segments for the three months ended June 30, 2022 and 2021:
Three Months Ended June 30,
2022 	2021
Market Technology 	(in millions)
Total revenues 	$ 	131 $ 	117
Operating income 	16 	17
Investment Intelligence
Total revenues 	283 	261
Operating income 	186 	169
Corporate Platforms
Total revenues 	168 	149
Operating income 	78 	62
Market Services
Total revenues 	969 	874
Transaction-based expenses 	(659) 	(566)
Revenues less transaction-based expenses 	310 	308
Operating income 	200 	200
Corporate Items
Total revenues 	1 	11
Operating loss 	(68) 	(72)
Consolidated
Total revenues 	$ 	1,552 $ 	1,412
Transaction-based expenses 	(659) 	(566)
Revenues less transaction-based expenses $ 	893 $ 	846
Operating income 	$ 	412 $ 	376
The following table presents certain information regarding our business
segments for the six months ended June 30, 2022 and 2021:
Six Months Ended June 30,
2022 	2021
Market Technology 	(in millions)
Total revenues 	$ 	255 $ 	217
Operating income 	20 	15
Investment Intelligence
Total revenues 	567 	516
Operating income 	369 	333
Corporate Platforms
Total revenues 	336 	296
Operating income 	152 	122
Market Services
Total revenues 	1,927 	2,010
Transaction-based expenses 	(1,302) 	(1,366)
Revenues less transaction-based expenses 	625 	644
Operating income 	401 	428
Corporate Items
Total revenues 	2 	24
Operating loss 	(125) 	(157)
Consolidated
Total revenues 	$ 	3,087 $ 	3,063
Transaction-based expenses 	(1,302) 	(1,366)
Revenues less transaction-based expenses $ 	1,785 $ 	1,697
Operating income 	$ 	817 $ 	741
Certain amounts are allocated to corporate items in our management
reports as we believe they do not contribute to a meaningful evaluation of
a particular segment's ongoing operating performance. These items, which
are presented in the table below, include the following:
• Amortization expense of acquired intangible assets: We amortize
intangible assets acquired in connection with various acquisitions.
Intangible asset amortization expense can vary from period to period due
to episodic acquisitions completed, rather than from our ongoing
business operations. As such, if intangible asset amortization is included
in performance measures, it is more difficult to assess the day-to-day
operating performance of the segments, and the relative operating
performance of the segments between periods. Management does not
consider intangible asset amortization expense for the purpose of
evaluating the performance of our segments or their managers or when
making decisions to allocate resources. Therefore, we believe
performance measures excluding intangible asset amortization expense
provide management with a useful representation of our segments'
ongoing activity in each period.
29

-- 34 of 121 --

• Merger and strategic initiatives expense: We have pursued various
strategic initiatives and completed acquisitions and divestitures in recent
years that have resulted in expenses which would not have otherwise
been incurred. These expenses generally include integration costs, as
well as legal, due diligence and other third-party transaction costs. The
frequency and the amount of such expenses vary significantly based on
the size, timing and complexity of the transaction. Management does not
consider merger and strategic initiatives expense for the purpose of
evaluating the performance of our segments or their managers or when
making decisions to allocate resources. Therefore, we believe
performance measures excluding merger and strategic initiatives
expense provide management with a useful representation of our
segments' ongoing activity in each period.
• Restructuring charges: We initiated the transition of certain technology
platforms to advance our strategic opportunities as a technology and
analytics provider and continue the realignment of certain business
areas. See Note 19, “Restructuring Charges,” for further discussion of
our 2019 restructuring plan. We believe performance measures
excluding restructuring charges provide management with a useful
representation of our segments' ongoing activity in each period.
• Revenues and expenses - divested/contributed businesses: We have
included in corporate items the revenues and expenses of our U.S. Fixed
Income business, which was previously included in our Market Services
and Investment Intelligence results. See “2021 Divestiture,” of Note 4,
“Acquisitions and Divestiture,” for further discussion of this divestiture.
Additionally, other revenues related to a transitional services agreement
associated with a divested business are included in corporate items. Also
included are the revenues and expenses associated with the NPM
business, which we contributed in July 2021 to a standalone,
independent company, of which we own the largest minority interest
together with a consortium of third-party financial institutions. Prior to
July 2021, these revenues were previously included in our Corporate
Platforms results.
• Other items: We have included certain other charges or gains in
corporate items, to the extent we believe they should be excluded when
evaluating the ongoing operating performance of each individual
segment. For the three and six months ended June 30, 2022, other items
primarily include a loss on extinguishment of debt.
The above charges are recorded in general, administrative and other
expense, unless otherwise noted, in our Condensed Consolidated
Statements of Income.
The following table summarizes our Corporate Items:
Three Months Ended June 30,
2022 	2021
(in millions)
Revenues - divested/contributed
businesses 	$ 	1 $ 	11
Expenses:
Amortization expense of acquired
intangible assets 	$ 	39 $ 	40
Merger and strategic initiatives expense 	12 	12
Restructuring charges 	— 	21
Extinguishment of debt 	16 	—
Expenses - divested/contributed
businesses 	— 	5
Other 	2 	5
Total expenses 	69 	83
Operating loss 	$ 	(68) $ 	(72)
Six Months Ended June 30,
2022 	2021
(in millions)
Revenues - divested/contributed
businesses 	$ 	2 $ 	24
Expenses:
Amortization expense of acquired
intangible assets 	78 	76
Merger and strategic initiatives expense 	27 	57
Restructuring charges 	— 	31
Extinguishment of debt 	16 	—
Expenses - divested/contributed
businesses 	— 	10
Other 	6 	7
Total expenses 	127 	181
Operating loss 	$ 	(125) $ 	(157)
For further discussion of our segments’ results, see “Segment Operating
Results,” of “Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.”
30

-- 35 of 121 --

19. RESTRUCTURING CHARGES
In September 2019, we initiated the transition of certain technology
platforms to advance the Company's strategic opportunities as a
technology and analytics provider and continue the realignment of certain
business areas. In connection with these restructuring efforts, we retired
certain elements of our marketplace infrastructure and technology product
offerings as we implement NFF and other technologies internally and
externally. This represented a fundamental shift in our strategy and
technology as well as executive realignment. In June 2021, we completed
our 2019 restructuring plan and recognized total pre-tax charges of $118
million over a two-year period. Total pre-tax charges related primarily to
non-cash items such as asset impairments and accelerated depreciation,
and third-party consulting costs. Severance and employee-related charges
were also incurred.
The following table presents a summary of the 2019 restructuring plan
charges in the Condensed Consolidated Statements of Income for the three
and six months ended June 30, 2021 which primarily consisted of
consulting services, asset impairment charges primarily related to
capitalized software that was retired, and accelerated depreciation expense
on certain assets as a result of a decrease in their useful life.
Three Months Ended June
30, 2021 Six Months Ended June
30, 2021
(in millions)
Asset impairment charges and
accelerated depreciation
expense 	$ 	3 $ 	4
Consulting services 	14 	19
Severance and employee-
related costs 	1 	1
Other 	3 	7
Total restructuring charges 	$ 	21 $ 	31
31

-- 36 of 121 --

Item 2. Management's Discussion and Analysis of Financial Condition
and Results Of Operations
The following discussion and analysis of the financial condition and
results of operations of Nasdaq should be read in conjunction with our
condensed consolidated financial statements and related notes included in
this Form 10-Q.
OVERVIEW
Nasdaq is a global technology company serving the capital markets and
other industries. Our diverse offerings of data, analytics, software and
services enables clients to optimize and execute their business vision with
confidence.
We manage, operate and provide our products and services in four
business segments: Market Technology, Investment Intelligence, Corporate
Platforms and Market Services.
Second Quarter 2022 and Recent Developments
Dividends on Common Stock
• For the three months ended June 30, 2022, we returned $98 million to
shareholders through dividend payments.
• In June 2022, the Company’s shareholders, and the SEC, approved the
Company’s proposed charter amendment to increase the number of
authorized shares of common stock. In July 2022, the charter was
amended and the board of directors approved and declared a 3-for-1
stock split in the form of a stock dividend on each share of common
stock. Trading on a split-adjusted basis is expected to take place on
August 29, 2022.
• In July 2022, the board of directors approved a regular quarterly cash
dividend of $0.20 per share on our outstanding common stock. On a
split-adjusted basis, the dividend is economically equivalent to the
pre-split quarterly dividend of $0.60 per share on our outstanding
common stock paid in the preceding quarter.
Share Repurchase Program
• In second quarter of 2022, we repurchased 1,086,000 shares of
common stock for an aggregate of $166 million.
• As of June 30, 2022, the remaining amount authorized for repurchases
under our share repurchase program was $293 million.
Corporate Highlights
• Our Index business continued to experience strong net inflows of $71
billion over the last 12 months and the number of contracts traded on
futures and options on futures tracking Nasdaq indexes increased 64%
year over year.
• The Nasdaq Stock Market led U.S. exchanges for IPOs during the
second quarter of 2022. The Nasdaq Stock Market IPO win rate was
88% in the second quarter of 2022, including 38 IPOs representing
$2.8 billion in capital raised. There were 22 operating company and
16 special purpose acquisition company IPOs during the period.
• Nasdaq led all exchanges in total multiply-listed options traded and
set a record for the number of shares traded during the 2022 Russell
U.S. indexes reconstitution. In the second quarter and first six months
of 2022, Nasdaq led all exchanges during the period in total volume
traded for multiply-listed equity options. Nasdaq achieved a record
day for rebalancing Nasdaq listed securities in the annual Russell
reconstitution, with 3.31 billion shares representing $63.8 billion,
executed in 2.04 seconds.
• Market Technology new order intake totaled $102 million in the
second quarter of 2022, with nearly 60% coming from new customers,
including a client agreement with Climate Impact X to leverage
Nasdaq’s Marketplace Services Platform.
32

-- 37 of 121 --

Financial Summary
The following tables summarize our financial performance for the three
and six months ended June 30, 2022 when compared to the same periods
in 2021. The comparability of our results of operations between reported
periods is impacted by the acquisition of Verafin in February 2021 and the
divestiture of our U.S. Fixed Income business in June 2021, which was
part of our FICC business within our Market Services segment, as well as
the contribution of our NPM business in July 2021 to a standalone,
independent company, of which we own the largest minority interest,
together with a consortium of third-party financial institutions. See “2021
Divestiture,” and “2021 Acquisition,” of Note 4, “Acquisitions and
Divestiture,” to the condensed consolidated financial statements for further
discussion. For a detailed discussion of our results of operations, see
“Segment Operating Results” below.
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions, except per share amounts)
Revenues less transaction-
based expenses 	$ 	893 $ 	846 	5.6 %
Operating expenses 	481 	470 	2.3 %
Operating income 	412 	376 	9.6 %
Net income attributable to
Nasdaq 	$ 	307 $ 	341 	(10.0)%
Diluted earnings per share $ 	1.85 $ 	2.05 	(9.8)%
Cash dividends declared
per common share 	$ 	0.60 $ 	0.54 	11.1 %
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions, except per share amounts)
Revenues less transaction-
based expenses 	$ 	1,785 $ 	1,697 	5.2 %
Operating expenses 	968 	956 	1.3 %
Operating income 	817 	741 	10.3 %
Net income attributable to
Nasdaq 	$ 	590 $ 	639 	(7.7)%
Diluted earnings per share $ 	3.55 $ 	3.83 	(7.3)%
Cash dividends declared
per common share 	$ 	1.14 $ 	1.03 	10.7 %
In countries with currencies other than the U.S. dollar, revenues and
expenses are translated using monthly average exchange rates. Impacts on
our revenues less transaction-based expenses and operating income
associated with fluctuations in foreign currency are discussed in more
detail under “Item 3. Quantitative and Qualitative Disclosures about
Market Risk.”
Nasdaq's Operating Results
The following chart summarizes our ARR (in millions):
ARR for a given period is the annualized revenue derived from
subscription contracts with a defined contract value. This excludes
contracts that are not recurring, are one-time in nature, or where the
contract value fluctuates based on defined metrics. ARR is one of our key
performance metrics to assess the health and trajectory of our recurring
business. ARR does not have any standardized definition and is therefore
unlikely to be comparable to similarly titled measures presented by other
companies. ARR should be viewed independently of revenue and deferred
revenue and is not intended to be combined with or to replace either of
those items. ARR is not a forecast and the active contracts at the end of a
reporting period used in calculating ARR may or may not be extended or
renewed by our customers.
33

-- 38 of 121 --

The ARR chart includes:
▪ Active Market Technology support and SaaS subscription
contracts.
▪
Proprietary market data and index data subscriptions as well as
subscription contracts for eVestment, Solovis, NDW Research
Platform, Nasdaq Fund Network and Nasdaq Data Link. It
also includes guaranteed minimum on futures contracts within
the Index business.
▪ U.S. and Nordic annual listing fees, IR and ESG products,
including subscription contracts for IR Insight, board portals
and OneReport, as well as IR advisory services.
▪ Trade Management Services business, excluding one-time
service requests.
The following chart summarizes our quarterly annualized SaaS revenues
for our Solutions Segments, which is comprised of the Market Technology,
Investment Intelligence and Corporate Platforms segments, for the second
quarter of 2022 and 2021 (in millions):
Segment Operating Results
The following table presents our revenues by segment, transaction-based
expenses for our Market Services segment and total revenues less
transaction-based expenses:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Market Technology 	$ 	131 $ 	117 	12.0 %
Investment Intelligence 	283 	261 	8.4 %
Corporate Platforms 	168 	149 	12.8 %
Market Services 	969 	874 	10.9 %
Other revenues 	1 	11 	(90.9)%
Total revenues 	$ 	1,552 $ 	1,412 	9.9 %
Transaction rebates 	(529) 	(517) 	2.3 %
Brokerage, clearance and
exchange fees 	(130) 	(49) 	165.3 %
Total revenues less
transaction-based
expenses 	$ 	893 $ 	846 	5.6 %
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Market Technology 	$ 	255 $ 	217 	17.5 %
Investment Intelligence 	567 	516 	9.9 %
Corporate Platforms 	336 	296 	13.5 %
Market Services 	1,927 	2,010 	(4.1)%
Other revenues 	2 	24 	(91.7)%
Total revenues 	3,087 	3,063 	0.8 %
Transaction rebates 	(1,111) 	(1,170) 	(5.0)%
Brokerage, clearance and
exchange fees 	(191) 	(196) 	(2.6)%
Total revenues less
transaction-based
expenses 	$ 	1,785 $ 	1,697 	5.2 %
34

-- 39 of 121 --

The following charts present our Market Technology, Investment
Intelligence, Corporate Platforms and Market Services segments as a
percentage of our total revenues, less transaction-based expenses.
Percentage of Revenues Less Transaction-based Expenses by Segment
for the:
35

-- 40 of 121 --

MARKET TECHNOLOGY
The following tables present revenues and key drivers from our Market
Technology segment:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Anti Financial Crime
Technology 	$ 	75 $ 	58 	29.3 %
Marketplace Infrastructure
Technology 	56 	59 	(5.1)%
Total Market Technology $ 	131 $ 	117 	12.0 %
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Anti Financial Crime
Technology 	$ 	147 $ 	101 	45.5 %
Marketplace Infrastructure
Technology 	108 	116 	(6.9)%
Total Market Technology $ 	255 $ 	217 	17.5 %
Three Months Ended June 30,
2022 	2021
(in millions)
Order intake (in millions) 	$ 	102 $ 	119
ARR 	451 	428
Quarterly annualized SaaS revenues 	312 	268
Six Months Ended June 30,
2022 	2021
(in millions)
Order intake 	$ 	150 $ 	160
In the tables above, order intake is the total contract value of orders signed
during the period, excluding Verafin. ARR and SaaS revenues include
Verafin.
Anti Financial Crime Technology Revenues
Anti-financial crime technology revenues increased in both the second
quarter and first six months of 2022 compared with the same periods in
2021 primarily due to increased demand for fraud and anti-money
laundering and surveillance solutions.
Marketplace Infrastructure Technology Revenues
Marketplace infrastructure technology revenues decreased in both the
second quarter and first six months of 2022 compared with the same
periods in 2021 primarily due to the unfavorable impact of changes in
foreign exchange rates and the successful completion of a significant long-
term contract, partially offset by growth in SaaS revenues.
INVESTMENT INTELLIGENCE
The following tables present revenues and key drivers from our Investment
Intelligence segment:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Market Data 	$ 	105 $ 	104 	1.0 %
Index 	124 	107 	15.9 %
Analytics 	54 	50 	8.0 %
Total Investment
Intelligence 	$ 	283 $ 	261 	8.4 %
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Market Data 	$ 	213 $ 	209 	1.9 %
Index 	246 	209 	17.7 %
Analytics 	108 	98 	10.2 %
Total Investment
Intelligence 	$ 	567 $ 	516 	9.9 %
As of or
Three Months Ended June 30,
2022 	2021
Number of licensed ETPs 	374 	359
TTM Change in Period End ETP AUM tracking Nasdaq indexes (in
billions)
Beginning balance 	$ 	415 $ 	272
Net (depreciation) appreciation 	(90) 	113
Net impact of ETP sponsor switches 	(75) 	(17)
Net inflows 	71 	47
Ending balance 	$ 	321 $ 	415
ARR (in millions) 	$ 	586 $ 	547
Quarterly annualized SaaS revenues (in
millions) 	$ 	215 $ 	192
In the table above, TTM represents trailing twelve months.
Market Data Revenues
Market data revenues increased in both the second quarter and first six
months of 2022 compared with the same periods in 2021 primarily due to
an increase in proprietary data revenues driven by higher international
demand, partially offset by an unfavorable impact from changes in foreign
exchange rates.
Index Revenues
Index revenues increased in both the second quarter and first six months of
2022 compared with the same periods in 2021 primarily due to higher
licensing revenues from futures trading linked to the Nasdaq-100 Index.
The increase in the first six months of 2022 also reflects higher licensing
revenues resulting from higher average AUM in ETPs linked to Nasdaq
indexes.
36

-- 41 of 121 --

Analytics Revenues
Analytics revenues increased in both the second quarter and first six
months of 2022 compared with the same periods in 2021 primarily due to
the growth in our eVestment platform driven by new sales and strong net
retention.
CORPORATE PLATFORMS
The following tables present revenues and key drivers from our Corporate
Platforms segment:
Three Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Listing Services 	$ 	107 $ 	93 	15.1 %
IR & ESG Services 	61 	56 	8.9 %
Total Corporate Platforms $ 	168 $ 	149 	12.8 %
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Listing Services 	$ 	214 $ 	184 	16.3 %
IR & ESG Services 	122 	112 	8.9 %
Total Corporate Platforms $ 	336 $ 	296 	13.5 %
As of or
Three Months Ended June 30,
2022 	2021
IPOs
The Nasdaq Stock Market 	38 	135
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic 	17 	62
Total new listings
The Nasdaq Stock Market 	84 	192
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic 	25 	72
Number of listed companies
The Nasdaq Stock Market 	4,269 	3,817
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic 	1,260 	1,152
ARR (in millions) 	$ 	586 $ 	509
Quarterly annualized SaaS
revenues (in millions) 	$ 	152 $ 	144
As of or
Six Months Ended June 30,
2022 	2021
IPOs
The Nasdaq Stock Market 	108 	410
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic 	30 	86
Total new listings
The Nasdaq Stock Market 	194 	511
Exchanges that comprise Nasdaq
Nordic and Nasdaq Baltic 	44 	104
In the tables above:
• The Nasdaq Stock Market new listings include IPOs, including issuers
that switched from other listing venues and separately listed ETPs. For
the three months ended June 30, 2022 and 2021, IPOs included 16 and
47 SPACs, respectively. For the six months ended June 30, 2022 and
2021, IPOs included 59 and 243 SPACs, respectively.
• Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic new listings
include IPOs and represent companies listed on the Nasdaq Nordic and
Nasdaq Baltic exchanges and companies on the alternative markets of
Nasdaq First North.
• Number of total listed companies on The Nasdaq Stock Market at period
end includes 465 ETPs as of June 30, 2022 and 419 ETPs as of June 30,
2021.
• Number of total listed companies on the exchanges that comprise
Nasdaq Nordic and Nasdaq Baltic represents companies listed on these
exchanges and companies on the alternative markets of Nasdaq First
North.
37

-- 42 of 121 --

Listing Services Revenues
Listing services revenues increased in both the second quarter and first six
months of 2022 compared with the same periods in 2021 primarily due to
an increase in the overall number of listed companies.
IR & ESG Services Revenues
IR & ESG Services revenues increased in both the second quarter and first
six months of 2022 compared with the same periods in 2021 primarily due
to increased sales and higher retention rates. Growth in revenues reflect
higher adoption across the breadth of investor relations and newer ESG
advisory and reporting offerings as well as an increase in the number of
corporate issuer clients.
MARKET SERVICES
Equity Derivative Trading and Clearing Revenues
The following tables present total revenues, transaction-based expenses,
and total revenues less transaction-based expenses as well as key drivers
from our Equity Derivative Trading and Clearing business:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Equity Derivative Trading and
Clearing Revenues 	$ 	324 $ 	364 	(11.0)%
Transaction-based expenses:
Transaction rebates 	(206) 	(255) 	(19.2)%
Brokerage, clearance and
exchange fees 	(15) 	(6) 	150.0 %
Equity derivative trading and
clearing revenues less
transaction-based expenses $ 	103 $ 	103 	— %
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Equity Derivative Trading and
Clearing Revenues 	$ 	674 $ 	785 	(14.1)%
Transaction-based expenses:
Transaction rebates 	(438) 	(550) 	(20.4)%
Brokerage, clearance and
exchange fees 	(21) 	(26) 	(19.2)%
Equity derivative trading and
clearing revenues less
transaction-based expenses $ 	215 $ 	209 	2.9 %
In the tables above, brokerage, clearance and exchange fees includes
Section 31 fees of $14 million in the second quarter of 2022, $5 million in
the second quarter of 2021, $20 million in the first six months of 2022 and
$22 million in the first six months of 2021. Section 31 fees are recorded as
equity derivative trading and clearing revenues with a corresponding
amount recorded in transaction-based expenses.
Three Months Ended June 30,
2022 	2021
U.S. equity options
Total industry average daily volume (in
millions) 	36.7 	34.6
Nasdaq PHLX matched market share 	11.7 % 	12.7 %
The Nasdaq Options Market matched
market share 	8.2 % 	8.4 %
Nasdaq BX Options matched market share 	2.1 % 	1.1 %
Nasdaq ISE Options matched market share 	5.4 % 	6.1 %
Nasdaq GEMX Options matched market
share 	2.4 % 	6.1 %
Nasdaq MRX Options matched market
share 	1.6 % 	1.5 %
Total matched market share executed on
Nasdaq’s exchanges 	31.4 % 	35.9 %
Nasdaq Nordic and Nasdaq Baltic options and futures
Total average daily volume of options and
futures contracts 	277,008 	262,890
Six Months Ended June 30,
2022 	2021
U.S. equity options
Total industry average daily volume (in
millions) 	38.3 	37.3
Nasdaq PHLX matched market share 	11.6 % 	12.8 %
The Nasdaq Options Market matched
market share 	8.3 % 	8.1 %
Nasdaq BX Options matched market share 	2.1 % 	0.9 %
Nasdaq ISE Options matched market share 	5.6 % 	7.0 %
Nasdaq GEMX Options matched market
share 	2.4 % 	6.0 %
Nasdaq MRX Options matched market
share 	1.7 % 	1.4 %
Total matched market share executed on
Nasdaq’s exchanges 	31.7 % 	36.2 %
Nasdaq Nordic and Nasdaq Baltic options and futures
Total average daily volume of options and
futures contracts 	322,390 	311,016
In the tables above, Nasdaq Nordic and Nasdaq Baltic total average daily
volume of options and futures contracts include Finnish option contracts
traded on Eurex for which Nasdaq and Eurex have a revenue sharing
arrangement.
38

-- 43 of 121 --

Equity derivative trading and clearing revenues decreased in both the
second quarter and first six months of 2022 compared with the same
periods in 2021. The decrease in the second quarter of 2022 was primarily
due to lower U.S. matched market share executed on Nasdaq's exchanges,
partially offset by a higher gross capture rate and higher Section 31 pass-
through fee revenue. The decrease for the first six months of 2022 was
primarily due to lower U.S. matched market share executed on Nasdaq's
exchanges and lower gross capture rate, partially offset by higher U.S. and
European industry trading volumes.
Equity derivative trading and clearing revenues less transaction-based
expenses remained flat in the second quarter of 2022 compared with the
same period in 2021 primarily due to higher net capture rates and higher
U.S. and European industry trading volumes, offset by lower U.S. matched
market share executed on Nasdaq's exchanges and the unfavorable impact
of the changes in foreign exchange rates. Equity derivative trading and
clearing revenues less transaction-based expenses increased in the first six
months of 2022 compared with the same period in 2021 primarily due to
higher net capture rates and higher U.S. and European industry trading
volumes, partially offset by lower U.S. matched market share executed on
Nasdaq's exchanges.
Section 31 fees are recorded as equity derivative trading and clearing
revenues with a corresponding amount recorded as brokerage, clearance
and exchange fees in the Condensed Consolidated Statements of Income.
In the U.S., we are assessed these fees from the SEC and pass them
through to our customers in the form of incremental fees. Pass-through
fees can increase or decrease due to rate changes by the SEC, our
percentage of the overall industry volumes processed on our systems, and
differences in actual dollar value traded. Since the amount recorded in
revenues is equal to the amount recorded as brokerage, clearance and
exchange fees, there is no impact on our revenues less transaction-based
expenses. Section 31 fees increased in the second quarter of 2022
compared with same period in 2021 primarily due to higher average SEC
fee rates, following the increase in SEC 31 fee rates in May 2022. Section
31 fees decreased in the first six months of 2022 compared with same
period in 2021 primarily due to lower average SEC fee rates, following the
decrease in SEC 31 fee rates in February 2021.
Transaction rebates, in which we credit a portion of the execution charge
to the market participant, decreased in both the second quarter and first six
months of 2022 compared with the same periods in 2021. The decrease in
the second quarter of 2022 was primarily due to lower overall U.S.
matched market share executed on Nasdaq's exchanges and lower
volumes, partially offset by a higher rebate capture rate. The decrease in
the first six months of 2022 was primarily due to lower overall U.S.
matched market share executed on Nasdaq's exchanges and lower rebate
capture rate, partially offset by higher U.S. and European industry trading
volumes.
Cash Equity Trading Revenues
The following tables present total revenues, transaction-based expenses,
and total revenues less transaction-based expenses as well as key drivers
and other metrics from our Cash Equity Trading business:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Cash Equity Trading Revenues $ 	546 $ 	415 	31.6 %
Transaction-based expenses:
Transaction rebates 	(323) 	(262) 	23.3 %
Brokerage, clearance and
exchange fees 	(115) 	(43) 	167.4 %
Cash equity trading revenues
less transaction-based
expenses 	$ 	108 $ 	110 	(1.8)%
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Cash Equity Trading Revenues $ 	1,056 $ 	1,033 	2.2 %
Transaction-based expenses:
Transaction rebates 	(673) 	(620) 	8.5 %
Brokerage, clearance and
exchange fees 	(170) 	(170) 	— %
Cash equity trading revenues
less transaction-based
expenses 	$ 	213 $ 	243 	(12.3)%
In the tables above, brokerage, clearance and exchange fees includes
Section 31 fees of $108 million in the second quarter of 2022, $36 million
in the second quarter of 2021, $156 million in the first six months of 2022
and $151 million in the first six months of 2021. Section 31 fees are
recorded as cash equity trading revenues with a corresponding amount
recorded in transaction-based expenses.
39

-- 44 of 121 --

Three Months Ended June 30,
2022 	2021
Total U.S.-listed securities
Total industry average daily share
volume (in billions) 	12.6 	10.6
Matched share volume (in billions) 	139.0 	114.2
The Nasdaq Stock Market matched
market share 	16.5 % 	15.8 %
Nasdaq BX matched market share 	0.5 % 	0.7 %
Nasdaq PSX matched market share 	0.8 % 	0.7 %
Total matched market share executed on
Nasdaq’s exchanges 	17.8 % 	17.2 %
Market share reported to the
FINRA/Nasdaq Trade Reporting
Facility 	34.3 % 	35.3 %
Total market share 	52.1 % 	52.5 %
Nasdaq Nordic and Nasdaq Baltic securities
Average daily number of equity trades
executed on Nasdaq’s exchanges 	948,874 	1,019,162
Total average daily value of shares traded
(in billions) 	$ 	5.7 	$ 	6.6
Total market share executed on Nasdaq’s
exchanges 	72.2 % 	77.3 %
Six Months Ended June 30,
2022 	2021
Total U.S.-listed securities
Total industry average daily share
volume (in billions) 	12.7 	12.6
Matched share volume (in billions) 	281.2 	266.8
The Nasdaq Stock Market matched
market share 	16.4 % 	15.8 %
Nasdaq BX matched market share 	0.5 % 	0.6 %
Nasdaq PSX matched market share 	0.8 % 	0.7 %
Total matched market share executed on
Nasdaq’s exchanges 	17.7 % 	17.1 %
Market share reported to the
FINRA/Nasdaq Trade Reporting
Facility 	33.9 % 	35.3 %
Total market share 	51.6 % 	52.4 %
Nasdaq Nordic and Nasdaq Baltic securities
Average daily number of equity trades
executed on Nasdaq’s exchanges 	1,043,461 	1,056,726
Total average daily value of shares traded
(in billions) 	$ 	6.4 	$ 	6.8
Total market share executed on Nasdaq’s
exchanges 	72.6 % 	77.9 %
In the tables above, total market shares includes transactions executed on
The Nasdaq Stock Market’s, Nasdaq BX’s and Nasdaq PSX’s systems plus
trades reported through the FINRA/Nasdaq Trade Reporting Facility.
Cash equity trading revenues increased in the second quarter and first six
months of 2022 compared with the same periods in 2021 primarily due to
higher U.S. industry trading volumes and higher U.S. matched market
share executed on Nasdaq's exchanges, partially offset by lower U.S. gross
capture rate, lower European market share and the unfavorable impact of
changes in foreign exchange rates.
Cash equity trading revenues less transaction-based expenses decreased in
the second quarter and first six months of 2022 compared with the same
periods in 2021 primarily due to lower U.S. net capture rate, lower
European market share and the unfavorable impact of changes in foreign
exchange rates, partially offset by higher U.S. industry volumes and higher
U.S. matched market share executed on Nasdaq's exchanges. The decrease
in cash equity trading revenues was also due to higher transaction rebates.
Similar to equity derivative trading and clearing, in the U.S. we record
Section 31 fees as cash equity trading revenues with a corresponding
amount recorded as brokerage, clearance and exchange fees in the
Condensed Consolidated Statements of Income. We are assessed these fees
from the SEC and pass them through to our customers in the form of
incremental fees. Since the amount recorded as revenues is equal to the
amount recorded as brokerage, clearance and exchange fees, there is no
impact on our revenues less transaction-based expenses. Section 31 fees
increased in the second quarter and first six months of 2022 compared with
the same periods in 2021 primarily due to higher average SEC fee rates.
Transaction rebates increased in the second quarter and the first six months
of 2022 compared with the same periods in 2021. For The Nasdaq Stock
Market and Nasdaq PSX, we credit a portion of the per share execution
charge to the market participant that provides the liquidity, and for Nasdaq
BX, we credit a portion of the per share execution charge to the market
participant that takes the liquidity. The increase was primarily due to
higher US industry volumes, higher U.S. matched market share executed
on Nasdaq's exchanges and a higher rebate capture rate.
40

-- 45 of 121 --

FICC Revenues
The following tables present revenues from our FICC business:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
FICC Revenues 	$ 	12 $ 	14 	(14.3)%
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
FICC Revenues 	$ 	26 $ 	31 	(16.1)%
FICC revenues decreased in the second quarter and first six months of
2022 compared with the same periods in 2021 primarily due to the
unfavorable impact of changes in foreign exchange rates. FICC revenues
also decreased in the first six months of 2022 due to lower commodities
products revenues.
Trade Management Services Revenues
The following tables present revenues and key drivers from our Trade
Management Services business:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Trade Management Services
Revenues 	$ 	87 $ 	81 	7.4 %
Six Months Ended June 30, Percentage
Change	2022 	2021
(in millions)
Trade Management Services
Revenues 	$ 	171 $ 	161 	6.2 %
Three Months Ended June 30,
2022 	2021
(in millions)
ARR 	$ 	342 $ 	320
Trade management services revenues increased in the second quarter and
first six months of 2022 compared with the same periods in 2021 primarily
due to higher demand for connectivity and infrastructure services.
OTHER REVENUES
For the three and six months ended June 30, 2021, other revenues include
the revenues associated with our U.S. Fixed Income business, which was
sold in June 2021. Prior to the sale date, these revenues were included in
our Market Services and Investment Intelligence segments. See “2021
Divestiture,” of Note 4, “Acquisitions and Divestiture,” to the condensed
consolidated financial statements for further discussion of this divestiture.
Additionally, other revenues include revenues associated with the NPM
business which we contributed in July 2021 to a standalone, independent
company, of which we own the largest minority interest, together with a
consortium of third-party financial institutions. Prior to July 2021, these
revenues were included in our Corporate Platforms segment. For the three
and six months ended June 30, 2022, other revenues were related to a
transitional services agreement associated with a divested business.
41

-- 46 of 121 --

EXPENSES
Operating Expenses
The following tables present our operating expenses:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Compensation and benefits $ 	247 $ 	231 	6.9 %
Professional and contract
services 	29 	38 	(23.7)%
Computer operations and
data communications 	50 	46 	8.7 %
Occupancy 	25 	26 	(3.8)%
General, administrative and
other 	34 	12 	183.3 %
Marketing and advertising 	11 	9 	22.2 %
Depreciation and
amortization 	65 	68 	(4.4)%
Regulatory 	8 	7 	14.3 %
Merger and strategic
initiatives 	12 	12 	— %
Restructuring charges 	— 	21 	(100.0)%
Total operating expenses $ 	481 $ 	470 	2.3 %
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Compensation and benefits $ 	501 $ 	470 	6.6 %
Professional and contract
services 	64 	65 	(1.5)%
Computer operations and
data communications 	101 	90 	12.2 %
Occupancy 	52 	55 	(5.5)%
General, administrative and
other 	55 	24 	129.2 %
Marketing and advertising 	21 	19 	10.5 %
Depreciation and
amortization 	132 	131 	0.8 %
Regulatory 	15 	14 	7.1 %
Merger and strategic
initiatives 	27 	57 	(52.6)%
Restructuring charges 	— 	31 	(100.0)%
Total operating
expenses 	$ 	968 $ 	956 	1.3 %
The increase in compensation and benefits expense in both the second
quarter and first six months of 2022 compared with the same periods in
2021 was primarily driven by continued investment in employees to drive
growth and inflationary pressures, partially offset by a favorable impact
from foreign exchange rates.
Headcount increased to 6,214 employees as of June 30, 2022 from 5,696
as of June 30, 2021 primarily due to growth in various businesses.
Professional and contract services expense decreased in both the second
quarter and first six months of 2022 compared with the same periods in
2021 primarily due to a decrease in legal fees.
Computer operations and data communications expense increased in both
the second quarter and first six months of 2022 compared with the same
periods in 2021 primarily due to higher software costs related to new cloud
initiatives.
Occupancy expense decreased in both the second quarter and first six
months of 2022 compared with the same periods in 2021 primarily due to
a favorable impact from foreign exchange rates.
General, administrative and other expense increased in both the second
quarter and first six months of 2022 compared with the same periods in
2021 due to debt extinguishment costs following the repayment of our
2024 Notes and higher travel costs.
Depreciation and amortization expense decreased for the second quarter of
2022 compared with the same period in 2021 due to a favorable impact
from foreign exchange rates. Depreciation and amortization expense
remained relatively flat in the first six months of 2022 compared with the
same period in 2021.
Regulatory expense remained relatively flat in the second quarter and first
six months of 2022 compared with the same periods in 2021.
Merger and strategic initiatives expense remained relatively flat in the
second quarter of 2022 compared with the same period in 2021 and
decreased in the first six months of 2022 compared with the same period in
2021 due to acquisition costs associated with the Verafin transaction that
occurred in the first quarter of 2021. We have pursued various strategic
initiatives and completed acquisitions and divestitures in recent years,
which have resulted in expenses which would not have otherwise been
incurred. These expenses generally include integration costs, as well as
legal, due diligence and other third-party transaction costs and will vary
based on the size and frequency of the activities described above.
See Note 19, “Restructuring Charges,” to the condensed consolidated
financial statements for further discussion of our 2019 restructuring plan
and charges associated with this plan.
42

-- 47 of 121 --

Non-operating Income and Expenses
The following table presents our non-operating income and expenses:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Interest expense 	(32) 	(33) 	(3.0)%
Net gain on divestiture of
business 	— 	84 	(100.0)%
Other income 	8 	— 	N/M
Net income from
unconsolidated investees 	9 	27 	(66.7)%
Total non-operating income
(expenses) 	$ 	(15) $ 	78 	(119.2)%
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Interest income 	$ 	1 $ 	1 	— %
Interest expense 	(64) 	(62) 	3.2 %
Net interest expense 	(63) 	(61) 	3.3 %
Net gain on divestiture of
business 	— 	84 	(100.0)%
Other income 	2 	1 	100.0 %
Net income from
unconsolidated investees 	15 	84 	(82.1)%
Total non-operating income
(expenses) 	$ 	(46) $ 	108 	(142.6)%
_______
N/M Not meaningful.
The following table presents our interest expense:
Three Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Interest expense on debt 	$ 	30 $ 	30 	— %
Accretion of debt issuance
costs and debt discount 	1 	2 	(50.0)%
Other fees 	1 	1 	— %
Interest expense 	$ 	32 $ 	33 	(3.0)%
Six Months Ended June 30,
Percentage
Change	2022 	2021
(in millions)
Interest expense on debt 	$ 	59 $ 	57 	3.5 %
Accretion of debt issuance
costs and debt discount 	4 	4 	— %
Other fees 	1 	1 	— %
Interest expense 	$ 	64 $ 	62 	3.2 %
Interest expense remained relatively flat in the second quarter of 2022
compared with the same period in 2021 and slightly increased in the first
six months of 2022 compared with the same period in 2021 primarily due
to the issuance of the 2052 Notes in the first quarter of 2022 and the
repayment of the 2024 Notes in the second quarter of 2022. See Note 8,
“Debt Obligations,” to the condensed consolidated financial statements for
further discussion of our debt obligations.
The net gain on divestiture of business in the second quarter and first six
months of 2021 relates to the sale of our U.S. Fixed Income business,
which was part of our FICC business within our Market Services segment,
to Tradeweb. We recognized a pre-tax gain on the sale of $84 million, net
of disposal costs. See “2021 Divestiture,” of Note 4, “Acquisitions and
Divestiture,” to the condensed consolidated financial statements for further
discussion.
Other income increased in both the second quarter and first six months of
2022 compared with the same periods in 2021 primarily due to gains from
strategic investments related to our corporate venture program.
Net income from unconsolidated investees decreased in both the second
quarter and first six months of 2022 compared with the same period in
2021 primarily due to a decrease in income recognized from our equity
method investment in OCC. See “Equity Method Investments,” of Note 6,
“Investments,” to the condensed consolidated financial statements for
further discussion.
Tax Matters
The following table presents our income tax provision and effective tax
rate:
Three Months Ended June 30, Percentage
Change	2022 	2021
($ in millions)
Income tax provision 	$ 	90 $ 	113 	(20.4)%
Effective tax rate 	22.7 % 	24.9 %
Six Months Ended June 30, 	Percentage
Change	2022 	2021
(in millions)
Income tax provision 	$ 	182 $ 	210 	(13.3)%
Effective tax rate 	23.6 % 	24.7 %
For further discussion of our tax matters, see Note 16, “Income Taxes,” to
the condensed consolidated financial statements.
43

-- 48 of 121 --

NON-GAAP FINANCIAL MEASURES
In addition to disclosing results determined in accordance with U.S.
GAAP, we also provide non-GAAP net income attributable to Nasdaq and
non-GAAP diluted earnings per share. Management uses this non-GAAP
information internally, along with U.S. GAAP information, in evaluating
our performance and in making financial and operational decisions. We
believe our presentation of these measures provides investors with greater
transparency and supplemental data relating to our financial condition and
results of operations. In addition, we believe the presentation of these
measures is useful to investors for period-to-period comparisons of our
ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S.
GAAP, and may be different from non-GAAP measures used by other
companies. In addition, other companies, including companies in our
industry, may calculate such measures differently, which reduces their
usefulness as comparative measures. Investors should not rely on any
single financial measure when evaluating our business. This non-GAAP
information should be considered as supplemental in nature and is not
meant as a substitute for our operating results in accordance with U.S.
GAAP. We recommend investors review the U.S. GAAP financial
measures included in this Quarterly Report on Form 10-Q, including our
condensed consolidated financial statements and the notes thereto. When
viewed in conjunction with our U.S. GAAP results and the accompanying
reconciliation, we believe these non-GAAP measures provide greater
transparency and a more complete understanding of factors affecting our
business than U.S. GAAP measures alone.
We understand that analysts and investors regularly rely on non-GAAP
financial measures, such as non-GAAP net income attributable to Nasdaq
and non-GAAP diluted earnings per share, to assess operating
performance. We use non-GAAP net income attributable to Nasdaq and
non-GAAP diluted earnings per share because they highlight trends more
clearly in our business that may not otherwise be apparent when relying
solely on U.S. GAAP financial measures, since these measures eliminate
from our results specific financial items that have less bearing on our
ongoing operating performance. We believe that excluding the following
items from the non-GAAP net income attributable to Nasdaq provides a
more meaningful analysis of Nasdaq’s ongoing operating performance and
comparisons in Nasdaq’s performance between periods:
• Amortization expense of acquired intangible assets: We amortize
intangible assets acquired in connection with various acquisitions.
Intangible asset amortization expense can vary from period to period due
to episodic acquisitions completed, rather than from our ongoing
business operations. As such, if intangible asset amortization is included
in performance measures, it is more difficult to assess the day-to-day
operating performance of the businesses, the relative operating
performance of the businesses between periods, and the earnings power
of Nasdaq.
• Merger and strategic initiatives expense: We have pursued various
strategic initiatives and completed acquisitions and divestitures in recent
years that have resulted in expenses which would not have otherwise
been incurred. The frequency and the amount of such expenses vary
significantly based on the size, timing and complexity of the transaction.
These expenses primarily include integration costs, as well as legal, due
diligence and other third-party transaction costs.
• Restructuring charges: We initiated the transition of certain technology
platforms to advance our strategic opportunities as a technology and
analytics provider and continue the realignment of certain business
areas. See Note 19, “Restructuring Charges,” to the condensed
consolidated financial statements for further discussion of our 2019
restructuring plan, which was completed in June 2021. Charges
associated with this plan represented a fundamental shift in our strategy
and technology as well as executive realignment.
• Net income from unconsolidated investee: See “Equity Method
Investments,” of Note 6, “Investments,” to the condensed consolidated
financial statements for further discussion. Our income on our
investment in OCC may vary significantly compared to prior periods
due to the changes in OCC's capital management policy.
• Other items: We have excluded certain other charges or gains, including
certain tax items, that are the result of other non-comparable events to
measure operating performance. For the three and six months ended
June 30, 2022, other items primarily include a loss on extinguishment of
debt. For the three and six months ended June 30, 2021, other items
primarily include a net gain on divestiture of businesses, which
primarily represents our pre-tax net gain of $84 million on the sale of
our U.S. Fixed Income business.
• Significant tax items: The non-GAAP adjustment to the income tax
provision for the three and six months ended June 30, 2022 and 2021
primarily includes the tax impact of each non-GAAP adjustment.
44

-- 49 of 121 --

The following tables present reconciliations between U.S. GAAP net
income attributable to Nasdaq and diluted earnings per share and non-
GAAP net income attributable to Nasdaq and diluted earnings per share:
Three Months Ended June 30,
2022 	2021
(in millions, except per share amounts)
U.S. GAAP net income attributable
to Nasdaq 	$ 	307 $ 	341
Non-GAAP adjustments:
Amortization expense of acquired
intangible assets 	39 	40
Merger and strategic initiatives
expense 	12 	12
Restructuring charges 	— 	21
Net income from unconsolidated
investee 	(9) 	(26)
Extinguishment of debt 	16 	—
Net gain on divestiture of business 	— 	(84)
Other 	(8) 	5
Total non-GAAP adjustments 	50 	(32)
Total non-GAAP tax adjustments 	(15) 	7
Total non-GAAP adjustments, net
of tax 	35 	(25)
Non-GAAP net income attributable
to Nasdaq 	$ 	342 $ 	316
U.S. GAAP effective tax rate 	22.7 % 	24.9 %
Total adjustments from non-GAAP
tax rate 	0.8 % 	0.2 %
Non-GAAP effective tax rate 	23.5 % 	25.1 %
Weighted-average common shares
outstanding for diluted earnings per
share 	165.5 	166.4
U.S. GAAP diluted earnings per
share 	$ 	1.85 $ 	2.05
Total adjustments from non-GAAP
net income 	0.22 	(0.15)
Non-GAAP diluted earnings per
share 	$ 	2.07 $ 	1.90
Six Months Ended June 30,
2022 	2021
(in millions, except per share amounts)
U.S. GAAP net income attributable
to Nasdaq 	$ 	590 $ 	639
Non-GAAP adjustments:
Amortization expense of acquired
intangible assets 	78 	76
Merger and strategic initiatives
expense 	27 	57
Restructuring charges 	— 	31
Net income from unconsolidated
investee 	(14) 	(83)
Extinguishment of debt 	16 	—
Net gain on divestiture of business 	— 	(84)
Other 	2 	7
Total non-GAAP adjustments 	109 	4
Total non-GAAP tax adjustments 	(29) 	—
Total non-GAAP adjustments, net
of tax 	80 	4
Non-GAAP net income attributable
to Nasdaq 	$ 	670 $ 	643
U.S. GAAP effective tax rate 	23.6 % 	24.7 %
Total adjustments from non-GAAP
tax rate 	0.4 % 	(0.1)%
Non-GAAP effective tax rate 	24.0 % 	24.6 %
Weighted-average common shares
outstanding for diluted earnings per
share 	166.4 	166.8
U.S. GAAP diluted earnings per
share 	$ 	3.55 $ 	3.83
Total adjustments from non-GAAP
net income 	0.48 	0.02
Non-GAAP diluted earnings per
share 	$ 	4.03 $ 	3.85
LIQUIDITY AND CAPITAL RESOURCES
Historically, we have funded our operating activities and met our
commitments through cash generated by operations, augmented by the
periodic issuance of our common stock and debt. Currently, our cost and
availability of funding remain healthy. We continue to prudently assess our
capital deployment strategy through balancing acquisitions, internal
investments, debt repayments, and shareholder return activity, including
share repurchases and dividends.
In the near term, we expect that our operations and the availability under
our revolving credit facility and commercial paper program will provide
sufficient cash to fund our operating expenses, capital expenditures, debt
repayments, any share repurchases, and any dividends.
45

-- 50 of 121 --

The value of various assets and liabilities, including cash and cash
equivalents, receivables, accounts payable and accrued expenses, the
current portion of long-term debt, and commercial paper, can fluctuate
from month to month. Working capital (calculated as current assets less
current liabilities) was $(653) million as of June 30, 2022, compared with
$(449) million as of December 31, 2021, a decrease of $204 million. The
decrease was primarily due to increases in deferred revenue, Section 31
fees payable to SEC and other current liabilities and a decrease in other
current assets and financial investments, partially offset by a decrease in
accrued personnel costs and increases in receivables, net and cash and cash
equivalents.
Principal factors that could affect the availability of our internally-
generated funds include:
• deterioration of our revenues in any of our business segments;
• changes in regulatory and working capital requirements; and
• an increase in our expenses.
Principal factors that could affect our ability to obtain cash from external
sources include:
• operating covenants contained in our credit facilities that limit our total
borrowing capacity;
• credit rating downgrades, which could limit our access to additional
debt;
• a significant decrease in the market price of our common stock;
• volatility or disruption in the public debt and equity markets; and
• the impact of the COVID-19 pandemic on our business.
The following table summarizes our financial assets:
June 30, 2022 	December 31, 2021
(in millions)
Cash and cash equivalents 	$ 	454 $ 	393
Financial investments 	161 	208
Total financial assets 	$ 	615 $ 	601
Cash and Cash Equivalents
Cash and cash equivalents includes all non-restricted cash in banks and
highly liquid investments with original maturities of 90 days or less at the
time of purchase. The balance retained in cash and cash equivalents is a
function of anticipated or possible short-term cash needs, prevailing
interest rates, our investment policy, and alternative investment choices.
As of June 30, 2022, our cash and cash equivalents of $454 million were
primarily invested in money market funds, commercial paper and bank
deposits. In the long-term, we may use both internally generated funds and
external sources to satisfy our debt obligations and other long-term
liabilities. Cash and cash equivalents as of June 30, 2022 increased $61
million from December 31, 2021.
Repatriation of Cash
Our cash and cash equivalents held outside of the U.S. in various foreign
subsidiaries totaled $277 million as of June 30, 2022 and $266 million as
of December 31, 2021. The remaining balance held in the U.S. totaled
$177 million as of June 30, 2022 and $127 million as of December 31,
2021.
Unremitted earnings of certain subsidiaries outside of the U.S. are used to
finance our international operations and are considered to be indefinitely
reinvested.
Cash Flow Analysis
The following table summarizes the changes in cash flows:
Six Months Ended June 30,
Percentage
Change	2022 	2021
Net cash provided by (used in): 	(in millions)
Operating activities 	$ 	980 $ 	467 	109.9 %
Investing activities 	(244) 	(2,525) 	(90.3)%
Financing activities 	2,703 	(609) 	(543.8)%
Effect of exchange rate changes on
cash and cash equivalents and
restricted cash and cash equivalents 	(682) 	(108) 	531.5 %
Net increase (decrease) in cash and
cash equivalents and restricted cash
and cash equivalents 	2,757 	(2,775) 	(199.4)%
Cash and cash equivalents, restricted
cash and cash equivalents at
beginning of period 	5,496 	5,979 	(8.1)%
Cash and cash equivalents, restricted
cash and cash equivalents at end of
period 	$ 	8,253 $ 	3,204 	157.6 %
Reconciliation of Cash, Cash Equivalents
and Restricted Cash and Cash
Equivalents
Cash and cash equivalents 	$ 	454 $ 	390 	16.4 %
Restricted cash and cash equivalents 	30 	40 	(25.0)%
Restricted cash and cash equivalents
(default funds and margin deposits) 	7,769 	2,774 	180.1 %
Total 	$ 	8,253 $ 	3,204 	157.6 %
We have adjusted prior period presentation of opening and ending amounts
of cash, cash equivalents, and restricted cash and cash equivalents in our
condensed consolidated statements of cash flows to include restricted cash
and cash equivalents related to the default funds and margin deposits. See
Note 2, “Summary of Significant Accounting Policies,” to the condensed
consolidated financial statements for further discussion of this adjustment.
Net Cash Provided by Operating Activities
Net cash provided by operating activities primarily consists of net income
adjusted for certain non-cash items such as: depreciation and amortization
expense of property and equipment; amortization expense of acquired
finite-lived intangible assets; expense associated with share-based
compensation; deferred income taxes; expense associated with
extinguishment of debt; and net income from unconsolidated investees.
46

-- 51 of 121 --

Net cash provided by operating activities is also impacted by the effects of
changes in operating assets and liabilities such as: accounts receivable and
deferred revenue which are impacted by the timing of customer billings
and related collections from our customers; accounts payable and accrued
expenses due to timing of payments; accrued personnel costs, which are
impacted by employee performance targets and the timing of payments
related to employee bonus incentives; and Section 31 fees payable to the
SEC, which is impacted by the timing of collections from customers and
payments to the SEC.
Net cash provided by operating activities increased $513 million for the
six months ended June 30, 2022 compared with the same period in 2021.
The increase was primarily driven by cash payments made in the second
quarter of 2021 related to the acquisition of Verafin, including a tax
obligation paid on behalf of Verafin of $221 million and a cash payment of
$102 million, the release of which is subject to certain employment-related
conditions over three years following the closing of the acquisition of
Verafin as well as an increase in Section 31 fees payable to SEC due to
higher SEC fee rates in 2022. The remaining change was primarily due to
other fluctuations in our working capital.
Net Cash Used in Investing Activities
Net cash used in investing activities for the six months ended June 30,
2022 primarily related to net purchases of investments related to default
funds and margin deposits of $202 million, purchases of property and
equipment of $77 million and $41 million cash used for acquisitions, net
of cash and cash equivalents acquired, partially offset by proceeds of $55
million from other investing activities and net proceeds from sales and
redemptions of securities of $21 million.
Net cash used in investing activities for the six months ended June 30,
2021 primarily related to $2,430 million of cash used for acquisitions, net
of cash and cash equivalents acquired of $221 million which was utilized
to satisfy an acquisition-related tax obligation on behalf of Verafin, net
purchases of investments related to default funds and margin deposits of
$90 million, $81 million of purchases of property and equipment, other
investing activities of $67 million and payments of $47 million of net
purchases of securities, partially offset by proceeds from divestiture of
business, net of cash divested $190 million.
Net Cash Provided by Financing Activities
Net cash provided by financing activities for the six months ended June
30, 2022 primarily related to a net increase in default funds and margin
deposits of $3,554 million, proceeds of $541 million from the issuances of
long-term-debt, partially offset by $499 million extinguishment of our
2024 Notes, $325 million of repurchases of common stock pursuant to the
ASR agreement, $308 million in other repurchases of common stock and
$186 million of dividend payments to our shareholders.
Net cash provided by financing activities for the six months ended June
30, 2021 primarily related to $410 million in repurchases of common
stock, a decrease in default funds and margin deposits of $229 million and
$169 million of dividend payments to our shareholders, partially offset by
$221 million of proceeds from issuances of commercial paper, net.
See Note 4, “Acquisitions and Divestiture,” to the condensed consolidated
financial statements for further discussion of our acquisitions and
divestiture.
See Note 8, “Debt Obligations,” to the condensed consolidated financial
statements for further discussion of our debt obligations.
See “ASR Agreement,” “Share Repurchase Program,” and “Cash
Dividends on Common Stock,” of Note 11, “Nasdaq Stockholders’
Equity,” to the condensed consolidated financial statements for further
discussion of our ASR agreement, share repurchase program and cash
dividends paid on our common stock.
Financial Investments
Our financial investments totaled $161 million as of June 30, 2022 and
$208 million as of December 31, 2021. Of these securities, $147 million as
of June 30, 2022 and $162 million as of December 31, 2021 are assets
primarily utilized to meet regulatory capital requirements, mainly for our
clearing operations at Nasdaq Clearing. See Note 6, “Investments,” to the
condensed consolidated financial statements for further discussion.
Regulatory Capital Requirements
Clearing Operations Regulatory Capital Requirements
We are required to maintain minimum levels of regulatory capital for the
clearing operations of Nasdaq Clearing. The level of regulatory capital
required to be maintained is dependent upon many factors, including
market conditions and creditworthiness of the counterparty. As of June 30,
2022, our required regulatory capital of $123 million was comprised of
highly rated European government debt securities that are included in
financial investments in the Condensed Consolidated Balance Sheets.
Broker-Dealer Net Capital Requirements
Our broker-dealer subsidiaries, Nasdaq Execution Services, NFSTX, LLC,
and Nasdaq Capital Markets Advisory, are subject to regulatory
requirements intended to ensure their general financial soundness and
liquidity. These requirements obligate these subsidiaries to comply with
minimum net capital requirements. As of June 30, 2022, the combined
required minimum net capital totaled $1 million and the combined excess
capital totaled $22 million, substantially all of which is held in cash and
cash equivalents in the Condensed Consolidated Balance Sheets. The
required minimum net capital is included in restricted cash and cash
equivalents in the Condensed Consolidated Balance Sheets.
47

-- 52 of 121 --

Nordic and Baltic Exchange Regulatory Capital Requirements
The entities that operate trading venues in the Nordic and Baltic countries
are each subject to local regulations and are required to maintain
regulatory capital intended to ensure their general financial soundness and
liquidity. As of June 30, 2022, our required regulatory capital of $35
million was primarily invested in European government debt securities,
European mortgage bonds and Icelandic government bonds that are
included in financial investments in the Condensed Consolidated Balance
Sheets and cash, which is included in restricted cash and cash equivalents
in the Condensed Consolidated Balance Sheets.
Other Capital Requirements
We operate several other businesses, which are subject to local regulation
and are required to maintain certain levels of regulatory capital. As of June
30, 2022, other required regulatory capital of $9 million was primarily
related to Nasdaq Central Securities Depository and is included in
restricted cash in the Condensed Consolidated Balance Sheets.
Equity and dividends
Share Repurchase Program
See “Share Repurchase Program,” of Note 11, “Nasdaq Stockholders’
Equity,” to the condensed consolidated financial statements for further
discussion of our share repurchase program.
ASR Agreement
See “ASR Agreement,” of Note 11, “Nasdaq Stockholders’ Equity,” to the
condensed consolidated financial statements for further discussion of our
ASR agreement.
Cash Dividends on Common Stock
The following table presents our quarterly cash dividends paid per
common 	share 	on 	our 	outstanding 	common 	stock:
2022 	2021
First quarter 	$ 	0.54 $ 	0.49
Second quarter 	0.60 	0.54
Total 	$ 	1.14 $ 	1.03
See “Cash Dividends on Common Stock,” of Note 11, “Nasdaq
Stockholders’ Equity,” to the condensed consolidated financial statements
for further discussion of the dividends.
Debt Obligations
The following table summarizes our debt obligations by contractual
maturity:
Maturity Date 	June 30, 2022
December 31,
2021
(in millions)
Short-term debt:
Commercial paper 	$ 	421 $ 	420
2022 Notes 	December 2022 	599 	598
2024 Notes 	June 2024 	— 	499
Total short-term debt 	$ 	1,020 $ 	1,517
Long-term debt - senior unsecured notes:
2020 Credit
Facility 	December 2025 	(3) 	(4)
2026 Notes 	June 2026 	498 	498
2029 Notes 	March 2029 	623 	676
2030 Notes 	February 2030 	623 	676
2031 Notes 	January 2031 	644 	643
2033 Notes 	July 2033 	640 	694
2040 Notes 	December 2040 	644 	644
2050 Notes 	April 2050 	486 	486
2052 Notes 	March 2052 	541 	—
Total long-term debt 	$ 	4,696 $ 	4,313
Total debt obligations 	$ 	5,716 $ 	5,830
In the table above, the 2024 Notes were reclassified to short-term debt as
of March 31, 2022, and were repaid in April 2022.
In addition to the 2020 Credit Facility, we also have other credit facilities
primarily to support our Nasdaq Clearing operations in Europe, as well as
to provide a cash pool credit line for one subsidiary. These credit facilities,
which are available in multiple currencies, totaled $188 million as of June
30, 2022 and $212 million as of December 31, 2021 in available liquidity,
none of which was utilized.
As of June 30, 2022, we were in compliance with the covenants of all of
our debt obligations.
See Note 8, “Debt Obligations,” to the condensed consolidated financial
statements for further discussion of our debt obligations.
Contractual Obligations and Contingent Commitments
There were no significant changes to our contractual obligations and
contingent commitments from those disclosed in “Part I. Item 7.
Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in our Annual Report Form 10-K that was filed
with the SEC February 23, 2022.
48

-- 53 of 121 --

Off-Balance Sheet Arrangements
For discussion of off-balance sheet arrangements see:
• 	Note 14, “Clearing Operations,” to the condensed consolidated
financial statements for further discussion of our non-cash default fund
contributions and margin deposits received for clearing operations; and
• 	Note 17, “Commitments, Contingencies and Guarantees,” to the
condensed consolidated financial statements for further discussion of:
◦ Guarantees issued and credit facilities available;
◦ Other guarantees;
◦ Routing brokerage activities;
◦ Legal and regulatory matters; and
◦ Tax audits.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As a result of our operating, investing and financing activities, we are
exposed to market risks such as interest rate risk and foreign currency
exchange rate risk. We are also exposed to credit risk as a result of our
normal business activities.
We have implemented policies and procedures to measure, manage,
monitor and report risk exposures, which are reviewed regularly by
management and the board of directors. We identify risk exposures and
monitor and manage such risks on a daily basis.
We perform sensitivity analyses to determine the effects of market risk
exposures. We may use derivative instruments solely to hedge financial
risks related to our financial positions or risks that are incurred during the
normal course of business. We do not use derivative instruments for
speculative purposes.
Interest Rate Risk
We are subject to the risk of fluctuating interest rates in the normal course
of business. Our exposure to market risk for changes in interest rates
relates primarily to our financial investments and debt obligations, which
are discussed below.
Financial Investments
As of June 30, 2022, our investment portfolio was primarily comprised of
highly rated European government debt securities, which pay a fixed rate
of interest. These securities are subject to interest rate risk and the fair
value of these securities will decrease if market interest rates increase. If
market interest rates were to increase immediately and uniformly by a
hypothetical 100 basis points from levels as of June 30, 2022, the fair
value of this portfolio would have declined by $4 million.
Debt Obligations
As of June 30, 2022, the majority of our debt obligations were fixed-rate
obligations. Interest rates on certain tranches of notes are subject to
adjustment to the extent our debt rating is downgraded below investment
grade, as further discussed in Note 8, “Debt Obligations,” to the condensed
consolidated financial statements. While changes in interest rates will have
no impact on the interest we pay on fixed-rate obligations, we are exposed
to changes in interest rates as a result of the borrowings under our 2020
Credit Facility, as this facility has a variable interest rate. We are also
exposed to changes in interest rates as a result of the amounts outstanding
from the sale of commercial paper under our commercial paper program,
which have variable interest rates. As of June 30, 2022, we had principal
amounts outstanding of $421 million of commercial paper and no amounts
outstanding under our 2020 Credit Facility. A hypothetical 100 basis
points increase in interest rates on our outstanding commercial paper
would increase our annual interest expense by approximately $4 million
based on borrowings as of June 30, 2022.
We may utilize interest rate swap agreements to achieve a desired mix of
variable and fixed rate debt.
Foreign Currency Exchange Rate Risk
We are subject to foreign currency exchange rate risk. Our primary
transactional exposure to foreign currency denominated revenues less
transaction-based expenses and operating income for the three and six
months ended June 30, 2022 is presented in the following tables:
49

-- 54 of 121 --

Euro
Swedish
Krona Other Foreign
Currencies 	U.S. Dollar 	Total
(in millions, except currency rate)
Three Months End June 30, 2022
Average foreign
currency rate to
the U.S. dollar 	1.065 	0.102 	# 	N/A 	N/A
Percentage of
revenues less
transaction-
based expenses 	6.1 % 	5.4 % 	4.1 % 	84.4 % 	100.0 %
Percentage of
operating income 	9.6 % 	(3.3)% 	(9.8)% 	103.5 % 	100.0 %
Impact of a 10%
adverse
currency
fluctuation on
revenues less
transaction-
based expenses $ (5) $ (5) $ 	(4) $ 	— 	$ 	(14)
Impact of a 10%
adverse
currency
fluctuation on
operating
income 	$ (4) $ (1) $ 	(4) $ 	— 	$ 	(9)
Euro
Swedish
Krona Other Foreign
Currencies 	U.S. Dollar 	Total
(in millions, except currency rate)
Six Months Ended June 30, 2022
Average foreign
currency rate to
the U.S. dollar 	1.093 	0.104 	# 	N/A 	N/A
Percentage of
revenues less
transaction-
based expenses 	6.2 % 	5.7 % 	4.3 % 	83.8 % 	100.0 %
Percentage of
operating
income 	9.6 % 	(2.5)% 	(10.0)% 	102.9 % 	100.0 %
Impact of a 10%
adverse
currency
fluctuation on
revenues less
transaction-
based expenses $ (11) $ (10) $ 	(8) $ 	— 	$ 	(29)
Impact of a 10%
adverse
currency
fluctuation on
operating
income 	$ (8) $ (2) $ 	(8) $ 	— 	$ 	(18)
____________
# Represents multiple foreign currency rates.
N/A Not applicable.
Our investments in foreign subsidiaries are exposed to volatility in
currency exchange rates through translation of the foreign subsidiaries’ net
assets or equity to U.S. dollars. Substantially all of our foreign subsidiaries
operate in functional currencies other than the U.S. dollar. The financial
statements of these subsidiaries are translated into U.S. dollars for
consolidated reporting using a current rate of exchange, with net gains or
losses recorded in accumulated other comprehensive loss within
stockholders’ equity in the Condensed Consolidated Balance Sheets.
Our primary exposure to net assets in foreign currencies as of June 30,
2022 is presented in the following table:
Net Assets
Impact of a 10% Adverse
Currency Fluctuation
(in millions)
Swedish Krona 	$ 	2,971 $ 	297
British Pound 	159 	16
Norwegian Krone 	148 	15
Canadian Dollar 	157 	16
Australian Dollar 	109 	11
Euro 	50 	5
In the table above, Swedish Krona includes goodwill of $2,196 million and
intangible assets, net of $513 million.
Credit Risk
Credit risk is the potential loss due to the default or deterioration in credit
quality of customers or counterparties. We are exposed to credit risk from
third parties, including customers, counterparties and clearing agents.
These parties may default on their obligations to us due to bankruptcy, lack
of liquidity, operational failure or other reasons. We limit our exposure to
credit risk by evaluating the counterparties with which we make
investments and execute agreements. For our investment portfolio, our
objective is to invest in securities to preserve principal while maximizing
yields, without significantly increasing risk. Credit risk associated with
investments is minimized substantially by ensuring that these financial
assets are placed with governments which have investment grade ratings,
well-capitalized financial institutions and other creditworthy
counterparties.
Our subsidiary, Nasdaq Execution Services, may be exposed to credit risk
due to the default of trading counterparties in connection with the routing
services it provides for our trading customers. System trades in cash
equities routed to other market centers for members of our cash equity
exchanges are routed by Nasdaq Execution Services for clearing to the
NSCC. In this function, Nasdaq Execution Services is to be neutral by the
end of the trading day, but may be exposed to intraday risk if a trade
extends beyond the trading day and into the next day, thereby leaving
Nasdaq Execution Services susceptible to counterparty risk in the period
between accepting the trade and routing it to the clearinghouse. In this
interim period, Nasdaq Execution Services is not novating like a clearing
broker but instead is subject to the short-term risk of counterparty failure
before the clearinghouse enters the transaction. Once the clearinghouse
officially accepts the trade for novation, Nasdaq Execution Services is
legally removed from trade execution risk. However, Nasdaq has
membership obligations to NSCC independent of Nasdaq Execution
Services’ arrangements.
Pursuant to the rules of the NSCC and Nasdaq Execution Services’
clearing agreement, Nasdaq Execution Services is liable for any losses
incurred due to a counterparty or a clearing agent’s failure to satisfy its
contractual obligations, either by making payment or delivering securities.
Adverse
50

-- 55 of 121 --

movements in the prices of securities that are subject to these transactions
can increase our credit risk. However, we believe that the risk of material
loss is limited, as Nasdaq Execution Services’ customers are not permitted
to trade on margin and NSCC rules limit counterparty risk on self-cleared
transactions by establishing credit limits and capital deposit requirements
for all brokers that clear with NSCC. Historically, Nasdaq Execution
Services has never incurred a liability due to a customer’s failure to satisfy
its contractual obligations as counterparty to a system trade. Credit
difficulties or insolvency, or the perceived possibility of credit difficulties
or insolvency, of one or more larger or visible market participants could
also result in market-wide credit difficulties or other market disruptions.
We have credit risk related to transaction and subscription-based revenues
that are billed to customers on a monthly or quarterly basis, in arrears. Our
potential exposure to credit losses on these transactions is represented by
the receivable balances in our Condensed Consolidated Balance Sheets.
We review and evaluate changes in the status of our counterparties’
creditworthiness. Credit losses such as those described above could
adversely affect our condensed consolidated financial position and results
of operations.
We also are exposed to credit risk through our clearing operations with
Nasdaq Clearing. See Note 14, “Clearing Operations,” to the condensed
consolidated financial statements for further discussion. Our clearinghouse
holds material amounts of clearing member cash deposits, which are held
or invested primarily to provide security of capital while minimizing
credit, market and liquidity risks. While we seek to achieve a reasonable
rate of return, we are primarily concerned with preservation of capital and
managing the risks associated with these deposits. As the clearinghouse
may pass on interest revenues (minus costs) to the members, this could
include negative or reduced yield due to market conditions. The following
is a summary of the risks associated with these deposits and how these
risks are mitigated.
• Credit Risk. When the clearinghouse has the ability to hold cash
collateral at a central bank, the clearinghouse utilizes its access to the
central bank system to minimize credit risk exposures. When funds are
not held at a central bank, we seek to substantially mitigate credit risk by
ensuring that investments are primarily placed in large, highly rated
financial institutions, highly rated government debt instruments and
other creditworthy counterparties.
• Liquidity Risk. Liquidity risk is the risk a clearinghouse may not be able
to meet its payment obligations in the right currency, in the right place
and the right time. To mitigate this risk, the clearinghouse monitors
liquidity requirements closely and maintains funds and assets in a
manner which minimizes the risk of loss or delay in the access by the
clearinghouse to such funds and assets. For example, holding funds with
a central bank where possible or investing in highly liquid government
debt instruments serves to reduce liquidity risks.
• Interest Rate Risk. Interest rate risk is the risk that interest rates rise
causing the value of purchased securities to decline. If we were required
to sell securities prior to maturity, and interest rates had risen, the sale of
the securities might be made at a loss relative to the latest market price.
Our clearinghouse seeks to manage this risk by making short term
investments of members' cash deposits. In addition, the clearinghouse
investment guidelines allow for direct purchases or repurchase
agreements with short dated maturities of high quality sovereign debt
(for example, European government and U.S. Treasury securities),
central bank certificates and multilateral development bank debt
instruments.
• Security Issuer Risk. Security issuer risk is the risk that an issuer of a
security defaults on its payment when the security matures. This risk is
mitigated by limiting allowable investments and collateral under reverse
repurchase agreements to high quality sovereign, government agency or
multilateral development bank debt instruments.
Item 4. Controls and Procedures
Disclosure controls and procedures. Nasdaq’s management, with the
participation of Nasdaq’s President and Chief Executive Officer, and
Executive Vice President and Chief Financial Officer, has evaluated the
effectiveness of Nasdaq’s disclosure controls and procedures (as defined in
Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end
of the period covered by this report. Based upon that evaluation, Nasdaq’s
President and Chief Executive Officer and Executive Vice President and
Chief Financial Officer, have concluded that, as of the end of such period,
Nasdaq’s disclosure controls and procedures are effective.
Changes in internal control over financial reporting. There have been no
changes in Nasdaq’s internal control over financial reporting (as defined in
Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that occurred
during the quarter ended June 30, 2022 that have materially affected, or are
reasonably likely to materially affect, Nasdaq’s internal control over
financial reporting.
51

-- 56 of 121 --

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
For a description of our legal proceedings, if any, see “Legal and
Regulatory Matters - Litigation,” of Note 17, “Commitments,
Contingencies and Guarantees,” to the condensed consolidated financial
statements, which is incorporated herein by reference.
Item 1A. Risk Factors
In addition to the other information set forth in this Quarterly Report on
Form 10-Q, you should carefully consider the factors discussed under
“Risk Factors” in our most recent Form 10-K and Quarterly Report on
Form 10-Q for the quarter ended March 31, 2022. These risks could
materially and adversely affect our business, financial condition and
results of operations. These risks and uncertainties are not the only ones
facing us. Additional risks and uncertainties not presently known to us or
that we currently believe to be immaterial may also adversely affect our
business. As of the date of this Form 10-Q, there have been no material
changes to the risk factors described in our most recent Form 10-K, as
supplemented by our Quarterly Report on Form 10-Q for the quarter ended
March 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Share Repurchase Program
See “Share Repurchase Program,” of Note 11, “Nasdaq Stockholders’
Equity,” to the condensed consolidated financial statements for further
discussion of our share repurchase program.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
The table below represents repurchases made by or on behalf of us or any
“affiliated purchaser” of our common stock during the fiscal quarter ended
June 30, 2022:
Period
(a)
Total Number of
Shares Purchased
(b) Average
Price Paid Per
Share
(c)
Total Number of
Shares
Purchased as
Part of Publicly
Announced
Plans or
Programs
(d) Maximum
Dollar Value of
Shares that
May Yet Be
Purchased
Under the
Plans or
Programs (in
millions)
April 2022
Share
repurchase
program 	173,104 $ 163.28 	173,104 $ 	431
Employee
transactions 	106,717 $ 188.71 	N/A 	N/A
May 2022
Share
repurchase
program 	906,973 $ 151.17 	906,973 $ 	293
Employee
transactions 	170 $ 148.12 	N/A 	N/A
June 2022
Share
repurchase
program 	5,923 $ 153.59 	5,923 $ 	293
Employee
transactions 	345 $ 150.53 	N/A 	N/A
Total Quarter Ended June 30, 2022
Share
repurchase
program 	1,086,000 $ 153.11 	1,086,000 $ 	293
Employee
transactions 	107,232 $ 188.52 	N/A 	N/A
In the preceding table:
• N/A - Not applicable.
• See “Share Repurchase Program,” of Note 11, “Nasdaq Stockholders’
Equity,” to the condensed consolidated financial statements for further
discussion of our share repurchase program.
• Employee transactions represents shares surrendered to us to satisfy tax
withholding obligations arising from the vesting of restricted stock and
PSUs previously issued to employees.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
52

-- 57 of 121 --

Item 6. Exhibits
Exhibit Number
3.1
Certificate of Amendment to Nasdaq’s Amended and
Restated Certificate of Incorporation (incorporated by
reference to Exhibit 3.1 to the Company's Current
Report on Form 8-K filed on July 20, 2022).
10.1 Form of Nasdaq Restricted Stock Unit Award
Certificate (employees)*
10.2 Form of Nasdaq Restricted Stock Unit Award
Certificate (directors)*.
10.3 Form of Nasdaq Three-Year Performance Share Unit
Agreement*.
10.4
Nasdaq, Inc. Deferred Compensation Plan
(incorporated by reference to Exhibit 10.1 to the
Company's Current Report on Form 8-K filed on June
16, 2022).
10.5 Employment Agreement by and between Nasdaq, Inc.
and Bradley J. Peterson, dated June 22, 2022*.
31.1 Certification of President and Chief Executive Officer
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002 (“Sarbanes-Oxley”).
31.2 Certification of Executive Vice President and Chief
Financial Officer pursuant to Section 302 of Sarbanes-
Oxley.
32.1 Certifications Pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of Sarbanes-Oxley.
101
The following materials from the Nasdaq, Inc.
Quarterly Report on Form 10-Q for the quarter ended
June 30, 2022, formatted in iXBRL (Inline eXtensible
Business Reporting Language): (i) Condensed
Consolidated Balance Sheets as of June 30, 2022 and
December 31, 2021; (ii) Condensed Consolidated
Statements of Income for the three and six months end
June 30, 2022 and 2021; (iii) Condensed Consolidated
Statements of Comprehensive Income for the three and
six months end June 30, 2022 and 2021; (iv)
Condensed Consolidated Statements of Changes in
Stockholders' Equity for the three and six months end
June 30, 2022 and 2021; (v) Condensed Consolidated
Statements of Cash Flows for the six months end June
30, 2022 and 2021; and (vi) notes to condensed
consolidated financial statements.
104 Cover Page Interactive Data File, formatted in iXBRL
and contained in Exhibit 101.
* Management contract or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Nasdaq, Inc.
(Registrant)
By: 	/s/ Adena T. Friedman
Name: 	Adena T. Friedman
Title: 	President and Chief Executive Officer
Date: 	August 3, 2022
By: 	/s/ Ann M. Dennison
Name: 	Ann M. Dennison
Title: 	Executive Vice President and Chief Financial
Officer
Date: 	August 3, 2022
53

-- 58 of 121 --

Exhibit 10.1
NASDAQ, INC.
RESTRICTED STOCK UNIT AWARD CERTIFICATE
Award Date: April 1, 2022 	Number of Restricted Stock Units:
TOTAL_SHARES_GRANTED
Final Vesting Date: 	(See below)
THIS CERTIFIES THAT Nasdaq, Inc. (the “Company”) has on the Award Date specified above granted to
[NAME]
(the “Participant”) an award (the “Award”) to receive the number of Restricted Stock Units (the “RSUs”) indicated in the box
above labeled “Number of Restricted Stock Units,” each RSU representing the right to receive one share of the Company’s
common stock, $0.01 per value per share (the “Share”), subject to certain restrictions and on the terms and conditions contained
in this award certificate (“Award Certificate”) and the Nasdaq, Inc. Equity Incentive Plan (as amended and restated April 24,
2018) (the “Plan”). Capitalized terms not otherwise defined have the meanings set forth in the Plan. A copy of the Plan is
available from Human Resources, and is also available on the Company’s website.
* * *
1. 	Rights of the Participant with Respect to the Restricted Stock Units.
(a) 	Prior to vesting of the RSUs pursuant to Section 2, (i) the Participant shall not be treated as a shareholder as to
Shares issuable to the Participant with respect to such RSUs, and shall only have a contractual right to receive such Shares
following such vesting, unsecured by any assets of the Company or its Subsidiaries; (ii) the Participant shall not be permitted to
vote the RSUs or the Shares issuable with respect to such RSUs; and (iii) the Participant’s right to receive such Shares following
vesting of the RSUs shall be subject to the adjustment provisions set forth in Section 13 of the Plan. The RSUs shall be subject to
all of the restrictions hereinafter set forth.
(b) 	At the sole discretion of the Committee, the Participant shall be permitted to receive cash payments equal to the
dividends and distributions paid on Shares (other than dividends or distributions of securities of the Company which may be
issued with respect to Shares by virtue of any stock split, combination, stock dividend or recapitalization) to the same extent as if
each RSU was a Share, and those Shares were not subject to the restrictions imposed by this Award Certificate and the Plan;
provided, however, that no dividends or distributions shall be payable to or for the benefit of the Participant with respect to record
dates for such dividends or distributions occurring on or after the date, if any, on which the Participant has forfeited the RSUs.

-- 59 of 121 --

2. 	Vesting.
(a) 	Except as otherwise provided under this Award Certificate, the RSUs shall vest in accordance with the following
vesting schedule: 33% of the RSUs shall vest on the second anniversary of the Award Date (specified above); an additional 33%
of the RSUs shall vest on the third anniversary of the Award Date; and the remaining balance of the RSUs shall vest on the fourth
anniversary of the Award Date (the “Final Vesting Date”); provided, in each case, that the Participant remains in continuous
employment with the Company or any of its Subsidiaries until such date(s).
(b) 	If, prior to the Final Vesting Date of the RSUs under paragraph (a) above the Participant has a Separation from
Service (as defined in the Plan) with the Company or any of its Subsidiaries for any reason (voluntary or involuntary), then such
non-vested RSUs shall be immediately and irrevocably forfeited, except as otherwise provided in Section 8(e)(ii) of the Plan
(Separation from Service by reason of death or Retirement) or Section 12 of the Plan (Separation from Service following a
Change in Control). Notwithstanding anything to the contrary in the Plan or this Award Certificate, and for purposes of clarity,
any Separation from Service shall be effective as of the date the Participant’s active employment ends and shall not be extended
by any statutory or common law notice period.
(c) 	If, prior to the vesting of the RSUs under paragraph (a) above the Participant is determined by the insurance
carrier under the Company’s then-current long-term disability plan to be entitled to receive benefits under such plan, and, by
reason of such Disability, is deemed to have a Separation from Service (within the meaning of the Plan), then an amount of
unvested RSUs shall vest as described in Section 8(e)(iii) of the Plan.
3. 	Issuance of Shares. Following the applicable vesting date with respect to the RSUs, and subject to the terms and
conditions of the Plan, the Company will issue Shares with respect to such vested RSUs net of any Shares withheld by the
Company to satisfy the payment of taxes as described in Section 6 of this Award Certificate. Such issuance shall take place as
soon as practicable following the applicable vesting date (but in no event later than 60 days following the applicable vesting date
described in Section 2(a), (b) or (c) above). The Shares issued in respect of the RSUs shall be subject to such stop transfer orders
and other restrictions as the Committee may determine is required by the rules, regulations, and other requirements of the
Securities and Exchange Commission, The Nasdaq Stock Market, any applicable federal, state or local laws and the Company’s
Certificate of Incorporation and By-Laws, and the Committee may cause a legend or legends to be put on such Shares to make
appropriate reference to such restrictions. The Company may make delivery of Shares in settlement of RSUs by either (A)
delivering certificates representing such Shares to the Participant, registered in the name of the Participant, or (B) by depositing
such Shares into a stock brokerage account maintained for the Participant. The Company will not deliver any fractional Shares
but will instead round down to the next full number the amount of Shares to be delivered.
4. 	No Right to Continued Employment. Neither the Plan nor this Award Certificate shall confer on the Participant any right
to be retained, in any position, as an employee, consultant or director of the Company, and nothing in this Award Certificate or
the Plan shall be construed to limit the discretion of the Company (or subsidiary that employs the Participant) to terminate the
Participant’s employment at any time, with or without cause.
-2-

-- 60 of 121 --

5. 	Transferability.
(a) 	The RSUs are not transferable and may not be sold, assigned, transferred, disposed of, pledged or otherwise
encumbered by the Participant, other than by will or the laws of descent and distribution. Upon such transfer (by will or the laws
of descent and distribution), such transferee in interest shall take the rights granted herein subject to all the terms and conditions
hereof.
(b) 	Subject to Section 5(a) hereof, in order to comply with any applicable securities laws, the Shares issued to the
Participant with respect to vested RSUs may only be sold by the Participant following registration of such Shares under the U.S.
Securities Act of 1933, as amended, or pursuant to an exemption therefrom.
(c) Following settlement and issuance of Shares, in the event the Company permits Participant to arrange for sale of
Shares through a broker or another designated agent of the Company, Participant acknowledges and agrees that the Company
may block any such sale and/or cancel any order to sell placed by the Participant, in each case if the Participant is not then
permitted under the Company’s insider trading policy to engage in transactions with respect to securities of the Company. If the
Committee determines that the ability of the Participant to sell or transfer Shares is restricted, then the Company may notify the
Participant in accordance with Section 14 of this Award Certificate. The Participant may only sell such Shares in compliance with
such notification from the Company.
6. 	Withholding.
(a) 	In order to comply with all applicable federal, state and local tax laws or regulations, the Company may take such
actions as it deems appropriate to ensure that all applicable federal, state and local income, payroll or other taxes are withheld or
collected from the Participant.
(b) 	In accordance with the terms of the Plan, and such rules as may be adopted by the Committee under the Plan, the
Participant may elect to satisfy the Participant’s federal, state and local tax withholding obligations arising from the receipt of, the
vesting of or the lapse of restrictions relating to, or the settlement of, the RSUs, by one or a combination of (i) delivering cash,
check or money order payable to the Company, (ii) delivering to the Company other Shares, (iii) having the Company withhold a
portion of the Shares otherwise to be delivered having a Fair Market Value sufficient to satisfy the statutory withholding required
with respect thereto to the extent permitted by the Company; or (iv) having the Company (or the Subsidiary that employs the
Participant) withhold any amounts necessary to pay the statutory withholding required from the Participant’s salary or other
amounts payable to the Participant. The Company will not deliver any fractional Shares but will instead round down to the next
full number the amount of Shares to be delivered. The Participant’s election must be made on or before the date that any such
withholding obligation with respect to the RSUs arises. If the Participant fails to timely make such an election, the Company shall
have the right to withhold a portion of the Shares otherwise to be delivered having a Fair Market Value equal to the statutory
amount of withholding with respect to applicable taxes, as determined by the Company in its sole discretion. The net settlement
of the shares underlying the vested RSUs and the delivery of Shares previously owned are hereby specifically authorized
alternatives for the satisfaction of the foregoing withholding obligation. To the extent necessary to meet any obligation to
withhold
-3-

-- 61 of 121 --

Federal Insurance Contributions Act taxes before delivery of the Shares, the Company is authorized to deduct those taxes from
other current wages or other compensation.
7. 	Governing Law. This Award Certificate shall be governed by and construed in accordance with the laws of the State of
Delaware, without regard to the conflicts of law provisions thereof.
8. 	Amendments. The Company, acting by means of the Committee, has the right, as set forth in the Plan, to amend, alter,
suspend, discontinue or cancel this Award, prospectively or retroactively; provided however, that no such amendment, alteration,
suspension, discontinuance or cancelation of the RSUs will adversely affect the Participant’s material rights under this Award
Certificate without the Participant’s consent. The Company has the authority to amend this Award Certificate, consistent with the
foregoing, without the Participant’s written agreement, except as set forth in this Section 8.
In the event that the Company is reorganized or liquidated, or if all or substantially all of its assets are sold, or if the
Company is merged or consolidated with another corporation or entity (or in the event the Company consummates a written
agreement to accomplish any of the foregoing), the Committee may, in its sole discretion and upon at least 10 days advance
notice to the Participant, cancel any outstanding RSUs and cause the Participant to be paid (in cash or in stock, or any
combination thereof) the value of such RSUs based upon the price per Share received or to be received in the transaction.
9. 	Administration. This Award Certificate shall at all times be subject to the terms and conditions of the Plan. The
Committee shall have sole and complete discretion with respect to all matters reserved to it by the Plan and decisions of the
Committee with respect thereto and this Award Certificate shall be final and binding upon the Participant and the Company. The
Committee has the authority and discretion to determine any questions which arise in connection with the award of the RSUs
hereunder.
10. 	Compliance with Code Section 409A for U.S. Taxpayers.
(a) 	Distributions of Shares in settlement of RSUs as described herein which represent a “deferral of compensation”
within the meaning of Code section 409A shall conform to the applicable requirements of Code section 409A, including, without
limitation, the requirement that a distribution to a Participant who is a “specified employee” within the meaning of Code section
409A(a)(2)(B)(i) which is made on account of the specified employee’s Separation from Service shall not be made before the
date which is six (6) months after the date of Separation from Service. However, distributions as aforesaid shall not be deemed to
be a “deferral of compensation” subject to Code section 409A to the extent provided in the exception in Treasury Regulation
Section 1.409A-1(b)(4) for short-term deferrals.
(b) 	It is the intention of the Company and Participant that this Award Certificate not result in an unfavorable tax
consequences to Participant under Code Section 409A. Accordingly, as permitted by the Plan, the Company may at any time
(without the consent of the Participant) modify or amend the Plan or this Award Certificate to the extent necessary to ensure that
the Award is not “deferred compensation” subject to Code Section 409A (or, alternatively, to conform to the requirements of
Code Section 409A). Any such amendments shall be made in a manner that preserves to the maximum extent possible the
intended benefits to Participant. This paragraph does not create an obligation on the part of Company to modify this Award
Certificate
-4-

-- 62 of 121 --

and does not guarantee that the amounts or benefits owed under this Award Certificate will not be subject to interest and penalties
under Code Section 409A. For purposes of applying the provisions of Code Section 409A, to the extent applicable, each group of
Restricted Stock Units that would vest in accordance with Section 2(a) shall be treated as a separate payment.
(c) 	While the Company intends that this Award Certificate and the RSUs granted hereunder comply with or be exempt
from the requirements of Code Section 409A and any related regulations or other guidance promulgated thereunder, neither the
Company or the Committee nor any of their respective affiliates shall be liable to any person for the tax consequences of any
failure to comply with the requirements of Code Section 409A or any other tax consequences relating to this Award.
11. 	Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s
participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is
necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Participant,
as a condition of receipt of Shares underlying an RSU, to sign any additional Award Certificates or undertakings that may be
necessary to accomplish the foregoing.
12. 	Nature of Grant. In accepting the Award, the Participant acknowledges, understands and agrees that:
(i) the Plan is established voluntarily by the Company, it is discretionary in nature, and may be modified, amended,
suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(ii) all decisions with respect to future Awards or other grants, if any, will be at the sole discretion of the Company;
(iii) the grant of the RSUs and the Participant’s participation in the Plan shall not create a right to employment or be
interpreted as forming an employment or service contract with the Company, the Participant's employer or any Subsidiary,
and shall not interfere with the ability of the Company, the Participant's employer or any Subsidiary, as applicable, to
terminate the Participant’s employment or service relationship (if any);
(iv) the Participant is voluntarily participating in the Plan;
(v) the RSUs and any Shares issued under the Plan and the income and value of the same are not intended to replace
any pension rights or compensation;
(vi) the future value of the Shares underlying the RSUs is unknown and indeterminable;
(vii) unless otherwise agreed with the Company, the Award and the Shares subject to the Award, and the income and
value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director
of a Subsidiary of the Company; and
-5-

-- 63 of 121 --

(viii) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs resulting from
Separation from Service (for any reason whatsoever, whether or not later found to be invalid or in breach of employment
laws in the jurisdiction where the Participant is employed or the terms of the Participant’s employment agreement, if any),
and in consideration of the grant of the RSUs to which the Participant is otherwise not entitled, the Participant irrevocably
agrees never to institute any claim against the Company, any of its Subsidiaries or the Participant's employer, waives his
ability, if any, to bring any such claim, and releases the Company, its Subsidiaries and the Participant's employer from any
such claim; if, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by
participating in the Plan, the Participant shall be deemed irrevocably to have agreed not to pursue such claim and agrees
to execute any and all documents necessary to request dismissal or withdrawal of such claim.
13. 	Consent to Collection, Processing and Transfer of Personal Data. Pursuant to applicable personal data protection laws, the
Company hereby notifies the Participant of the following in relation to the Participant’s personal data and the collection,
processing and transfer of such data in relation to the Company’s grant of this Award and the Participant’s participation in the
Plan. The collection, processing and transfer of the Participant’s personal data are necessary for the Company’s administration of
the Plan and the Participant’s participation in the Plan. The Participant’s denial and/or objection to the collection, processing and
transfer of personal data may affect the Participant’s participation in the Plan. As such, the Participant voluntarily explicitly and
unambiguously acknowledges and consents (where required under applicable law) to the collection, use, processing and transfer
of personal data as described in this Award Certificate and any other Award grant materials by and among, as applicable, the
Company, its Subsidiaries and/or the Participant's employer for the purpose of implementing, administering and managing the
Participant's participation in the Plan.
The Company and the Subsidiaries, including the Participants employer hold certain personal information about the
Participant, including, but not limited to his or her name, home address, email address and telephone number, date of birth, social
security number, passport number or other employee identification number, salary, nationality, job title, any Shares or
directorships held in the Company, details of all Awards or any other entitlement to Shares awarded, canceled, purchased, vested,
unvested or outstanding in Participant’s favor, for the exclusive purpose of managing and administering the Plan (“Data”).
The Company and its Subsidiaries, including the Participant’s employer, will transfer Data amongst themselves as necessary
for the purpose of implementation, administration and management of the Participant’s participation in the Plan, and the
Company and its Subsidiaries, including the Participant’s employer, may each further transfer Data to a designated Plan
broker, administrative agent or such other stock plan service provider as may be selected by the Company presently or in the
future (a “Plan Service Provider”), which may be assisting the Company in the implementation, administration and
management of the Plan. These recipients may be located throughout the world. The Participant understands that if he or she
resides outside the United States, the Participant may request a list with the names and addresses of any potential recipients of
the Data by contacting the Participant’s local human
-6-

-- 64 of 121 --

resources representative. The Participant hereby authorizes (where required under applicable law) the Company, any Plan
Service Provider and any other possible recipients which may assist the Company (presently or in the future) to receive,
possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering
and managing the Participant’s participation in the Plan. Furthermore, the Participant acknowledges and understands that
the transfer of the Data to the Company or its Subsidiaries, including the Participant’s employer, to any Plan Service Provider,
or to any third parties is necessary for the Participant’s participation in the Plan. The Participant understands that Data will
be held only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. If the
Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s employment status
or service and career with the Company and its Subsidiaries will not be affected. The only consequence of refusing or
withdrawing the Participant’s consent is that the Company may not be able to grant the Participant RSUs or other awards or
administer or maintain such awards. Therefore, the Participant acknowledges that withdrawal of consent may affect the
Participant’s ability to vest in or realize benefits from the RSUs, and the Participant’s ability to participate in the Plan, in
which case neither the Company nor any of its Subsidiaries, including the Participant’s employer, will have any liability or
obligation to the Participant related to this Award. For more information on the consequences of refusal to consent or
withdrawal of consent, the Participant understands that he or she may contact his or her local human resources
representative.
Finally, upon request of the Company or the Participant’s employer, the Participant agrees to provide an executed data
privacy consent form (or any other agreements or consents that may be required by the Company and/or the Participant’s
employer) that the Company and/or the Participant’s employer may deem necessary to obtain from the Participant for the
purpose of administering the Participant’s participation in the Plan in compliance with the data privacy laws in the
Participant’s country, either now or in the future. The Participant understands and agrees that the Participant will not be able
to participate in the Plan if the Participant fails to provide any such consent or agreement requested by the Company and/or
the Participant’s employer.
14. 	Notices. Any notice, request, instruction or other document given under this Award Certificate shall be in writing and may
be delivered by such method as may be permitted by the Company, and shall be addressed and delivered, in the case of the
Company, to the Secretary of the Company at the principal office of the Company and, in the case of the Participant, to the
Participant’s address as shown in the records of the Company or to such other address as may be designated in writing (or by
such other method approved by the Company) by either party.
15. 	Severability. The invalidity or unenforceability of any provision of this Award Certificate shall not affect the validity or
enforceability of any other provision of this Award Certificate, and each other provision of the Award Certificate shall be
severable and enforceable to the extent permitted by law.
16. 	Award Subject to Plan; Amendments to Award. This Award is subject to the Plan as approved by the shareholders of the
Company. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by
reference. In the event of a conflict between any term or provision contained in this Award Certificate and a term or
-7-

-- 65 of 121 --

provision of the Plan, the applicable terms and provisions of this Award Certificate will govern and prevail.
17. 	Discretionary Nature of Plan; No Vested Rights. The Plan is discretionary in nature and limited in duration, and may be
amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the Award represented by this
Award Certificate is exceptional, voluntary and occasional and does not create any contractual or other right to receive an award
or benefit in lieu of an award in the future, even if awards have been granted repeatedly in the past. Future Awards, if any, will be
at the sole discretion of the Company, including, but not limited to, the form and timing of an Award, the number of Shares
subject to the Award, and the vesting provisions. Any amendment, modification or termination of the Plan shall not constitute a
change or impairment of the terms and conditions of the Participant’s employment with the Company.
18. 	No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making
any recommendations regarding the Participant's participation in the Plan, or his acquisition or sale of the underlying Shares. The
Participant acknowledges that he should consult with his own personal tax, legal and financial advisors regarding his
participation in the Plan before taking any action related to the Plan.
19. 	Entire Agreement. This Award Certificate represents the entire understanding and agreement between the parties with
respect to the subject matter of this Award Certificate and supersedes and replaces all previous agreements, arrangements,
understandings, rights, obligations and liabilities between the parties in respect of such matters.
20. 	Execution of Agreement. By electronically or otherwise accepting this Award Certificate, the Participant acknowledges
his or her understanding and acceptance of the terms and conditions of the Award. The Company has no obligation to issue the
Participant Shares under this Award Certificate if the Participant does not accept the Award. Further, any acceptance of Shares
issued pursuant to this Award Certificate shall constitute the Participant’s acceptance of the Award and the Participant’s
agreement with all terms and conditions of the Award, as set forth in the Plan and this Award Certificate
NASDAQ, INC.
By: Bryan Smith
Title: EVP and Chief People Officer
-8-

-- 66 of 121 --

Exhibit 10.2
NASDAQ, INC.
RESTRICTED STOCK UNIT AWARD CERTIFICATE
Award Date: June 22, 2022 	Number of Restricted Stock Units: # GRANTED
THIS CERTIFIES THAT Nasdaq, Inc. (the “Company”) has on the Award Date specified above granted to
NAME
(the “Director”) an award (the “Award”) to receive the number of Restricted Stock Units (the “RSUs” or “Restricted Stock
Units”) indicated in the box above labeled “Number of Restricted Stock Units,” with each RSU representing the right to receive
one share (“Share”) of the Company’s common stock, $0.01 per value per share (the “Common Stock”), subject to certain
restrictions and on the terms and conditions contained in this award certificate (the “Award Certificate”) and the Nasdaq, Inc.
Equity Incentive Plan (as amended and restated April 24, 2018) (the “Plan”). Capitalized terms not otherwise defined have the
meanings set forth in the Plan. A copy of the Plan is available from the People @ Nasdaq team, and is also available on the
Company’s website.
* * *
1. 	Rights of the Director with Respect to the Restricted Stock Units.
(a) 	Prior to vesting of the Restricted Stock Units pursuant to Section 2, (i) the Director shall not be treated as a
shareholder as to Shares issuable to the Director with respect to such Restricted Stock Units, and shall only have a contractual
right to receive such Shares following such vesting, unsecured by any assets of the Company or its Subsidiaries; (ii) the Director
shall not be permitted to vote the Restricted Stock Units or the Shares issuable with respect to such Restricted Stock Units; and
(iii) the Director’s right to receive such Shares following vesting of the Restricted Stock Units shall be subject to the adjustment
provisions set forth in Section 13 of the Plan. The Restricted Stock Units shall be subject to all of the restrictions hereinafter set
forth.
(b) 	At the sole discretion of the Committee, the Director shall be permitted to receive cash payments equal to the
dividends and distributions paid on Shares (other than dividends or distributions of securities of the Company which may be
issued with respect to Shares by virtue of any stock split, combination, stock dividend or recapitalization) to the same extent as if
each Restricted Stock Unit was a Share, and those Shares were not subject to the restrictions imposed by this Award Certificate
and the Plan; provided, however, that no dividends or distributions shall be payable to or for the benefit of the Director with
respect to record dates for such dividends or distributions occurring on or after the date, if any, on which the Director has
forfeited the Restricted Stock Units.

-- 67 of 121 --

2. 	Vesting.
(a) 	Except as otherwise provided under this Award Certificate, and contingent upon the Director’s continued service,
the Restricted Stock Units shall vest in accordance with the following vesting schedule: 100% of the Restricted Stock Units shall
vest on the first anniversary of the Award Date (specified above) (the “Final Vesting Date”).
3. 	Termination of Service.
(b) 	If the Company terminates the Director’s service on the Board on account of “Misconduct” (as such term is
defined below), all Restricted Stock Units which have not as of the date of such termination become vested shall be deemed
canceled and forfeited on the effective date of such termination without further consideration to the Director.
(c) 	If the Director’s service on the Board terminates by reason of death or “Disability” (as such term is defined
below), all Restricted Stock Units shall become vested on the date of such termination.
(d) 	If the Director’s service on the Board terminates by reason of the expiration of his “Term” (as such term is defined
below) prior to the date his Restricted Stock Units would otherwise vest pursuant to Section 2 hereof, all Restricted Stock Units
shall become vested Restricted Stock Units.
(d) If the Director’s service on the Board terminates for any reason other than those set forth in Sections (a) through (c)
of this Section 3, all Restricted Stock Units which have not as of the date of such termination become vested shall be deemed
canceled and forfeited on the effective date of such termination without further consideration to the Director.
(e) For purposes of this Award Certificate the terms “Misconduct,” “Disability,” and “Term” shall have meanings set
forth in this Section 3(e):
(i) 	“Misconduct” means the Director’s conviction of, or pleading nolo contendre to a felony or to any crime,
whether a felony or misdemeanor, involving the purchase or sale of any security, mail or wire fraud, theft
or embezzlement of Company property or a material breach of the Director’s fiduciary duty to the
Company or its shareholders.
(ii) 	“Disability” means the Director’s physical or mental incapacity for a period of 45 consecutive working
days or 60 days in a six (6) month period which makes the Director unable to perform his duties to the
Company. Any question as to the existence of the Disability of the Director shall be determined by a
qualified physician selected by the Company.
(iii) 	“Term” shall mean each term of service on the Board commencing on the Director’s election or most
recent re-election to the Board and ending on the first anniversary thereafter unless the Director was
elected for a longer or shorter period, in which event the longer or shorter period shall be the Term;
provided, however, that the Term shall be deemed to include any automatic renewal thereof.
-2-

-- 68 of 121 --

4. 	Issuance of Shares. Following the applicable vesting date with respect to the Restricted Stock Units, and subject to the
terms and conditions of the Plan, the Company will issue Shares with respect to such vested Restricted Stock Units, net of any
Shares withheld by the Company to satisfy the payment of taxes as described in Section 7 herein. Such issuance shall take place
as soon as practicable following the applicable vesting date (but in no event later than 60 days following the applicable vesting
date described in Section 2 above). The Shares issued in respect of the Restricted Stock Units shall be subject to such stop
transfer orders and other restrictions as the Committee may determine is required by the rules, regulations, and other
requirements of the Securities and Exchange Commission, The Nasdaq Stock Market, any applicable federal, state or local laws
and the Company’s Certificate of Incorporation and By-Laws, and the Committee may cause a legend or legends to be put on
such Shares to make appropriate reference to such restrictions. The Company may make delivery of Shares in settlement of
Restricted Stock Units by either (A) delivering certificates representing such Shares to the Director, registered in the name of the
Director, or (B) by depositing such Shares into a stock brokerage account maintained for the Director. The Company will not
deliver any fractional shares of Common Stock but will instead round down to the next full number the amount of shares of
Common Stock to be delivered.
Notwithstanding anything in this Section 4 to the contrary, the Company may, in its sole discretion, settle the Restricted Stock
Units in the form of a cash payment to the extent settlement in Shares is prohibited under local law, or would require the Director,
the Company and/or a Subsidiary to obtain the approval of any governmental and/or regulatory body in the Director’s country of
residence (and country where the Director performs services, if different). Alternatively, the Company may, in its sole discretion,
settle the Restricted Stock Units in the form of Shares but require the Director to immediately sell such Shares (in which case, the
Award Certificate shall give the Company the authority to issue sales instructions on behalf of the Director).
5. 	No Right to Continued Service. Neither the Plan nor this Award Certificate shall confer on the Director any right to be
retained, in any position, as an employee, consultant or director of the Company.
6. 	Transferability.
(a) 	At any time prior to becoming vested, the Restricted Stock Units are not transferable and may not be sold,
assigned, transferred, disposed of, pledged or otherwise encumbered by the Director, other than by will or the laws of descent and
distribution. Upon such transfer (by will or the laws of descent and distribution), such transferee in interest shall take the rights
granted herein subject to all the terms and conditions hereof.
(b) 	Subject to Section 6(a) hereof, in order to comply with any applicable securities laws, the Shares issued to the
Director with respect to vested Restricted Stock Units may only be sold by the Director following registration of such Shares
under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption therefrom.
(c) 	Following settlement and issuance of Shares, in the event the Company permits the Director to arrange for sale of
Shares through a broker or another designated agent of the Company, Director acknowledges and agrees that the Company may
block any such sale and/or cancel any order to sell placed by the Director, in each case if the Director is not then permitted under
the Company’s insider trading policy to engage in transactions with respect to securities of
-3-

-- 69 of 121 --

the Company. If the Committee determines that the ability of the Director to sell or transfer Shares is restricted, then the
Company may notify the Director in accordance with Section 13 of this Award Certificate. The Director may only sell such
Shares in compliance with such notification from the Company.
7. 	Withholding.
(a) 	The Director acknowledges that, regardless of any action taken by the Company, the ultimate liability for all
income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the
Director's participation in the Plan and legally applicable to the Director (“Tax-Related Items”), is and remains the Director's
responsibility and may exceed any amount actually withheld by the Company and/or any Subsidiary. The Director further
acknowledges that the Company (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in
connection with any aspect of the Restricted Stock Units, including the grant, vesting or settlement of the Restricted Stock Units,
the issuance of Shares upon settlement of the RSUs, the subsequent sale of Shares acquired pursuant to such issuance and the
receipt of any dividends and/or dividend equivalent amounts; and (ii) do not commit to, and are under no obligation to, structure
the terms of the grant or any aspect of the Restricted Stock Units to reduce or eliminate Director's liability for Tax-Related Items
or achieve any particular tax result. Further, if the Director has become subject to Tax-Related Items in more than one
jurisdiction, the Director acknowledges that the Company may be required to withhold or account for Tax-Related Items in more
than one jurisdiction.
(b) 	In order to comply with all applicable federal, state and local tax laws or regulations, the Company may take such
actions as it deems appropriate to ensure that all applicable Tax-Related Items are withheld or collected from the Director.
(c) 	In accordance with the terms of the Plan, and such rules as may be adopted by the Committee under the Plan, the
Director may elect to satisfy the Director’s obligations with regard to all Tax-Related Items arising from the receipt of, the
vesting of or the lapse of restrictions relating to, the Restricted Stock Units, by (i) delivering cash, check or money order payable
to the Company, (ii) delivering to the Company other Shares, (iii) having the Company withhold a portion of the Shares
otherwise to be delivered having a Fair Market Value sufficient to satisfy the statutory withholding required with respect thereto
to the extent permitted by the Company; or (iv) having the Company withhold any amounts necessary to pay the statutory
withholding required from the Director’s salary or other amounts payable to the Director. The Company will not deliver any
fractional Shares but will instead round down to the next full number the amount of Shares to be delivered. The Director’s
election must be made on or before the date that any such withholding obligation with respect to the Restricted Stock Units
arises. If the Director fails to timely make such an election, the Company shall have the right to withhold a portion of the Shares
otherwise to be delivered having a Fair Market Value equal to the statutory amount of withholding with respect to applicable
taxes, as determined by the Company in its sole discretion. The net settlement of the shares underlying the vested Restricted
Stock Units and the delivery of Shares previously owned are hereby specifically authorized alternatives for the satisfaction of the
foregoing withholding obligation. To the extent necessary to meet any obligation to withhold Federal Insurance Contributions
Act taxes before delivery of the Shares, the Company is authorized to deduct those taxes from other compensation.
-4-

-- 70 of 121 --

8. 	Governing Law. This Award Certificate shall be governed by and construed in accordance with the laws of the State of
Delaware, without regard to the conflicts of law provisions thereof.
9. 	Amendments. The Company, acting by means of the Committee, has the right, as set forth in the Plan, to amend, alter,
suspend, discontinue or cancel this Award, prospectively or retroactively; provided however, that no such amendment, alteration,
suspension, discontinuance or cancelation of the RSUs will adversely affect the Director’s material rights under this Award
Certificate without the Director’s consent. The Company has the authority to amend this Award Certificate, consistent with the
foregoing, without the Director’s written agreement, except as set forth in this Section 9.
In the event that the Company is reorganized or liquidated, or if all or substantially all of its assets are sold, or if the Company is
merged or consolidated with another corporation or entity (or in the event the Company consummates a written agreement to
accomplish any of the foregoing), the Committee may, in its sole discretion and upon at least 10 days advance notice to the
Director, cancel any outstanding RSUs and cause the Director to be paid (in cash or in stock, or any combination thereof) the
value of such RSUs based upon the price per share of Common Stock received or to be received in the transaction.
10. 	Administration. This Award Certificate shall at all times be subject to the terms and conditions of the Plan. Capitalized
terms not defined in this Award Certificate shall have the meanings set forth in the Plan. The Committee shall have sole and
complete discretion with respect to all matters reserved to it by the Plan and decisions of the Committee with respect thereto and
this Award Certificate shall be final and binding upon the Director and the Company. The Committee has the authority and
discretion to determine any questions which arise in connection with the award of the Restricted Stock Units hereunder.
11. 	Compliance with Code Section 409A for U.S. Taxpayers.
(a) 	Distributions of Shares in settlement of Restricted Stock Units as described herein which represent a “deferral of
compensation” within the meaning of Code Section 409A shall conform to the applicable requirements of Code Section 409A.
However, distributions as aforesaid shall not be deemed to be a "deferral of compensation" subject to Code section 409A to the
extent provided in the exception in Treasury Regulation Section 1.409A-1(b)(4) for short-term deferrals.
(b) 	It is the intention of the Company and Director that this Award Certificate not result in an unfavorable tax
consequence to the Director under Code Section 409A. Accordingly, as permitted by the Plan, the Company may at any time
(without the consent of the Director) modify or amend the Plan or this Award Certificate to the extent necessary to ensure that the
Award is not “deferred compensation” subject to Code Section 409A (or, alternatively, to conform to the requirements of Code
Section 409A). Any such amendments shall be made in a manner that preserves to the maximum extent possible the intended
benefits to Director. This paragraph does not create an obligation on the part of Company to modify this Award Certificate and
does not guarantee that the amounts or benefits owed under this Award Certificate will not be subject to interest and penalties
under Code Section 409A. For purposes of applying the provisions of Code Section 409A, to the extent applicable, each group of
Restricted Stock Units that would vest in accordance with Section 2 shall be treated as a separate payment.
-5-

-- 71 of 121 --

(c) 	While the Company intends that this Award Certificate and the RSUs granted hereunder comply with or be exempt
from the requirements of Code Section 409A and any related regulations or other guidance promulgated thereunder, neither the
Company or the Committee nor any of their respective affiliates shall be liable to any person for the tax consequences of any
failure to comply with the requirements of Code Section 409A or any other tax consequences relating to this Award.
12. 	Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Director’s
participation in the Plan, on the Restricted Stock Units and on any Shares acquired under the Plan, to the extent the Company
determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require
the Director, as a condition of receipt of Shares underlying a Restricted Stock Unit, to sign any additional Award Certificates or
undertakings that may be necessary to accomplish the foregoing.
13. 	Notices. Any notice, request, instruction or other document given under this Award Certificate shall be in writing and may
be delivered by such method as may be permitted by the Company, and shall be addressed and delivered, in the case of the
Company, to the Secretary of the Company at the principal office of the Company and, in the case of the Director, to the
Director’s address as shown in the records of the Company or to such other address as may be designated in writing (or by such
other method approved by the Company) by either party.
14. 	Severability. The invalidity or unenforceability of any provision of this Award Certificate shall not affect the validity or
enforceability of any other provision of this Award Certificate, and each other provision of the Award Certificate shall be
severable and enforceable to the extent permitted by law.
15. 	Award Subject to Plan; Amendments to Award. This Award is subject to the Plan as approved by the shareholders of the
Company. The terms and provisions of the Plan as it may be amended from time to time are hereby incorporated herein by
reference. In the event of a conflict between any term or provision contained in this Award Certificate and a term or provision of
the Plan, the applicable terms and provisions of this Award Certificate will govern and prevail.
16. 	Discretionary Nature of Plan; No Vested Rights. The Plan is discretionary in nature and limited in duration, and may be
amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the Award represented by this
Award Certificate is exceptional, voluntary and occasional and does not create any contractual or other right to receive an award
or benefit in lieu of an award in the future, even if awards have been granted repeatedly in the past. Future Awards, if any, will be
at the sole discretion of the Company, including, but not limited to, the form and timing of an Award, the number of Shares
subject to the Award, and the vesting provisions. Any amendment, modification or termination of the Plan shall not constitute a
change or impairment of the terms and conditions of the Director’s service with the Company.
17. Electronic Delivery. The Company may, in its sole discretion, decide to deliver any documents related to the RSU or future
Awards granted under the Plan by electronic means or request the Director’s consent to participate in the Plan by electronic
means. By accepting this Award, the Director hereby consents and agrees to receive such documents by electronic delivery
-6-

-- 72 of 121 --

and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or
another third party designated by the Company.
18. 	English Language. The Director acknowledges and agrees that it is the Director’s express intent that the Plan, this Award
Certificate, any addendum and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the
Award, be drawn up in English. Unless specifically indicated, if the Director has received the Plan, this Award Certificate, any
addendum or any other documents related to the Award translated into a language other than English, and if the meaning of the
translated version is different than the English version, the English version shall control.
19. 	Nature of Grant. In accepting the Award, the Director acknowledges, understands and agrees that:
(i) the Plan is established voluntarily by the Company, it is discretionary in nature, and may be modified, amended,
suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(ii) the Award is voluntary and occasional and does not create any contractual or other right to receive future grants of
RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;
(iii) all decisions with respect to future Awards or other grants, if any, will be at the sole discretion of the Company;
(iv) the Director is voluntarily participating in the Plan;
(v) 	the future value of the Shares underlying the RSUs is unknown and indeterminable; and
(vi) the Director acknowledges and agrees that neither the Company nor any Subsidiary shall be liable for any foreign
exchange rate fluctuation between the Director’s local currency and the United States Dollar that may affect the
value of the RSUs or of any amounts due to the Director pursuant to the vesting and settlement of the RSU or the
subsequent sale of any Shares issued upon settlement.
20. 	Consent to Collection, Processing and Transfer of Personal Data. Pursuant to applicable personal data protection
laws, the Company hereby notifies the Director of the following in relation to the Director’s personal data and the collection,
processing and transfer of such data in relation to the Company’s grant of this Award and the Director’s participation in the
Plan. The collection, processing and transfer of the Director’s personal data are necessary for the Company’s administration
of the Plan and the Director’s participation in the Plan. The Director’s denial and/or objection to the collection, processing
and transfer of personal data may affect the Director’s participation in the Plan. As such, the Director voluntarily explicitly
and unambiguously acknowledges and consents (where required under applicable law) to the collection, use, processing and
transfer of personal data as described in this Award Certificate and any other Award grant materials by and among, as
applicable, the Company and its Subsidiaries for the purpose of implementing, administering and managing the Director's
participation in the Plan.
-7-

-- 73 of 121 --

The Company holds certain personal information about the Director, including name, home address, email address and
telephone number, date of birth, social security number, passport number or other employee identification number, salary,
nationality, job title, any Shares or directorships held in the Company, details of all Awards or any other entitlement to Shares
awarded, canceled, purchased, vested, unvested or outstanding in Director’s favor, for the purpose of managing and
administering the Plan (“Data”). The Data may be provided by the Director or collected, where lawful, from third parties, and
the Company will process the Data for the exclusive purpose of implementing, administering and managing the Director’s
participation in the Plan. The Data processing will take place through electronic and non-electronic means according to
logics and procedures strictly correlated to the purposes for which Data are collected and with confidentiality and security
provisions as set forth by applicable laws and regulations in the Director’s country of residence. Data processing operations
will be performed minimizing the use of personal and identification data when such operations are unnecessary for the
processing purposes sought. Data will be accessible within the Company’s organization only by those persons requiring access
for purposes of the implementation, administration and operation of the Plan and for the Director’s participation in the Plan.
The Company may further transfer Data to any third parties assisting the Company in the implementation, administration
and management of the Plan. These recipients may be located in the European Economic Area, or elsewhere throughout the
world, such as the United States. The Director hereby authorizes (where required under applicable law) them to receive,
possess, use, retain and transfer the Data, in electronic or other form, for purposes of implementing, administering and
managing the Director’s participation in the Plan, including any requisite transfer of such Data as may be required for the
administration of the Plan and/or the subsequent holding of Shares on the Director’s behalf to a broker or other third party
with whom the Director may elect to deposit any Shares acquired pursuant to the Plan.
The Director may, at any time, exercise his or her rights provided under applicable personal data protection laws, which may
include the right to (a) obtain confirmation as to the existence of the Data, (b) verify the content, origin and accuracy of the
Data, (c) request the integration, update, amendment, deletion, or blockage (for breach of applicable laws) of the Data, and
(d) to oppose, for legal reasons, the collection, processing or transfer of the Data which is not necessary or required for the
implementation, administration and/or operation of the Plan and the Director’s participation in the Plan. The Director may
seek to exercise these rights by contacting the Office of the Corporate Secretary.
-8-

-- 74 of 121 --

Finally, upon request of the Company, the Director agrees to provide an executed data privacy consent form (or any other
agreements or consents that may be required by the Company) that the Company may deem necessary to obtain from the
Director for the purpose of administering the Director’s participation in the Plan in compliance with the data privacy laws in
the Director’s country, either now or in the future. The Director understands and agrees that the Director will not be able to
participate in the Plan if the Director fails to provide any such consent or agreement requested by the Company.
21. 	Private Placement. The grant of the RSUs is not intended to be a public offering of securities in the Director’s country of
residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or
other filings with the local securities authorities (unless otherwise required under local law), and the grant of the RSUs is not
subject to the supervision of the local securities authorities.
22. 	Addendum to Award Certificate. Notwithstanding any provisions of this Award Certificate to the contrary, the Award shall
be subject to any special terms and conditions for the Director’s country of residence (and country where services are primarily
performed, if different), as are set forth in the applicable addendum (the “Addendum”) as attached to the Award Certificate.
Further, if the Director transfers residence to another country reflected in an Addendum to the Award Certificate, the special
terms and conditions for such country will apply to the Director to the extent the Company determines, in its sole discretion, that
the application of such terms is necessary or advisable in order to comply with local laws, rules, and regulations, or to facilitate
operation and administration of the Plan. Any applicable Addendum shall constitute part of this Award Certificate.
23. 	No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making
any recommendations regarding the Director's participation in the Plan, or his acquisition or sale of the underlying Shares. The
Director acknowledges that he should consult with his own personal tax, legal and financial advisors regarding his participation
in the Plan before taking any action related to the Plan.
24. 	Entire Agreement. This Award Certificate represents the entire understanding and agreement between the parties with
respect to the subject matter of this Award Certificate and supersedes and replaces all previous agreements, arrangements,
understandings, rights, obligations and liabilities between the parties in respect of such matters.
25. 	Insider Trading / Market Abuse Laws. The Director acknowledges that, depending on the Director’s or the Director’s
broker’s country of residence or where the Shares are listed, the Director may be subject to insider trading and/or market abuse
laws, which may affect the Director's ability to accept, acquire, sell or otherwise dispose of Shares, rights to shares (e.g., RSUs)
or rights linked to the value of shares (e.g., phantom awards, futures) during such times as the Director is considered to have
"inside information" (regarding the Company as defined by the laws or regulations in the Director's country). Local insider
trading laws and regulations may prohibit the cancellation or amendment or amendment of orders the Director placed before the
Director possessed inside information. Furthermore, the Director could be prohibited from (i) disclosing the inside information to
any third party (other than on a "need to know") and (ii) "tipping" third parties or causing them otherwise to buy or sell securities.
The Director should keep in mind third parties includes fellow directors and employees of the Company. Any restrictions under
these laws and regulations are separate from and in addition to any restrictions that that may be imposed under any applicable
Company’s insider trading policy. The Director
-9-

-- 75 of 121 --

acknowledges that it is his or her responsibility to be informed of and compliant with any such laws and such Company’s
policies, and is hereby advised to speak to his or her personal legal advisor on this matter.
26. 	Waiver. The Director acknowledges that a waiver by the Company of a breach of any provision of this Award Certificate
shall not operate or be construed as a waiver of any other provision of this Award Certificate, or of a prior or subsequent breach
by the Director or any other Director.
[Signature Page Follows]
-10-

-- 76 of 121 --

NASDAQ, INC.
By: ___________________
Name: Bryan Smith
Title: EVP and Chief People Officer
-11-

-- 77 of 121 --

ADDENDUM
Terms and Conditions
This Addendum includes additional terms and conditions that govern the award of Restricted Stock Units granted to the Director
under the Nasdaq, Inc. Equity Incentive Plan (as amended and restated April 24, 2018) (the “Plan”) if the Director is resident
and/or primarily performs services in one of the countries listed below. If the Director transfers residency and/or employment to
another country reflected below following the Award Date, the additional terms and conditions for such country will apply to the
Director’s RSUs to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is
necessary or advisable in order to comply with local laws, rules, and regulations or to facilitate the operation and administration
of the RSUs and the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to
accommodate the Director’s transfer). Certain capitalized terms used but not defined in this Addendum have the meanings set
forth in the Plan and/or the Restricted Stock Unit Award Certificate (the “Award Certificate”).
Notifications
This Addendum also includes information regarding exchange controls and certain other issues of which the Director should be
aware with respect to participation in the Plan. The information is based on the securities, exchange control and other laws in
effect in the respective countries as of June 2021. Such laws are often complex and change frequently. As a result, the Company
strongly recommends that the Director not rely on the information in this Addendum as the only source of information relating to
the consequences of participation in the Plan because the information may be out of date at the time that the RSUs vest or the
Director sells Shares acquired under the Plan.
In addition, the information contained herein is general in nature and may not apply to the Director’s particular situation and the
Company is not in a position to assure the Director of any particular result. Accordingly, the Director is advised to seek
appropriate professional advice as to how the relevant laws in the Director’s country may apply to his or her situation.
SWEDEN
There are no country-specific provisions.
UNITED ARAB EMIRATES
Notifications
1. Securities Law Information. This Award Certificate and the Plan are intended for distribution only to directors, employees or
former employees of the Company and its Subsidiaries or affiliates for the purposes of implementing an equity compensation
plan. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in
connection with this Award Certificate and the Plan. Neither the Ministry of Economy nor the Dubai Department of Economic
Development have approved this Award Certificate and/or the Plan nor taken steps to verify the information set out in it, and
have no responsibility for it. The securities to which this Award Certificate and the Plan relate may be
-12-

-- 78 of 121 --

illiquid and/or subject to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due
diligence on the securities. If the Director does not understand the contents of this document he is advised to consult an
authorized financial adviser.
-13-

-- 79 of 121 --

Exhibit 10.3
NASDAQ, INC.
THREE-YEAR PERFORMANCE SHARE UNIT AGREEMENT
This PERFORMANCE SHARE UNIT AGREEMENT (this “Agreement”) between Nasdaq, Inc., a Delaware
corporation (the “Company”), and [EMPLOYEE NAME] (the “Grantee”) memorializes the grant by the Management
Compensation Committee of the Board of Directors of the Company (the “Committee”) on April 1, 2022 (the “Grant Date”) of
performance share units (the “PSUs”) to the Grantee on the terms and conditions set out below.
RECITALS:
The Company has adopted the Nasdaq, Inc. Equity Incentive Plan (as amended and restated April 24, 2018) (the
“Plan”), which Plan is incorporated herein by reference and made a part of this Agreement. Capitalized terms not otherwise
defined herein shall have the meaning ascribed to them in the Plan. The Plan in relevant part provides for the issuance of stock-
based awards that are subject to the attainment of performance goals as established by the Committee.
The Committee has determined that it is in the best interests of the Company and its shareholders to grant the
PSUs provided for herein to the Grantee pursuant to the Plan and under the terms set forth herein as an increased incentive for the
Grantee to contribute to the Company’s future success and prosperity.
Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Plan.
NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth, the parties hereto agree as
follows:
1. 	Grant of Performance-Based Award. The Company hereby grants to the Grantee [TARGET NUMBER
OF SHARES] PSUs, which PSUs shall entitle the Grantee to receive up to [200% OF TARGET NUMBER OF SHARES]
Shares (or a lesser number of Shares, or no Shares whatsoever), subject to the terms and conditions set forth in this Agreement
and the Plan. (A complete copy of the Plan, as in effect on the Grant Date, is available to the Grantee upon request.). Shares
corresponding to the PSUs granted herein are in all events to be delivered to the Grantee only after the Grantee has become
vested in the PSUs pursuant to Section 4, below.
2. 	Performance Period. For purposes of this Agreement, the term “Performance Period” shall be the period
commencing on January 1, 2022 and ending on December 31, 2024.
3. 	Performance Goal.
(a) 	Subject to the following sentence, the Performance Goal is set out in Appendix A hereto, which
Appendix A is incorporated by reference herein and made a part hereof. Notwithstanding the foregoing, the provisions of Section
13 or any other provision of this Agreement to the contrary, the Committee reserves the right to unilaterally change or
A-1

-- 80 of 121 --

otherwise modify the Performance Goal in any manner whatsoever (including substituting a new Performance Goal). If the
Committee exercises such discretionary authority to any extent, the Committee shall provide the Grantee with a new Appendix A
in substitution for the Appendix A attached hereto, and such new Appendix A and the Performance Goal set out therein (rather
than the Appendix A attached hereto and the Performance Goal set out therein) shall in all events apply for all purposes of this
Agreement.
(b) 	Depending upon the extent, if any, to which the Performance Goal has been achieved, and subject
to compliance with the requirements of Section 4, each PSU shall entitle the Grantee to receive, at such time as is determined in
accordance with the provisions of Section 5, between 0 and 2.0 Shares for each PSU. The Committee shall, as soon as practicable
following the last day of the Performance Period, certify (i) the extent, if any, to which, in accordance with Appendix A, the
Performance Goal has been achieved with respect to the Performance Period and (ii) the number of whole and/or partial Shares,
if any, which, subject to compliance with the vesting requirements of Section 4, the Grantee shall be entitled to receive with
respect to each PSU (with such number of whole and/or partial Shares being hereafter referred to as the “Share Delivery Factor”).
Such certification shall be final, conclusive and binding on the Grantee, and on all other persons, to the maximum extent
permitted by law.
4. 	Vesting.
(c) 	The PSUs are subject to forfeiture to the Company until they become non-forfeitable in accordance
with this Section 4. Except as provided in the following sentence, the risk of forfeiture will lapse on the PSUs, and such PSUs
shall thereupon become vested, only if the Grantee remains employed by the Company (or a subsidiary) through and on
December 31, 2024 (the “Vest Date”). Notwithstanding the foregoing, if the Grantee’s employment with the Company (or a
subsidiary) terminates by reason of death prior to December 31, 2024, the risk of forfeiture shall lapse on all PSUs, and all
unvested PSUs shall thereupon become vested on the date of death (or, if later, on the date, following the end of the Performance
Period on which the Committee determines whether, and to what extent the PSUs are earned in accordance with Section 3(b) of
this Agreement).
(d) 	Subject to any conflicting provisions in any employment agreement between the Company and the
Grantee, which shall control in the event of a conflict with this Agreement, in the event that (i) the Company or a subsidiary
terminates the Grantee’s employment with the Company or a subsidiary for any reason prior to the Vest Date or (ii) the Grantee
terminates employment with the Company or a subsidiary for any reason (other than death) prior to such date, all unvested PSUs
shall be cancelled and forfeited, effective as of the Grantee’s separation from service. Notwithstanding anything to the contrary in
the Plan or this Agreement, and for purposes of clarity, any separation from service shall be effective as of the date the Grantee’s
active employment ends and shall not be extended by any statutory or common law notice period.
2

-- 81 of 121 --

5. 	Delivery of Shares. As soon as practicable following the Vest Date, and compliance with all applicable tax
withholding as described in Section 11 hereof, but in no event later than two and one-half months after the end of the calendar
year in which the Vest Date occurs, the Company shall instruct the registrar for the Company to make an entry on its books and
records evidencing that the Shares underlying such vested PSUs have been duly issued as of that date; provided, however, that
the Grantee may, in the alternative, elect in writing prior thereto to receive a stock certificate representing the full number of
Shares acquired, which certificate may bear a restrictive legend prohibiting the transfer of such Shares for such period as may be
prescribed by the Company. The Company shall not be liable to the Grantee for damages relating to any delays in issuing the
certificates. The underlying Shares may be registered in the name of the Grantee’s legal representative or estate in the event of the
death of the Grantee. In the event of the acceleration of the lapse of forfeiture restrictions upon the death of the Grantee as
contemplated by Section 4(a) of this Agreement, this process shall occur as soon as possible following such vesting date, but in
no event later than two and one-half months after the end of the calendar year in which such vesting date occurs. Notwithstanding
anything in the Agreement, the Company may make delivery of Shares in settlement of PSUs by either (A) delivering certificates
representing such Shares to the Grantee, registered in the name of the Grantee, or (B) by depositing such Shares into a stock
brokerage account maintained for the Grantee.
6. 	Electronic Delivery/Acceptance. The Company may, in its sole discretion, decide to deliver any documents
related to the PSUs or future Awards granted under the Plan by electronic means or request the Grantee’s consent to participate in
the Plan by electronic means. By accepting this Award, the Grantee hereby consents and agrees to receive such documents by
electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the
Company or another third party designated by the Company.
7. 	Transferability.
(e) 	Except as provided below, or except to the minimal extent required by law, the PSUs are
nontransferable and may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the
Grantee, except by will or the laws of descent and distribution, and upon any such transfer, by will or the laws of descent and
distribution (or upon such transfer required by law), the transferee shall hold such PSUs subject to all the terms and conditions
that were applicable to the Grantee immediately prior to such transfer. Notwithstanding the foregoing, the Grantee may transfer
any vested PSUs to members of his immediate family (defined as his spouse, children or grandchildren) or to one or more trusts
for the exclusive benefit of such immediate family members or partnerships in which such immediate family members are the
only partners if the transfer is approved by the Committee and the Grantee does not receive any consideration for the transfer.
Any such transferred portion of the PSUs shall continue to be subject to the same terms and conditions that were applicable to
such portion of the PSUs immediately prior to transfer (except that such transferred PSUs shall not be further transferable by the
transferee). No transfer of a portion of the PSUs shall be effective to bind the Company unless the Company shall have been
furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity
of the transfer and the acceptance by the transferee of the terms and conditions hereof.
(f) 	Upon any transfer by will or the laws of descent and distribution (or upon any such transfer
required by law), such transferee shall take the PSUs and the Shares
3

-- 82 of 121 --

delivered in connection therewith (the “Transferee Shares”) subject to all the terms and conditions that were (or would have been)
applicable to the PSUs and the Transferee Shares immediately prior to such transfer.
(g) 	Following settlement and issuance of Shares, in the event the Company permits Grantee to arrange
for sale of Shares through a broker or another designated agent of the Company, Grantee acknowledges and agrees that the
Company may block any such sale and/or cancel any order to sell placed by the Grantee, in each case if the Grantee is not then
permitted under the Company’s insider trading policy to engage in transactions with respect to securities of the Company. If the
Committee determines that the ability of the Grantee to sell or transfer shares of Common Stock is restricted, then the Company
may notify the Grantee in accordance with Section 18 of this Agreement. The Grantee may only sell such Shares in compliance
with such notification from the Company.
8. 	Rights of Grantee. Prior to the delivery, if any, of Shares to the Grantee pursuant to the provisions of
Section 5, the Grantee shall not have any rights of a shareholder of the Company, including, but not limited to, the right to receive
dividend payments, on account of the PSUs.
9. 	Unfunded Nature of PSUs. The Company will not segregate any funds representing the potential liability
arising under this Agreement. The Grantee’s rights in respect of this Agreement are those of an unsecured general creditor of the
Company. The liability for any payment under this Agreement will be a liability of the Company and not a liability of any of its
officers, directors or Affiliates.
10. 	Securities Laws. The Company may condition delivery of Shares for any vested PSUs upon the prior
receipt from the Grantee of any undertakings which it may determine are required to assure that the Shares are being issued in
compliance with federal and state securities laws.
11. 	Withholding. Regardless of any action the Company, any of its Subsidiaries and/or the Grantee's employer
takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related items related to
the Grantee’s participation in the Plan and legally applicable to the Grantee (“Tax-Related Items”), the Grantee acknowledges
that the ultimate liability for all Tax-Related Items is and remains the Grantee’s responsibility and may exceed the amount
actually withheld by the Company or any of its affiliates. The Grantee further acknowledges that the Company and/or its
Subsidiaries (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any
aspect of the PSUs, including, but not limited to, the grant, vesting or settlement of the PSUs, the issuance of Shares or cash upon
settlement of the PSUs, the subsequent sale of Shares acquired pursuant to such delivery and the receipt of any dividends and/or
dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of any award to reduce or
eliminate the Grantee’s liability for Tax-Related Items or achieve any particular tax result. Further, if the Grantee becomes subject
to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Grantee acknowledges
that the Company and/or its Subsidiaries may be required to withhold or account for Tax-Related Items in more than one
jurisdiction.
4

-- 83 of 121 --

Prior to any relevant taxable or tax withholding event, as applicable, the Grantee will pay or make adequate arrangements
satisfactory to the Company and/or its Subsidiaries to satisfy all Tax-Related Items. In this regard, the Grantee authorizes the
Company and/or its Subsidiaries, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-
Related Items by one or a combination of the following:
(h) 	withholding from the Grantee’s wages or other cash compensation paid to the Grantee by the Company
and/or its Subsidiaries; or
(i) 	withholding from proceeds of the Shares acquired following settlement either through a voluntary sale or
through a mandatory sale arranged by the Company (on the Grantee’s behalf pursuant to this
authorization); or
(j) 	withholding in Shares to be delivered upon settlement.
To avoid negative accounting treatment, the Company and/or its Subsidiaries may withhold or account for Tax-Related Items by
considering applicable statutory withholding amounts or other applicable withholding rates. If the obligation for Tax-Related
Items is satisfied by withholding in Shares, for tax purposes, the Grantee is deemed to have been issued the full number of Shares
attributable to the awarded PSUs, notwithstanding that a number of Shares are held back solely for the purpose of paying the Tax-
Related Items due as a result of any aspect of the Grantee’s participation in the Plan.
The Grantee shall pay to the Company and/or its Subsidiaries any amount of Tax-Related Items that the Company and/or its
Subsidiaries may be required to withhold or account for as a result of the Grantee’s participation in the Plan that are not satisfied
by the means previously described. The Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares,
if the Grantee fails to comply with the Grantee’s obligations in connection with the Tax-Related Items.
By accepting this grant of PSUs, the Grantee expressly consents to the methods of withholding Tax-Related Items by the
Company and/or its subsidiaries as set forth hereunder, including the withholding of Shares and the withholding from the
Grantee’s wages/salary or other amounts payable to the Grantee. All other Tax-Related Items related to the PSUs and any Shares
delivered in satisfaction thereof are the Grantee’s sole responsibility.
12. 	Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the
State of Delaware, without giving effect to any principle of law that could result in the application of the law of any other
jurisdiction.
13. 	Amendments. This Agreement may be amended or modified at any time by an instrument in writing signed
by the parties hereto, except as otherwise provided in Section 3(a) or Sections 15 or 16 of this Agreement regarding permitted
unilateral action by the Committee or in Section 13(a) of the Plan related to amendments or alterations that do not adversely
affect the rights of the Grantee in this Award.
5

-- 84 of 121 --

14. 	Administration. This Agreement shall at all times be subject to the terms and conditions of the Plan. The
Committee shall have sole and complete discretion with respect to all matters reserved to it by the Plan and decisions of the
Committee with respect thereto and this Agreement shall be final and binding upon the Grantee and the Company. In the event of
any conflict between the terms and conditions of this Agreement and the Plan, the provisions of this Agreement shall control. The
Committee has the authority and discretion to determine any questions which arise in connection with the award of the PSUs
hereunder.
15. 	Compliance with Code Section 409A. It is the intention of the Company and Grantee that this Agreement
not result in an unfavorable tax consequences to Grantee under Code Section 409A. Accordingly, Grantee consents to any
amendment of this Agreement as the Company may reasonably make in furtherance of such intention, and the Company shall
promptly provide, or make available to, Grantee a copy of such amendment. Any such amendments shall be made in a manner
that preserves to the maximum extent possible the intended benefits to Grantee. This paragraph does not create an obligation on
the part of Company to modify this Agreement and does not guarantee that the amounts or benefits owed under the Agreement
will not be subject to interest and penalties under Code Section 409A.
16. 	Imposition of Other Requirements. The Company reserves the right to impose other requirements on the
Grantee’s participation in the Plan, on the PSUs and on any Shares acquired under the Plan, to the extent the Company
determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require
the Grantee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. The Grantee
agrees, upon demand of the Company or the Committee, to do all acts and execute, deliver and perform all additional documents,
instruments and agreements which may be reasonably required by the Company or the Committee, as the case may be, to
implement the provisions and purposes of the Plan and this Agreement.
17. 	No Right to Continued Employment. Neither the plan nor this agreement shall confer on the Grantee any
right to be retained, in any position, as an employee, consultant or director of the Company, and nothing in this agreement or the
Plan shall be construed to limit the discretion of the Company (or the subsidiary that employees the Grantee) to terminate the
Grantee’s employment at any time, with or without cause.
18. 	Notices. Any notice, request, instruction or other document given under this Agreement shall be in writing
and may be delivered by such method as may be permitted by the Company, and shall be addressed and delivered, in the case of
the Company, to the Secretary of the Company at the principal office of the Company and, in the case of the Grantee, to the
Grantee’s address as shown in the records of the Company or to such other address as may be designated in writing (or by such
other method approved by the Company) by either party.
19. 	Award Subject to Plan. This Award is subject to the Plan as approved by the shareholders of the Company.
In the event of conflict between any term or provision contained herein and a term or provision of the Plan, the applicable terms
and provisions of this Agreement will govern and prevail.
6

-- 85 of 121 --

20. 	Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the
validity or enforceability of any other provision of this Agreement and each other provision of this Agreement shall be severable
and enforceable to the extent permitted by law.
21. 	Discretionary Nature of Plan; No Vested Rights. The Plan is discretionary in nature and limited in duration,
and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time. The grant of the Award
represented by this Agreement is exceptional, voluntary and occasional and does not create any contractual or other right to
receive an award or benefit in lieu of an award in the future, even if awards have been granted repeatedly in the past. Future
Awards, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of an Award, the
number of Shares subject to the Award, and the vesting provisions. Any amendment, modification or termination of the Plan shall
not constitute a change or impairment of the terms and conditions of the Grantee’s employment with the Company.
22. 	Termination Indemnities. The Grantee’s Award and the Shares subject to the Award, and the income and
value of the same, are extraordinary items of compensation outside the scope of the Grantee’s employment or services contract, if
any. As such, the PSUs are not part of normal or expected compensation for purposes of calculating any severance, resignation,
termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension, or retirement benefits or
welfare benefits or similar payments.
23. 	English Language. The Grantee acknowledges and agrees that it is the Grantee’s express intent that the
Plan, this Agreement, any addendum and all other documents, notices and legal proceedings entered into, given or instituted
pursuant to the Award, be drawn up in English. Unless specifically indicated, if the Grantee has received the Plan, this
Agreement, any addendum or any other documents related to the Award translated into a language other than English, and if the
meaning of the translated version is different than the English version, the English version shall control.
24. 	Nature of Grant. In accepting the Award, the Grantee acknowledges, understands and agrees that:
(i) the Plan is established voluntarily by the Company, it is discretionary in nature, and may be modified,
amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(ii) all decisions with respect to future Awards or other grants, if any, will be at the sole discretion of the
Company;
(iii) the grant of the PSUs and the Grantee’s participation in the Plan shall not create a right to employment or
be interpreted as forming an employment or service contract with the Company, the Grantee's employer or any Subsidiary, and
shall not interfere with the ability of the Company, the Grantee's employer or any Subsidiary, as applicable, to terminate the
Grantee’s employment or service relationship (if any);
7

-- 86 of 121 --

(iv) the Grantee is voluntarily participating in the Plan;
(v) the PSUs and any Shares issued under the Plan and the income and value of the same are not intended to
replace any pension rights or compensation;
(vi) the future value of the Shares underlying the PSUs is unknown and indeterminable;
(vii) unless otherwise agreed with the Company, the Award and the Shares subject to the Award, and the income
and value of same, are not granted as consideration for, or in connection with, the service Grantee may provide as a director of a
Subsidiary of the Company;
(viii) no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from
separation from service (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in
the jurisdiction where the Grantee is employed or the terms of the Grantee’s employment agreement, if any), and in consideration
of the grant of the PSUs to which the Grantee is otherwise not entitled, the Grantee irrevocably agrees never to institute any claim
against the Company, any of its Subsidiaries or the Grantee's employer, waives his ability, if any, to bring any such claim, and
releases the Company, its Subsidiaries and the Grantee's employer from any such claim; if, notwithstanding the foregoing, any
such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Grantee shall be deemed
irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal
or withdrawal of such claim; and
(ix) the Grantee acknowledges and agrees that neither the Company, the Grantee's employer nor any Subsidiary
shall be liable for any foreign exchange rate fluctuation between the Grantee’s local currency and the United States Dollar that
may affect the value of the PSUs or of any amounts due to the Grantee pursuant to the vesting and settlement of the PSU or the
subsequent sale of any Shares issued upon settlement.
25. 	Data Protection. Except if the Grantee resides in the European Union, the European Economic Area or
other jurisdiction designated by the Company, in which case the Grantee is subject to the special terms and conditions set forth in
the Addendum, the Grantee explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form,
of the Grantee’s personal data as described in the Agreement and any other PSU grant materials by and among, as applicable, the
Grantee, the Company, the Grantee’s employer, and the Company’s Subsidiaries for the exclusive purpose of implementing,
administering and managing the Grantee’s participation in the Plan.
The Company and its Subsidiaries, including the Grantee’s employer hold certain personal information
about the Grantee, including, but not limited to, his or her name, home address, email address and telephone number, date of
birth, social security number, passport number or other employee identification number, salary, nationality, job title, any
Shares or directorships held in the Company, details of all Awards or any other entitlement to Shares awarded, canceled,
purchased, vested, unvested or outstanding in Grantee’s favor (“Data”), for the exclusive purpose of managing and
administering the Plan.
8

-- 87 of 121 --

The Company and its Subsidiaries, including the Grantee’s employer, will transfer Data amongst themselves
as necessary for the purpose of implementation, administration and management of the Grantee’s participation in the Plan,
and the Company and its Subsidiaries, including the Grantee’s employer, may each further transfer Data to a designated Plan
broker, administrative agent or such other stock plan service provider as may be selected by the Company presently or in the
future (a “Plan Service Provider”), which may be assisting the Company in the implementation, administration and
management of the Plan. These recipients may be located in the Grantee’s country or elsewhere throughout the world, such
as the United States and any recipient’s country (e.g., the United States) may have different data privacy laws and protections
than the Grantee’s country. The Grantee understands that if he or she resides outside the United States, the Grantee may
request a list with the names and addresses of any potential recipients of the Data by contacting the Grantee’s local human
resources representative. The Grantee hereby authorizes (where required under applicable law) the Company, any Plan
Service Provider and any other possible recipients which may assist the Company (presently or in the future) to receive,
possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering
and managing the Grantee’s participation in the Plan. Furthermore, the Grantee acknowledges and understands that the
transfer of the Data to the Company or its Subsidiaries, including the Grantee’s employer, to any Plan Service Provider, or to
any third parties is necessary for the Grantee’s participation in the Plan. The Grantee understands that Data will be held only
as long as is necessary to implement, administer and manage the Grantee’s participation in the Plan. The Grantee
understands that if he or she resides outside the United States, the Grantee may, at any time, view the Data, request additional
information about the storage and processing of the Data, require any necessary amendments to the Data or refuse or
withdraw the consents herein by contacting the Grantee’s local human resources representative in writing. The Grantee
understands that he or she is providing the consents herein on a purely voluntary basis. If the Grantee does not consent, or if
the Grantee later seeks to revoke his or her consent, the Grantee’s employment status or service and career with the Company
and its Subsidiaries will not be affected. The only consequence of refusing or withdrawing the Grantee’s consent is that the
Company may not be able to grant the Grantee PSUs or other awards or administer or maintain such awards. Therefore, the
Grantee acknowledges that withdrawal of consent may affect the Grantee’s ability to vest in or realize benefits from the PSUs,
and the Grantee’s ability to participate in the Plan, in which case neither the Company nor any of its Subsidiaries, including
the Grantee’s employer, will have any liability or obligation to the Grantee related to this Award. For more information on the
consequences of refusal to consent or withdrawal of consent, the Grantee understands that he or she may contact his or her
local human resources representative.
Finally, upon request of the Company or the Grantee’s employer, the Grantee agrees to provide an executed
data privacy consent form (or any other agreements or consents that may be required by the Company and/or the Grantee’s
employer) that the Company and/or the Grantee’s employer may deem necessary to obtain from the Grantee for the purpose of
administering the Grantee’s participation in the Plan in compliance with the data privacy laws in the Grantee’s country, either
now or in the future. The Grantee understands and agrees that the Grantee will not be able to participate in the Plan if the
Grantee fails to provide any such consent or agreement requested by the Company and/or the Grantee’s employer.
9

-- 88 of 121 --

26. 	Private Placement. The grant of the PSUs is not intended to be a public offering of securities in the
Grantee’s country of residence (and country of employment, if different). The Company has not submitted any registration
statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the
grant of the PSUs is not subject to the supervision of the local securities authorities.
27. 	Addendum to Agreement. Notwithstanding any provisions of this Agreement to the contrary, the Award
shall be subject to any special terms and conditions for the Grantee’s country of residence (and country of employment, if
different), as are set forth in the applicable addendum (the “Addendum”) as attached to the Agreement. Further, if the Grantee
transfers residence and/or employment to another country reflected in an Addendum to the Agreement, the special terms and
conditions for such country will apply to the Grantee to the extent the Company determines, in its sole discretion, that the
application of such terms is necessary or advisable in order to comply with local laws, rules and regulations or to facilitate
operation and administration of the Plan. Any applicable Addendum shall constitute part of this Agreement.
28. 	No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the
Company making any recommendations regarding the Grantee's participation in the Plan, or his acquisition or sale of the
underlying Shares. The Grantee acknowledges that he should consult with his own personal tax, legal and financial advisors
regarding his participation in the Plan before taking any action related to the Plan.
29. 	Entire Agreement. This Agreement represents the entire understanding and agreement between the parties
with respect to the subject matter of this Agreement and supersedes and replaces all previous agreements, arrangements,
understandings, rights, obligations and liabilities between the parties in respect of such matters.
30. 	Execution. By electronically or otherwise accepting this Agreement, the Grantee acknowledges his or her
understanding and acceptance of the terms and conditions of the Award. The Company has no obligation to issue the Grantee
Shares under this Agreement if the Grantee does not accept the Award. Further, any acceptance of Shares issued pursuant to this
Agreement shall constitute the Grantee’s acceptance of the Award and the Grantee’s agreement with all terms and conditions of
the Award, as set forth in the Plan and this Agreement.
31. 	Insider Trading / Market Abuse Laws. The Grantee acknowledges that, depending on the Grantee’s or the
Grantee’s broker’s country of residence or where the Shares are listed, the Grantee may be subject to insider trading and/or
market abuse laws, which may affect the Grantee’s ability to accept, acquire, sell or otherwise dispose of Shares, rights to shares
(e.g., PSUs) or rights linked to the value of shares (e.g., phantom awards, futures) during such times as the Grantee is considered
to have “inside information” regarding the Company as defined by the laws or regulations in the Grantee’s country. Local insider
trading laws and regulations may prohibit the cancellation or amendment or amendment of orders the Grantee placed before the
Grantee possessed inside information. Furthermore, the Grantee could be prohibited from (i) disclosing the inside information to
any third party (other than on a "need to know") and (ii) "tipping" third parties or causing them otherwise to buy or sell securities.
The Grantee should keep in mind third parties includes fellow employees. The requirements of these laws may or may not be
consistent with the terms of any applicable Company’s insider trading policy. The Grantee acknowledges that it is his or her
responsibility to be informed of and
10

-- 89 of 121 --

compliant with any such laws and such Company policies, and is hereby advised to speak to his or her personal legal advisor on
this matter.
32. 	Waiver. The Grantee acknowledges that a waiver by the Company of a breach of any provision of this
Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of a prior or subsequent
breach by the Grantee or any other Grantee.
11

-- 90 of 121 --

IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the ___ day of _____, 2022. By
execution of this Agreement the Grantee acknowledges receipt of a copy of the Plan, and agrees to the terms and conditions of
the Plan and this Agreement.
NASDAQ, INC.
By: Bryan Smith
Title: EVP and Chief People Officer
[EMPLOYEE NAME]
12

-- 91 of 121 --

Appendix A
Performance Goals for PSU Grant
2022-2024 Performance Period
This Appendix A to the Agreement sets forth the Performance Goals to be achieved and, depending upon the
extent (if any) to which the Performance Goals are achieved, the number of whole and/or partial Shares, if any, which the Grantee
shall have the right to receive with respect to each PSU. Capitalized terms not otherwise defined herein shall have the meaning
ascribed to them in the Agreement and the Plan.
Certain Definitions
“Closing Price” means the 30-day calendar average closing price of a share of a company’s stock ending on the
last trading day of the Performance Period.
“Opening Price” means the 30-day calendar average closing price of a share of a company’s stock ending on the
trading day preceding the first day of the Performance Period. The Opening Price shall be adjusted for stock splits and reverse
stock splits that occur during the Performance Period.
“Payout Governor” means that regardless of percentile ranking for either Performance Goal, if the Company’s
TSR is negative, the Grantee shall be entitled to receive no more than 100% of the PSUs.
“Peer Group” means a group of peer companies consisting of the following global exchanges: (i) ASX Limited,
(ii) B3 S.A., (iii) Bolsa Mexicana de Valores, S.A.B. de C.V., (iv) Cboe Global Markets, Inc., (v) CME Group, Inc., (vi) Deutsche
Börse AG, (vii) Euronext N.V., (viii) Hong Kong Exchanges and Clearing Limited, (ix) Intercontinental Exchange, Inc. (x) Japan
Exchange Group, Inc., (xi) London Stock Exchange Group plc, (xii) Singapore Exchange Limited and (xiii) TMX Group
Limited.
“Price Cap” means that regardless of the actual stock price growth over the Performance Period, the final stock
price will be limited to 250% of the grant date price for purposes of calculating the final award of PSUs to the Grantee.
“S&P 500” means the companies constituting the Standard & Poor’s 500 Index as of the beginning of the
Performance Period. Any component company of the Standard & Poor’s 500 Index that is acquired, taken private, delisted,
liquidated or no longer publicly traded due to filing for bankruptcy protection at any time during the Performance Period will be
eliminated from the S&P 500 for the entire Performance Period. There will be no adjustments to the S&P 500 to account for any
other changes to the Standard & Poor’s 500 Index during the Performance Period.
“TSR” means the total shareholder return during the Performance Period, which will be calculated as the (i)
Closing Price minus Opening Price plus cumulative dividends, divided by (ii) Opening Price. No adjustments to TSR shall be
made for stock issuances or stock buybacks during the Performance Period. Each company’s TSR shall be calculated in the local
currency to eliminate foreign exchange fluctuations.
13

-- 92 of 121 --

Goal 1: TSR Performance Relative to the S&P 500
The Performance Goal for 50% of the PSUs shall be the Company’s three-year TSR percentile rank versus the
S&P 500.
For this portion of the award, each PSU shall, subject to the vesting provisions set forth in the Agreement and the
Payout Governor, entitle the Grantee to receive Shares based on the levels of achievement in the following table.
Table 1: Levels of Achievement
Percentile Rank of the Company’s Three-Year TSR Versus
the S&P 500 Resulting Shares Earned (% of Half of Target)
≥85 Percentile 	200%
67.5 Percentile 	150%
50 Percentile 	100%
25 Percentile 	50%
15 Percentile 	30%
0 Percentile 	0%
For levels of achievement between points, the resulting Shares earned will be calculated based on straight-line
interpolation.
The resulting shares earned will be subject to the 250% Price Cap. If the Nasdaq stock price grows greater than
250% over the Performance Period, the resulting number of shares will be fewer than 200% of target shares. For example:
(formulaic resulting shares earned X 250% Price Cap) / (stock price at time of delivery of shares) = resulting actual shares
earned.
Goal 2: TSR Performance Relative to a Peer Group
The Performance Goal for 50% of the PSUs shall be the Company’s three-year TSR percentile rank versus the
Peer Group. For this portion of the award, each PSU shall, subject to the vesting provisions set forth in the Agreement and the
Payout Governor, entitle the Grantee to receive Shares based on the levels of achievement in the following table.
th
th
th
th
th
14

-- 93 of 121 --

Table 2: Levels of Achievement
Percentile Rank of the Company’s Three-Year TSR Versus
the Peer Group Resulting Shares Earned (% of Half of Target)
≥85 Percentile 	200%
67.5 Percentile 	150%
50 Percentile 	100%
25 Percentile 	50%
15 Percentile 	30%
0 Percentile 	0%
For levels of achievement between points, the resulting Shares earned will be calculated based on straight-line
interpolation.
The resulting shares earned will be subject to the 250% Price Cap. If the Nasdaq stock price grows greater than
250% over the Performance Period, the resulting number of shares will be fewer than 200% of target shares. For example:
(formulaic resulting shares earned X 250% Price Cap) / (stock price at time of delivery of shares) = resulting actual shares
earned.
Other Terms and Conditions
To the extent consistent with the Code and the Plan, the Committee reserves the right to modify any calculation
described in this Appendix A to adjust for unanticipated circumstances or situations, as it deems necessary. All actions taken by
the Committee pursuant to this Appendix A shall be final, conclusive and binding upon the Grantee, and all other persons, to the
maximum extent permitted by law.
th
th
th
th
th
15

-- 94 of 121 --

Exhibit 10.5
EMPLOYMENT AGREEMENT
EMPLOYMENT AGREEMENT (this "Agreement"), made and entered into and effective as of June 22, 2022 (the
"Effective Date"), by and between Nasdaq, Inc. (the "Company") and Bradley Peterson (the “Executive").
In consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties
hereby agree as follows:
1. Term of Agreement. Subject to Section 8 below, the term of this Agreement shall commence on the Effective Date and
end on December 31, 2025 (the "Term").
2. Position.
(a) Duties. The Executive shall serve as the Company's Executive Vice President and Chief Information and Chief
Technology Officer and shall have such other duties as agreed to by the Executive, the President and Chief Executive Officer, and
the Board of Directors of the Company (the “Board”). In such position, the Executive shall have such duties and authority as
shall be determined from time to time by the President and Chief Executive Officer and the Board and as shall be consistent with
the by-laws of the Company as in effect from time to time. During the Term, the Executive shall devote his full time and best
efforts to his duties hereunder. The Executive shall report directly to the President and Chief Executive Officer. The scope, duties
and responsibilities of the role will be evaluated at least annually and increased, as appropriate, based on performance in the role.
(b) Company Code of Ethics. The Executive shall comply in all respects with the Company’s Code of Ethics and all
applicable corporate policies referenced in the Code of Ethics, as may be amended from time to time (the "Code of Ethics"). The
Executive may, in accordance with the Code of Ethics, (i) engage in personal activities involving charitable, community,
educational, religious or similar organizations and (ii) manage his personal investments; provided, however, that, in each case,
such activities are in all respects consistent with applicable law, the Continuing Obligations Agreement attached as Exhibit A
(“Continuing Obligations Agreement”) and Section 9 below.
3. Base Salary. During the Term, the Company shall pay the Executive a base salary (the "Base Salary") at an annual
rate of not less than $650,000. The Base Salary shall be payable in regular payroll installments in accordance with the Company's
payroll practices as in effect from time to time (but no less frequently than monthly). The Management Compensation Committee
of the Board (the "Compensation Committee") shall review the Base Salary at least annually and may (but shall be under no
obligation to) increase (but not decrease) the Base Salary on the basis of such review.
1

-- 95 of 121 --

4. Annual Bonus.
(a) Annual Bonus. For each calendar year during the Term, the Executive shall be eligible to participate in the
Executive Incentive Plan of the Company (the "Bonus Program") in accordance with the terms and provisions of such Bonus
Program as established from time to time by the Compensation Committee and pursuant to which the Executive will be eligible
to earn an annual cash bonus (the "Annual Bonus"). Pursuant to the terms of the Bonus Program, the Executive shall be eligible to
earn, for each full calendar year during the Term, a target Annual Bonus of not less than $975,000 (the "Target Bonus") based
upon the achievement of one or more performance goals established for such year by the President and Chief Executive Officer
and the Compensation Committee. The Executive shall have the opportunity to make suggestions to the President and Chief
Executive Officer and the Compensation Committee prior to the determination of the performance goals for the Bonus Program
for each performance period, but the Compensation Committee will have final power and authority concerning the establishment
of such goals. The President and Chief Executive Officer and the Compensation Committee shall review the Target Bonus at least
annually and may (but shall be under no obligation to) increase (but shall not decrease) the Target Bonus on the basis of such
review. The Target Bonus for each year during the Term shall never be less than the Target Bonus for the immediately preceding
year.
(b) Timing and Deferral of Annual Bonus. The Annual Bonus for each year shall be paid to the Executive as soon as
reasonably practicable following the end of such year, but in no event later than March 15 following the end of the calendar year
to which such Annual Bonus relates.
5. Equity Compensation. The Executive shall be eligible for a target equity compensation award of not less than
$2,500,000 (the "Target Equity Incentive"), in accordance with the terms and provisions of the Company’s Equity Incentive Plan
(the “Stock Plan”), which has been adopted by the Board and may from time to time be amended. The applicable provisions of
the Company’s Stock Plan or each equity award agreement executed by the Executive and the Company shall govern the
treatment of the equity awards.
6. Employee Benefits. During the Term, the Company shall provide the Executive with benefits on the same basis as
benefits are generally made available to other senior executives of the Company, including, without limitation, medical, dental,
vision, disability and life insurance, financial and tax planning services and retirement benefits. The Executive shall be entitled to
four weeks of paid vacation to be used in accordance with the Company’s then current vacation policy; provided, however, that,
in the event the Executive's employment ends for any reason, the Executive shall be paid only for unused vacation that accrued in
the calendar year his employment terminated and any unused vacation for any prior year shall be forfeited.
7. Business and Other Expenses.
(a) Business Expenses. During the Term, the Company shall reimburse the Executive for reasonable business
expenses incurred by his in the performance of his duties hereunder in accordance with the policy established by the Company.
th
2

-- 96 of 121 --

8. Termination. Notwithstanding any other provision of this Agreement, subject to the further provisions of this
Section 8, the Company may terminate the Executive's employment or the Executive may resign such employment for any reason
or no stated reason at any time, subject to the notice and other provisions set forth below:
(a) Generally. In the event of the termination of the Executive's employment for any reason, the Executive shall
receive payment of (i) any unpaid Base Salary through the Date of Termination (as defined below), to be paid in accordance with
Section 3 above, (ii) subject to Section 6 above, any accrued but unpaid vacation through the Date of Termination payable within
14 days of the Date of Termination (iii) any earned but unpaid Annual Bonus with respect to the calendar year ended prior to the
Date of Termination, payable in accordance with Section 4(b) (the "Base Obligations"). In addition, in the event of the
Executive's termination of employment, the applicable provisions of the Company’s Stock Plan or each equity award agreement
executed by the Executive and the Company shall govern the treatment of the equity awards.
For purposes of this Agreement, "Date of Termination" means (i) in the event of a termination of the Executive's
employment by the Company for Cause or by the Executive for Good Reason, the date specified in a written notice of
termination (or, if not specified therein, the date of delivery of such notice), but in no event earlier than the expiration of the cure
periods set forth in Section 8(b)(ii) or 8(b)(iii) below, respectively; (ii) in the event of a termination of the Executive's
employment by the Company without Cause, the date specified in a written notice of termination (or if not specified therein, the
date of delivery of such notice); (iii) in the event of a termination of the Executive's employment by the Executive without Good
Reason, the date specified in a written notice of termination, but in no event less than 60 days following the date of delivery of
such notice; (iv) in the event of a termination of the Executive's employment due to Permanent Disability (as defined below), the
date the Company terminates the Executive's employment following the certification of the Executive's Permanent Disability; or
(v) in the event of a termination of employment due to the Executive's death, the date of the Executive's death.
(b) Termination Without Cause, Termination by the Executive for Good Reason (other than Change in Control), or
Retirement at end of Term.
(i) The Executive's employment hereunder may be terminated by the Company without Cause, by the
Executive for Good Reason (other than Change in Control), or by the Executive for Retirement at the end of the Term. Upon the
termination of the Executive's employment pursuant to this Section 8(b), the Executive shall, subject to Section 8(h) below, be
entitled to receive, in addition to the Base Obligations, the following payments and benefits (the "Severance Benefits"):
(A) Payments. The Executive shall, subject to Section 8(h), be entitled to receive, in addition to the Base
Obligations, a pro-rata Target Bonus with respect to the calendar year in which the Date of Termination occurs, determined in
accordance with the Pro Rata Target Bonus Calculation and payable in substantially equal monthly installments for the twelve
month period following the Executive’s Date of Termination with the first installment to be paid in the month following the
month in with the Release Effective Date occurs (provided that if the 60 day period described in Section 8(h) below begins in one
calendar year and ends in another, the pro rata Target Bonus shall be paid not earlier than January 1 of the calendar year
following the Date of Termination), the equity awards described in Section 5 and continued vesting of outstanding performance
share units, and/or other forms of equity compensation issued prior to the Date of Termination as though the Executive were
employed through all applicable performance periods (“Continued Vesting Period”), based on actual performance
3

-- 97 of 121 --

during the respective performance periods. Any vested stock options shall remain exercisable until the expiration date specified
in the applicable award agreement.
The Pro Rata Target Bonus is intended to be a fixed severance payment and not a performance-contingent payment dependent on
current year or prior year performance. “Pro-Rata Target Bonus Calculation” is determined by multiplying the Target Bonus by a
fraction, the numerator of which is the number of days in the fiscal year in which the Date of Termination occurs through the
Date of Termination and the denominator of which is three hundred sixty-five.
The Executive acknowledges and agrees that the compensation paid under this Section 8(b) is fair and reasonable, and are his
sole and exclusive remedy, in lieu of all other remedies at law or in equity, with respect to the termination of his employment
hereunder, and is subject to the Executive complying in all material respects with his obligations under Section 9 or the
Continuing Obligations Agreement. All other benefits, if any, due the Executive following termination pursuant to this
Section 8(b) shall be determined in accordance with the plans, policies and practices of the Company; provided, however, that the
Executive shall not participate in any severance plan, policy or program of the Company.
(B) Benefits. The Executive will receive $40,000 to offset the cost of premiums associated with the
Executive’s post-retirement health benefits. The Executive will receive this amount in one lump sum payment, minus applicable
taxes and withholdings, within 60 days of the last day of his employment.
The Company will continue to provide, for a period of 24 months following the Date of Termination, financial and tax services
(currently provided by Ayco) and executive physical exams (currently provided by EHE International).
All other benefits, if any, due the Executive following termination pursuant to this Section 8(b) shall be determined in accordance
with the plans, policies and practices of the Company; provided, however, that the Executive shall not participate in any
severance plan, policy or program of the Company. The Severance Benefits are payments and benefits to which the Executive is
not otherwise entitled, are given in consideration for the Release (as described in Section 8(h) below) and are in lieu of any
severance plan, policy or program of the Company or any of its subsidiaries that may now or hereafter exist. The payments and
benefits to be provided pursuant to this Section 8(b)(i) shall constitute liquidated damages and shall be deemed to satisfy and be
in full and final settlement of all obligations of the Company to the Executive under this Agreement. The Executive
acknowledges and agrees that such amounts are fair and reasonable, and are his sole and exclusive remedy, in lieu of all other
remedies at law or in equity, with respect to the termination of his employment hereunder. If, during the Continued Vesting
Period, the Executive breaches in any material respect any of his obligations under Section 9, or the Continuing Obligations
Agreement, the Company may, upon written notice to the Executive terminate the Continued Vesting Period and cease any
benefits continuation coverage or payments, except in each case as required by applicable law.
4

-- 98 of 121 --

(ii) For purposes of this Agreement, "Cause" shall mean (A) the Executive's conviction of, or pleading nolo
contendere to, any crime, whether a felony or misdemeanor, involving the purchase or sale of any security, mail or wire fraud,
theft, embezzlement, moral turpitude, or Company property (with the exception of minor traffic violations or similar
misdemeanors); (B) the Executive's repeated neglect of his duties to the Company; or (C) the Executive's willful misconduct in
connection with the performance of his duties or other material breach by the Executive of this Agreement provided that the
Company may not terminate the Executive's employment for Cause unless (x) the Company first gives the Executive written
notice of its intention to terminate and of the grounds for such termination within 90 days following the date the Board is
informed of such grounds at a meeting of the Board and (y) the Executive has not, within 30 days following receipt of such
notice, cured such Cause (if capable of cure) in a manner that is reasonably satisfactory to the Board.
(iii) For purposes of this Agreement, "Good Reason" shall mean the Company (A) reducing the Executive's
position, duties, or authority; (B) failing to secure the agreement of any successor entity to the Company that the Executive shall
continue in his position without reduction in position, duties or authority; (C) relocating the Executive’s principal work location,
excluding working from home remotely, beyond a 50 mile radius of his work location as of the Effective Date (provided that this
Clause (C) shall apply only to a relocation that occurs during the two year period beginning upon a Change of Control, as defined
below, and ending two years thereafter); or (D) committing any other material breach of this Agreement; provided, however, that
the occurrence of a Change in Control, following which the Company continues to have its common stock publicly traded and the
Executive is offered continued employment as an executive officer with substantially the same duties and authority as she has
hereunder of such publicly traded entity, shall not be deemed to give rise to an event or condition constituting Good Reason; and
provided further that no event or condition shall constitute Good Reason unless (x) the Executive gives the Company a Notice of
Termination specifying his objection to such event or condition within 90 days following the occurrence of such event or
condition, (y) such event or condition is not corrected, in all material respects, by the Company in a manner that is reasonably
satisfactory to the Executive within 30 days following the Company's receipt of such notice and (z) the Executive resigns from
his employment with the Company not more than 30 days following the expiration of the 30-day period described in the
foregoing clause (y).
5

-- 99 of 121 --

(c) Permanent Disability.
(i) The Executive's employment hereunder shall terminate upon his Permanent Disability. Upon termination of the
Executive's employment due to Permanent Disability, the Executive shall, subject to Section 8(h) below, be entitled to receive, in
addition to the Base Obligations, (A) a pro rata Target Bonus with respect to the calendar year in which the Date of Termination
occurs, determined in accordance with the Pro Rata Target Bonus Calculation and payable in a lump sum within 30 days
following the Release Effective Date (provided that if the 60 day period described in Section 8(h) below begins in one calendar
year and ends in another, the pro rata Target Bonus shall be paid not earlier than January 1 of the calendar year following the Date
of Termination) and (B) accelerated vesting of all unvested equity compensation awarded to the Executive by the Company as of
the Effective Date and, in accordance with Section 5, each equity award agreement executed by the Executive and the Company
shall describe the treatment of the equity awards under this Section 8(c). All other benefits, if any, due the Executive following
termination pursuant to this Section 8(c) shall be determined in accordance with the plans, policies and practices of the Company;
provided, however, that the Executive shall not participate in any other severance plan, policy or program of the Company.
(ii) For purposes of this Agreement, “Permanent Disability” means either (i) the inability of the Executive to
engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be
expected to result in death or can be expected to last for a continuous period of not less than 12 months or (ii) the Executive is, by
reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to
last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three
months under an accident and health plan covering employees of the Company. The Executive shall be deemed Permanently
Disabled if she is determined to be (i) totally disabled by the Social Security Administration or (ii) disabled in accordance with a
disability insurance program, provided such definition of disabled under the program complies with the definition of Permanent
Disability hereunder. Otherwise, such Permanent Disability shall be certified by a physician chosen by the Company and
reasonably acceptable to the Executive (unless she is then legally incapacitated, in which case such physician shall be reasonably
acceptable to the Executive’s authorized legal representative).
(d) Death. The Executive's employment hereunder shall terminate due to his death. Upon termination of the
Executive's employment hereunder due to death, the Executive's estate shall, subject to Section 8(h) below, be entitled to receive,
in addition to the Base Obligations,(A) a pro rata Target Bonus with respect to the calendar year in which the Date of Termination
occurs, determined in accordance with the Pro Rata Target Bonus Calculation and payable in a lump sum within 30 days
following the Release Effective Date (provided that if the 60 day period described in Section 8(h) below begins in one calendar
year and ends in another, the pro rata Target Bonus shall be paid not earlier than January 1 of the calendar year following the Date
of Termination) and (B) accelerated vesting of all unvested equity compensation awarded to the Executive by the Company as of
the Effective Date and, in accordance with Section 5, each equity award agreement executed by the Executive and the Company
shall describe the treatment of the equity awards under this Section 8(d). All other benefits, if any, due the Executive's estate
following termination pursuant to this Section 8(d) shall be determined in accordance with the plans, policies and practices of the
Company.
6

-- 100 of 121 --

(e) For Cause by the Company or Resignation, not for Good Reason, by Executive.
Upon termination of the Executive’s employment for Cause or resignation by the Executive, not for Good Reason, pursuant to
this Section 8(e), the Executive shall have no further rights to any compensation (including any Annual Bonus) or any other
benefits under this Agreement other than the Base Obligations. All other benefits, if any, due the Executive following the
Executive's termination of employment pursuant to this Section 8(e) shall be determined in accordance with the plans, policies
and practices of the Company; provided, however, that the Executive shall not participate in any severance plan, policy, or
program of the Company.
(f) Termination in Connection with Change in Control by the Company Without Cause or by the Executive for Good
Reason.
(i) If, within the period beginning on a Change in Control (as defined herein below), and ending two (2) years
following such Change in Control, the Executive's employment is terminated by the Company without Cause or by the Executive
for Good Reason, the Executive shall, subject to Section 8(h) below, be entitled to receive, in addition to the Base Obligations,
the following payments and benefits (the "CIC Severance Benefits"):
(A) CIC Severance Payment. On the first day of the seventh (7th) month following the Executive’s Date of
Termination, the Company shall pay the Executive a lump sum cash payment equal to the sum of (I) two times the Base Salary
paid to the Executive with respect to the calendar year immediately preceding the Executive's Date of Termination, (II) the Target
Bonus and (III) a pro rata portion of the Target Bonus for the calendar year in which Executive’s Date of Termination occurs and
determined in accordance with the Pro Rata Target Bonus Calculation. Target Bonus for severance purposes is defined under the
Executive Corporate Incentive Plan for the calendar year which precedes the year in which occurs the Executive’s Date of
Termination. Target Bonus is intended to be a fixed severance payment equal to the prior year Target Bonus and not a
performance-contingent payment dependent on current year or prior year performance. “Pro-Rata Target Bonus Calculation” is
determined by multiplying the Target Bonus by a fraction, the numerator of which is the number of days in the fiscal year in
which the Date of Termination occurs through the Date of Termination and the denominator of which is three hundred sixty-five.
Pro-rata Target Bonus with respect to the calendar year in which Executive’s Date of Termination occurs shall be paid only in the
event the performance goals established under the ECIP for that calendar year with respect to such Target Bonus have been
satisfied. Payment of the pro-rata Target Bonus shall be delayed until following the date the Company’s Compensation
Committee determines that such performance goals have been satisfied, in accordance with the rules under the ECIP (the
“Performance Goal Determination Date”). Payment of the pro-rata portion of the Severance Payment shall be paid in a lump sum
on the date described above or, if later, within 30 days of the Performance Goal Determination Date with respect to such
Performance-Conditioned Portion.
If (i) any amounts payable to the Executive under this Agreement or otherwise are characterized as excess parachute payments
pursuant to Section 4999 of the Internal Revenue Code of 1986, as amended (the “Section 4999”), and (ii) the Executive thereby
would be subject to any United States federal excise tax due to that characterization, the Executive’s termination benefits
hereunder will be reduced to an amount so that none of the amounts payable constitute excess parachute amounts payments if this
would result, after taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section
4999, in Executive’s receipt on an after-tax basis of the greatest amount of termination and other benefits. The determination of
any reduction required pursuant to this section (including the determination as to which
7

-- 101 of 121 --

specific payments shall be reduced) shall be made by a neutral party designated by the Company and such determination shall be
conclusive and binding upon the Company or any related corporation for all purposes.
(B) Health and Welfare Benefits. The Company shall pay to Executive on a monthly basis during the CIC
Coverage Period a taxable monthly cash payment equal to the COBRA premium for the highest level of coverage available under
the Company’s group health plans, but reduced by the monthly amount that Executive would pay for such coverage if the
Executive was an active employee. “CIC Coverage Period” shall mean the period (I) commencing on the first day of the month
following the Release Effective Date (provided that if the 60 day period described in Section 8(h) below begins in one calendar
year and ends in another, the CIC Coverage Period shall commence not earlier than January 1 of the calendar year following the
Date of Termination) and (II) ending on the earlier of (x) the expiration of 24 months from the first day of the CIC Coverage
Period, and (y) the date that the Executive is eligible for coverage under the health care plans of a subsequent employer. The
payments provided by this Section shall be conditioned upon the Executive being covered by the Company’s health care plans
immediately prior to the Date of Termination. The foregoing payments are not intended to limit or otherwise reduce any
entitlements that Executive may have under COBRA. In addition, the Company shall continue to provide the Executive with the
same level of accident (AD&D) and life insurance benefits upon substantially the same terms and conditions (including
contributions required by the Executive for such benefits) as existed immediately prior to the Executive’s Date of Termination
(or, if more favorable to the Executive, as such benefits and terms and conditions existed immediately prior to the Change in
Control) for the same period for which the Company shall provide the Executive with continued health care coverage payments.
All other benefits, if any, due the Executive following termination pursuant to this Section 8(g) shall be determined in
accordance with the plans, policies and practices of the Company; provided, however, that the Executive shall not participate in
any severance plan, policy or program of the Company. The payments and other benefits provided for in this Section 8(g) are
payments and benefits to which the Executive is not otherwise entitled, are given in consideration for the Release and are in lieu
of any severance plan, policy or program of the Company or any of its subsidiaries that may now or hereafter exist. The payments
and benefits to be provided pursuant to this Section 8(g)(i) shall constitute liquidated damages and shall be deemed to satisfy and
be in full and final settlement of all obligations of the Company to the Executive under this Agreement. The Executive
acknowledges and agrees that such amounts are fair and reasonable, and are his sole and exclusive remedy, in lieu of all other
remedies at law or in equity, with respect to the termination of his employment hereunder. If, during the CIC Coverage Period,
the Executive breaches in any material respect any of his obligations under Section 9 or the Confidentiality Agreement, the
Company may, upon written notice to the Executive, (x) terminate the CIC Coverage Period and cease to make any further
payments of the CIC Severance Payment and (y) cease any health and welfare benefits and payments, except in each case as
required by applicable law.
8

-- 102 of 121 --

(ii) For purposes of this Agreement “Change in Control” means the first to occur of any one of the following events:
(A) any “Person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934 (the “Exchange
Act”) (other than (1) the Company, (2) any Person who becomes the “beneficial owner” (as defined in Rule 13d-3 under the
Exchange Act) of more than 50% of the Company’s then outstanding securities eligible to vote in the election of the Board
(“Voting Securities”) as a result of a reduction in the number of Voting Securities outstanding due to the repurchase of Voting
Securities by the Company unless and until such Person, after becoming aware that such Person has become the beneficial owner
of more than 50% of the then outstanding Voting Securities, acquires beneficial ownership of additional Voting Securities
representing 1% or more of the Voting Securities then outstanding, (3) any trustee or other fiduciary holding securities under an
employee benefit plan of the Company, and (4) any entity owned, directly or indirectly, by the stockholders of the Company in
substantially the same proportions as their ownership of Voting Securities), is or becomes the beneficial owner, directly or
indirectly, of more than 50% of the Voting Securities (not including any securities acquired directly (or through an underwriter)
from the Company or the Companies);
(B) the date on which, within any twelve (12) month period (beginning on or after the Effective Date), a majority of
the directors then serving on the Board are replaced by directors not endorsed by at least two-thirds (2/3) of the members of the
Board before the date of appointment or election;
(C) there is consummated a merger or consolidation of the Company with any other corporation or entity or the Company
issues Voting Securities in connection with a merger or consolidation of any direct or indirect subsidiary of the Company with
any other corporation, other than (1) a merger or consolidation that would result in the Voting Securities outstanding immediately
prior thereto continuing to represent (either by remaining outstanding or by being converted into Voting Securities of the
surviving or parent entity) more than 50% of the Company’s then outstanding Voting Securities or more than 50% of the
combined voting power of such surviving or parent entity outstanding immediately after such merger or consolidation or (2) a
merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person,
directly or indirectly, acquired more than 50% of the Company’s then outstanding Voting Securities (not including any securities
acquired directly (or through an underwriter) from the Company or the Companies); or
(D) the consummation of an agreement for the sale or disposition by the Company of all or substantially all of the
Company’s assets (or any transaction having a similar effect), provided that such agreement or transaction of similar effect shall
in all events require the disposition, within any twelve (12) month period, of at least 40% of the gross fair market value of all of
the Company’s then assets; other than a sale or disposition by the Company of all or substantially all of the Company’s assets to
an entity, at least 50% of the combined voting power of the voting securities of which are owned directly or indirectly by
stockholders of the Company in substantially the same proportions as their ownership of the Company immediately prior to such
sale.
Notwithstanding the foregoing, in no event shall a Change in Control be deemed to occur hereunder unless such event
constitutes a change in ownership of the Company, a change in effective control of the Company or a change in ownership of a
substantial portion of the Company’s assets within the meaning of Section 409A.
9

-- 103 of 121 --

(g) Mitigation; Offset. Following the termination of his employment under any of the above clauses of this Section 8,
the Executive shall have no obligation or duty to seek subsequent employment or engagement as an employee (including self-
employment) or as a consultant or otherwise mitigate the Company's obligations hereunder; nor shall the payments provided by
this Section 8 be reduced by the compensation earned by the Executive as an employee or consultant from such subsequent
employment or consultancy.
(h) Release. Notwithstanding anything to the contrary in this Agreement, receipt of the Severance Benefits and the CIC
Severance Benefits or other compensation or benefits under this Section 8 (other than the Base Obligations), if any, by the
Executive is subject to the Executive executing and delivering to the Company a general release of claims following the Date of
Termination, in substantially the form attached as Exhibit B (the "Release"), that, within 60 days following the Executive’s Date
of Termination, has become irrevocable by the Executive (such date the Release becomes irrevocable being the “Release
Effective Date”). If the Executive dies or becomes legally incapacitated prior to the Release Effective Date, then the Release
requirements described in the preceding sentence shall apply with respect to the Executive’s estate and the Release shall be
modified as reasonably necessary to allow for execution and delivery by the personal representative of the Executive’s estate or
the Executive’s authorized legal representative, as applicable.
9. Non-Competition. The Executive acknowledges and recognizes the highly competitive nature of the businesses of the
Company and accordingly agrees as follows:
(a) Non-Competition. For a period of two years following the Date of Termination (the "Restricted Period"),
regardless of the circumstances surrounding such termination of employment, the Executive will not, directly or indirectly
(i) engage in any "Competitive Business" (as defined below) for the Executive’s own account while she is in self-employment or
acting as a sole proprietor, (ii) enter the employ of, or render any services to, any person engaged in a Competitive Business,
(iii) acquire a financial interest in, or otherwise become actively involved with, any person engaged in a Competitive Business,
directly or indirectly, as an individual, partner, shareholder, officer, director, principal, agent, trustee or consultant, or
(iv) interfere with business relationships (whether formed before or after the Effective Date) between the Company and
customers or suppliers of the Company. For purposes of this Agreement, "Competitive Business" shall mean (x) any national
securities exchange registered with the Securities and Exchange Commission, (y) any alternative trading system that trades listed
stocks and other exchange-traded products or (z) any other entity that engages in, or is considering engaging in, substantially the
same business as the Company, in each case in North America or in any other location in which the Company operates. For
purposes of this Agreement, "person" shall mean an individual, corporation, partnership, limited partnership, limited liability
company, syndicate, person (including, without limitation, a "person" as defined in Section 13(d)(3) of the Securities Exchange
Act of 1934, as amended), trust, association or entity or government, political subdivision, agency or instrumentality of a
government.
10

-- 104 of 121 --

(b) Securities Ownership. Notwithstanding anything to the contrary in this Agreement, the Executive may, directly or
indirectly, own, solely as an investment, securities of any person engaged in the business of the Company which are publicly
traded on a national or regional stock exchange or on the over-the-counter market if the Executive (i) is not a controlling person
of, or a member of a group which controls, such person and (ii) does not, directly or indirectly, own five percent or more of any
class of securities of such person.
(c) Severability. It is expressly understood and agreed that, although the Executive and the Company consider the
restrictions contained in this Section 9 to be reasonable, if a final judicial determination is made by a court of competent
jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against
the Executive, the provisions of this Agreement shall not be rendered void, but shall be deemed amended to apply as to such
maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable.
Alternatively, in the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be
affected thereby.
10. Specific Performance The Executive acknowledges and agrees that the Company's remedies at law for a breach or
threatened breach of Section 9 above would be inadequate and, in recognition of this fact, the Executive agrees that, in the event
of such a breach or threatened breach, in addition to any remedies at law, the Company, without posting any bond, shall be
entitled to obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent
injunction or any other equitable remedy which may then be available.
11. Disputes. Except as provided in Section 10 above, any dispute arising between the parties under this Agreement,
under any statute, regulation, or ordinance, under any other agreement between the parties, and/or in way relating to the
Executive’s employment, shall be submitted to binding arbitration before the American Arbitration Association (“AAA”) for
resolution. Such arbitration shall be conducted in New York, New York, and the arbitrator will apply New York law, including
federal law as applied in New York courts. The arbitration shall be conducted in accordance with the AAA’s Employment
Arbitration Rules as modified herein. The arbitration shall be conducted by a panel of three arbitrators that is mutually agreeable
to both the Executive and the Company, all in accordance with AAA’s Employment Arbitration Rules then in effect. If the
Executive and the Company cannot agree upon the panel of arbitrators, the arbitration shall be settled before a panel of three
arbitrators, one to be selected by the Company, one by the Executive, and the third to be selected by the two persons so selected,
all in accordance with AAA’s Employment Arbitration Rules. With respect to any and all costs and expenses associated with any
such arbitration that are not assignable to one of the parties by the arbitrator, each party shall pay their own costs and expenses,
including without limitation, attorney’s fees and costs, except that the Company shall pay the cost of the arbitrators and the filing
fees charged to Executive by the AAA, provided she is the claimant or counter claimant in such arbitration and is the prevailing
party. The award of the arbitrators shall be final and binding on the parties, and judgment on the award may be confirmed and
entered in any state or federal court in the State and City of New York. The arbitration shall be conducted on a strictly
confidential basis, and Executive shall not disclose the existence of a claim, the nature of a claim, any documents, exhibits, or
information exchanged or presented in connection with such a claim, or the result of any action (collectively, “Arbitration
Materials”), to any third party, with the sole exception of the Executive’s legal counsel, who also shall be bound by
confidentiality obligations no less protective than the provisions set forth in the Confidentiality Agreement. In the event of any
court proceeding to challenge or enforce an arbitrators’ award, the parties
11

-- 105 of 121 --

hereby consent to the exclusive jurisdiction of the state and federal courts in New York, New York and agree to venue in that
jurisdiction. The parties agree to take all steps necessary to protect the confidentiality of the Arbitration Materials in connection
with any such proceeding, agree to file all Confidential Information, as defined in the Confidentiality Agreement (and documents
containing Confidential Information) under seal, subject to court order and agree to the entry of an appropriate protective order
encompassing the confidentiality terms of this Agreement. Nothing contained in this Section 11 shall be construed to preclude the
Company from exercising its rights under Section 10 above.
12. Miscellaneous.
(a) Acceptance. The Executive hereby represents and warrants, as a material inducement to the Company's agreement
to enter into this Agreement, that there are no legal, contractual or other impediments precluding the Executive from entering into
this Agreement or from performing the services with the Company contemplated hereby. Any violation of this representation and
warranty by the Executive shall render all of the obligations of the Company under this Agreement void ab initio and of no force
and effect.
(b) Entire Agreement; Amendments. This Agreement, together with the equity award agreements between the
Executive and the Company contain the entire understanding of the parties with respect to the employment of the Executive by
the Company, and shall supersede any and all previous contracts, arrangements or understandings between the Company and the
Executive with respect to the subject matter set forth herein. There are no restrictions, agreements, promises, warranties, or
covenants by and between the Company and the Executive and undertakings between the parties with respect to the subject
matter herein other than those expressly set forth herein. This Agreement may not be altered, modified or amended except by
written instrument signed by the parties hereto.
(c) No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion
shall not be considered a waiver of such party's rights or deprive such party of the right thereafter to insist upon strict adherence
to that term or any other term of this Agreement.
(d) Successor; Assignment. This Agreement is confidential and personal and neither of the parties hereto shall,
without the consent of the other, assign or transfer this Agreement or any rights or obligations hereunder. Without limiting the
foregoing, the Executive's right to receive payments hereunder shall not be assignable or transferable whether by pledge, creation
of a security interest or otherwise, other than a transfer by the Executive's will or by the laws of descent and distribution. In the
event of any attempted assignment or transfer contrary to this Section 12(d), the Company shall have no liability to pay the
assignee or transferee any amount so attempted to be assigned or transferred. The Company shall cause this Agreement to be
assumed by any entity that succeeds to all or substantially all of the Company's business or assets and this Agreement shall be
binding upon any successor to all or substantially all of the Company's business or assets; provided, however, that no such
assumption shall release the Company of its obligations hereunder, to the extent not satisfied by such successor, without the
Executive's prior written consent.
(e) Confidentiality of Tax Treatment and Structure. Notwithstanding anything herein to the contrary, each party and its
representatives may consult any tax advisor regarding the tax treatment and tax structure of this Agreement and may disclose to
any person, without limitation of any kind, the tax treatment and tax structure of this Agreement and all materials (including
opinions or other tax analyses) that are provided relating to such treatment or structure.
12

-- 106 of 121 --

(f) Notice. For the purpose of this Agreement, notices and all other communications provided for in this Agreement
shall be in writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return
receipt requested, postage prepaid, addressed to the respective addresses set forth on the execution page of this Agreement,
provided that all notices to the Company shall be directed to the attention of the General Counsel or to such other address as
either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be
effective only upon receipt:
if to the Company:
The Office of the General Counsel
Nasdaq, Inc.
151 West 42 Street
New York, NY 100366
if to the Executive:
his address as shown in the records of the Company
(g) Withholding Taxes. The Company may withhold from any amounts payable under this Agreement such federal,
state and local taxes as may be required to be withheld pursuant to any applicable law or regulation.
(h) Section 409A. Notwithstanding any other provision of this Agreement, any payment, settlement or benefit
triggered by termination of the Executive’s employment with the Company shall not be made until six months and one day
following Date of Termination if such delay is necessary to avoid the imposition of any tax, penalty or interest under Section
409A of the Internal Revenue Code of 1986, as amended (Section “409A”). Any installment payments that are delayed pursuant
to this Section 12(h) shall be accumulated and paid in a lump sum on the day that is six months and one day following the Date of
Termination (or, if earlier, upon the Executive’s death) and the remaining installment payments shall begin on such date in
accordance with the schedule provided in this Agreement. For purposes of this Agreement, termination or severance of
employment will be read to mean a “separation from service” within the meaning of Section 409A where it is reasonably
anticipated that no further services would be performed after that date or that the level of services the Executive would perform
after that date (whether as an employee or independent contractor) would permanently decrease to no more than 20 percent of the
average level of bona fide services performed over the immediately preceding thirty-six (36) month period. Additionally, the
amount of expenses eligible for reimbursement or in-kind benefits to be provided during one calendar year may not affect the
expenses eligible for reimbursement or any in-kind benefits to be provided in any other calendar year and the right to
reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. All reimbursements shall be made
no later than the last day of the calendar year following the calendar year in which the Executive incurs the reimbursable expense.
This Agreement is intended to comply with the requirements of Section 409A (including the exceptions thereto), to the extent
applicable, and the Agreement shall be administered and interpreted in accordance with such intent. If any provision contained in
the Agreement conflicts with the requirements of Section 409A (or the exemptions intended to apply under the Agreement), the
Agreement shall be deemed to be reformed to comply with the requirements of Section 409A (or the applicable exemptions
thereto). The Company, after consulting with the Executive, may amend this Agreement or the terms of any award provided for
herein in any manner that the Company considers necessary or advisable to ensure that cash compensation,
nd
13

-- 107 of 121 --

equity awards or other benefits provided for herein are not subject to United States federal income tax, state or local income tax
or any equivalent taxes in territories outside the United States prior to payment, exercise, vesting or settlement, as applicable, or
any tax, interest or penalties pursuant to Section 409A. Any such amendments shall be made in a manner that preserves to the
maximum extent possible the intended benefits to the Executive. This Section 12(h) does not create an obligation on the part of
the Company to modify this Agreement and does not guarantee that the amounts or benefits owed under the Agreement will not
be subject to interest and penalties under Section 409A. For purposes of this Agreement, all rights to payments and benefits
hereunder shall be treated as rights to receive a series of separate payments and benefits to the fullest extent allowed by Section
409A.
(i) Clawback. The Executive agrees that compensation and benefits provided by the Company under this Agreement
or otherwise will be subject to recoupment or clawback by the Company under any applicable clawback or recoupment policy of
the Company that is generally applicable to the Company’s executives, as may be in effect from time-to-time, or as required by
applicable law.
(j) Audit Rights. Any and all equity compensation of any kind due hereunder to Executive after the Date of
Termination shall be accompanied by a detailed statement from the Company showing the calculation for such compensation for
the period being measured. Within thirty (30) days after the delivery of such statement, the Executive may notify the Company
of any objections or changes thereto, specifying in reasonable detail any such objections or changes. If the Executive does not
notify the Company of any objections or changes thereto or if within twenty (20) days of the delivery of an objection notice the
Executive and the Company agree on the resolution of all objections or changes, then such statements delivered by the
Company, with such changes as are agreed upon, shall be final and binding. If the parties shall fail to reach an agreement with
respect to all objections or changes within such twenty (20) day period, then all disputed objections or changes shall, be subject
to resolution in accordance with Section 11 above.
(k) Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same instrument.
(l) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of
New York.
* 	* 	*
14

-- 108 of 121 --

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first above written.
EXECUTIVE
/s/ Bradley J. Peterson
Bradley J. Peterson
Nasdaq, Inc.
By: 	/s/ Bryan E. Smith
Name:
Title:
Bryan E. Smith
Executive Vice President and Chief People Officer
15

-- 109 of 121 --

Exhibit A
NASDAQ CONTINUING OBLIGATIONS AGREEMENT
During the course of my employment or engagement with Nasdaq and/or its subsidiaries and affiliates (collectively, the “Company”), I
understand that I will have or be given access to, and/or receive, certain non-public, confidential, and proprietary information and or
specialized training and trade secrets pertaining to the business of the Company and Company’s customers or prospective customers
(“Company Parties”). Any unauthorized disclosure or use of such information would cause grave harm to the Company Parties. Therefore, to
assure the confidentiality and proper use of Confidential Information and other Company Property (each as defined herein), and in
consideration of my engagement with the Company, my access to confidential information, training and trade secrets, and the compensation
paid or to be paid for my services during that engagement, and the mutual covenants and promises contained herein, I agree to the following:
1. Confidentiality and Company Property.
All Confidential Information and Company Property (as those terms are defined below) is owned by and for the Company Parties
exclusively; is intended solely for authorized, work-related purposes on behalf of the Company Parties; and shall not be used for personal or
other non-work related purposes. Specifically, without limitation, I shall not, directly or indirectly, at any time during or after engagement
with the Company, without prior express written authorization from the Company (i) divulge, disclose, transmit, reproduce, convey,
summarize, quote, share, or make accessible to any other person or entity Confidential Information or non-public Company Property; (ii) use
any Confidential Information or Company Property for any purpose outside the course of performing the authorized duties of my work with
the Company; (iii) remove Company Property or Confidential Information from the Company Parties’ premises without obtaining prior
express written authorization from the Company; or (iv) review or seek to access any Confidential Information or Company Property except
as required in connection with my work for the Company.
2. Non-Solicitation.
I agree that, for a period of 24 months following my separation from service for any reason, I shall not, directly or indirectly, without express
written consent from Company’s Office of General Counsel:
a) 	Interfere with any customer relationship the Company has with any of its current customers or potential customers that I had any
involvement with, directly or indirectly, during the last twelve (12) months of my employment; or
b) Solicit, or induce to enter into any business arrangement with, any employee or contractor of the Company with whom I had any contact
or a relationship with during the last twelve (12) months of my employment; or
c) Solicit, or induce to enter into any business arrangement with, any employee or contractor of the Company’s customers that I knew, or
reasonably could be expected to know, was solicited by the Company for any technology, operations, sales or business role during
the last twelve (12) months of my employment with the Company.
Nothing in this Section shall be construed to prohibit me from becoming employed or engaged by another entity after my termination of
employment from the Company, as long as I am not engaged in duties that violate the non-solicitation provisions in this Section. Other non-
competition provisions in other Company agreements signed by me may apply depending on the law of the applicable jurisdiction.
16

-- 110 of 121 --

3. Inventions Assignment.
I will promptly disclose to the Company, or its designee, all Nasdaq Inventions (as defined below). All Nasdaq Inventions shall be the
exclusive property of the Company, and I acknowledge that all Nasdaq Inventions shall be considered as “works made for hire” belonging to
the Company. To the extent that any Nasdaq Inventions may not be considered works made for hire, I hereby assign to the Company, without
any further consideration, all right, title, and interest in and to all such Nasdaq Inventions, including, without limitation, all copyrights, all
patents, all patent applications all provisional applications, divisional applications, continuation applications, continuation in-part
applications, and all patents that may issue therefrom and all reissues, reexaminations and extensions thereof, all other intellectual property
rights, all moral rights, all contract and licensing rights, and all claims and causes of action of any kind with respect to such rights, including,
without limitation, the right to sue and recover damages or other compensation and/or obtain equitable relief for any past, present, or future
infringement or misappropriation thereof. The assignment to the Company herein of all rights to the Nasdaq Inventions is without additional
compensation to me. At the Company’s expense, I will assist in every proper way to perfect the Company’s rights in the Nasdaq Inventions
and to protect the Nasdaq Inventions throughout the world, including, without limitation, (i) executing in favor of the Company or its
designee(s) documents confirming patent, copyright, and other applications’ assignment to the Company relating to the Nasdaq Inventions
and (ii) the filing by the Company of such assignment in the United States Patent and Trademark Office, and any corresponding entities in
any applicable foreign countries or multinational authorities, to record the Company or its designee(s) of the Company’s patents or patent
applications as the assignee and owner of the patents or patent applications. I agree not to challenge the validity of the Nasdaq Inventions or
the ownership by the Company or its designee(s) of the Nasdaq Inventions.
4. Non-Disparagement.
I agree that I shall not issue, circulate, publish or utter any false or disparaging, statement, remarks, opinions or rumors about the Company or
its shareholders unless giving truthful testimony under subpoena or court order. Notwithstanding, I understand that I may provide truthful
information to any governmental agency or self-regulatory organization with or without subpoena or court order. With the exception of
communications made in a private corporate communication as an employee or consultant with regard to a listing decision of my employer or
my consulting client, I agree that public communications regarding a preference for listing a security on a market other than the Company,
that the quality of the Company as a securities market is in any way inferior to any other securities market or exchange, and/or that the
regulatory efforts and programs of the Company are or have been lax in any way, are specifically defined as disparaging and will constitute a
material breach of this Agreement. Nothing in this paragraph, however, shall prevent me from making good faith, factual and truthful
statements related to listing with the Company as long as my statements are not based on proprietary information.
5. Cooperation.
If I receive a subpoena or process from any person or entity (including, but not limited to, any governmental agency) which may or will
require me to disclose documents or information or provide testimony (in a deposition, court proceeding, or otherwise) regarding, in whole or
in part, any of the Company Parties or any Confidential Information or Company Property, I shall: (i) to the extent permissible by law, notify
Nasdaq’s Office of the General Counsel of the subpoena or other process within twenty-four (24) hours of receiving it; and (ii) to the
maximum extent possible, not make any disclosure until the Company Parties have had a reasonable opportunity to contest the right of the
requesting person or entity to such disclosure, limit the scope or nature of such disclosure, and/or seek to participate in the proceeding or
matter in which the disclosure is sought.
6. Definitions.
“Confidential Information” shall mean any non-public, proprietary information regarding the Company Parties, whether in writing or not,
whether in digital, hardcopy, or another format, including all personal
17

-- 111 of 121 --

information, all personnel information, financial data, commercial data, trade secrets, business plans, business models, organizational
structures and models, business strategies, pricing and advertising techniques and strategies, research and development activities, software
development, market development, exchange registration, studies, market penetration plans, listing retention plans and strategies, marketing
plans and strategies, communication and/or public relations products, plans, programs, recruiting strategies, databases, processes, work
product or inventions, financial formulas and methods relating to Company Parties’ business, computer software programs, accounting
policies and practices, and all strategic plans or other matters, strategies, and financial or operating information pertaining to current or
potential customers or transactions (including information regarding each Company Party’s current or prospective customers, customer
names, and customer representatives), templates and agreements, and all other information about or provided by the Company Parties,
including information regarding any actual or prospective business opportunities, employment opportunities, finances, investments, and other
proprietary information and trade secrets. Notwithstanding the above, Confidential Information shall not include any information that: (i) was
known to me prior to my engagement with the Company as evidenced by written records in my possession prior to such disclosure; or (ii) is
generally and publicly available and known to all persons in the industries where the Company conducts business, other than because of any
unauthorized disclosure by me.
“Company Property” shall mean all property and resources of the Company Parties, or any Company Party, including, without limitation,
Confidential Information, each Company Party’s products, each Company Party’s computer systems and all software, E-mail, web pages and
databases, telephone and facsimile services, and all other administrative and/or support services provided by the Company Parties. I further
agree that “Company Property” shall include processes, data, works of authorship, methods, Inventions (as that term is defined below),
developments, and improvements that I conceive, originate, develop, author, or create, solely or jointly with others, during or as a result of
my employment with the Company, or using Company Property, and without regard to whether any of the foregoing also may be included
within “Confidential Information” as defined under this Agreement.
“Nasdaq Inventions” shall mean all ideas, improvements, trade secrets, know-how, confidential technical or business information, sales and
other commercial relationships, potential sales and other commercial relationships, business methods or processes, copyrightable expression,
research, marketing plans, computer software (including, without limitation, source code(s)), computer programs, original works of
authorship, industrial designs, trade dress, developments, discoveries, trading systems, trading strategies and methodologies, improvements,
modifications, technology, algorithms and designs, (regardless of whether any of the foregoing are subject to patent or copyright protection),
that are (i) made, conceived, expressed, developed, or reduced to practice by me (solely or jointly with others) during or as a result of my
employment with the Company or using Company Property and (ii) which relate in any manner to the Company, the business of the
Company (including without limitation the services the Company provides to any of the Company Parties), or my engagement by the
Company.
7. Return Of Confidential Information And Company Property.
Upon my termination of engagement with the Company, for any reason, or if the Company so requests, I shall promptly deliver to the
Company all Confidential Information and Company Property, including Nasdaq Inventions in my possession or under my control, as well as
all documents, disks, tapes, or other electronic, digital, or computer means of storage, and all copies of such information and property.
8. Injunctive Action.
I acknowledge that the foregoing provisions and restrictions are reasonable and necessary for the protection of the Company Parties and
their respective businesses. These obligations are not limited in time to the duration of my engagement and rather shall survive the
termination of my engagement by the Company, regardless of the reason for its termination. I agree that my breach of any of the foregoing
provisions will result in irreparable injury to the Company Parties, that monetary relief alone will be inadequate to redress such a breach, and
further that the Company shall be entitled to obtain an injunction to prevent and/or remedy such a breach (without first having to post a
bond).
18

-- 112 of 121 --

(a) 	In any proceeding for an injunction and upon any motion for a temporary or permanent injunction (“Injunctive Action”), the
Company’s right to receive monetary damages shall not be a bar or interposed as a defense to the granting of such injunction. The
Company’s right to an injunction is in addition to, and not in lieu of, any other rights and remedies available to the Company under
law or in equity, including any remedy the Company may seek in any arbitration brought pursuant to Paragraph 9 of this Agreement.
(b) I hereby irrevocably submit to the jurisdiction of the courts of New York in any Injunctive Action and waive any claim or defense of
inconvenient or improper forum or lack of personal jurisdiction under any applicable law or decision. Upon the issuance (or denial)
of an injunction, the underlying merits of any such dispute shall be resolved in accordance with Paragraph 9 of this Agreement.
9. Arbitration.
Except as provided in Section 8 of this Agreement, any dispute arising between the Parties under this Agreement, under any statute,
regulation, or ordinance, under any other agreement between the Parties, and/or in way relating to my engagement by the Company, shall be
submitted to binding arbitration before the American Arbitration Association (“AAA”) for resolution. Such arbitration shall be conducted in
New York, New York, and the arbitrator will apply New York law, including federal law as applied in New York courts. The arbitration shall
be conducted in accordance with the AAA’s Employment Arbitration Rules as modified herein. The arbitration shall be conducted by a single
arbitrator, who shall be an attorney who specializes in the field of employment law and who shall have prior experience arbitrating
employment disputes. The award of the arbitrator shall be final and binding on the Parties, and judgment on the award may be confirmed and
entered in any state or federal court in the State of New York and City of New York. In the event of any court proceeding to challenge or
enforce an arbitrator’s award, the Parties hereby consent to the exclusive jurisdiction of the state and federal courts in New York, New York
and agree to venue in that jurisdiction.
The arbitration shall be conducted on a strictly confidential basis, and I shall not disclose the existence of a claim, the nature of a claim, any
documents, exhibits, or information exchanged or presented in connection with such a claim, or the result of any action (collectively,
“Arbitration Materials”), to any third party, with the sole exception of my legal counsel, who also shall be bound by these confidentiality
terms. The Parties agree to take all steps necessary to protect the confidentiality of the Arbitration Materials in connection with any such
proceeding, agree to file all Confidential Information (and documents containing Confidential Information) under seal, and agree to the entry
of an appropriate protective order encompassing the confidentiality terms of this Agreement.
10. Governing Law; Amendment; Waiver; Severability.
This Agreement shall be construed in accordance with and shall be governed by the laws of the State of New York, excluding any choice of
law principles. This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof, and may not be
amended, discharged, or terminated, nor may any of its provisions be waived, except upon the execution of a valid written instrument
executed by me and the Company.
(a) If any term or provision of this Agreement (or any portion thereof) is determined by an arbitrator or a court of competent jurisdiction
to be invalid, illegal, or incapable of being enforced, all other terms and provisions of this Agreement shall nevertheless remain in
full force and effect.
(b) 	Upon a determination that any term or provision (or any portion thereof) is invalid, illegal, or incapable of being enforced, the
Company and I agree that an arbitrator or reviewing court shall have the authority to amend or modify this Agreement so as to render
it enforceable and effect the original intent of the Parties to the fullest extent permitted by applicable law.
11. Miscellaneous.
This Agreement (i) may be executed in identical counterparts, which together shall constitute a single agreement; (ii) shall be fairly
interpreted in accordance with its terms and without any strict construction
19

-- 113 of 121 --

in favor of or against either Party, notwithstanding which Party may have drafted it; and (iii) the headings herein are included for reference
only and are not intended to affect the meaning or interpretation of the Agreement. This Agreement is binding upon, and shall inure to the
benefit of, me and the Company and our respective heirs, executors, administrators, successors and assigns.
Without limiting the scope or generality of the terms of this Agreement in any way, I acknowledge and agree that the terms of this Agreement
and all discussions regarding this Agreement are confidential, and accordingly I agree not to disclose any such information to any third party,
except to my attorney(s), or as otherwise may be required by law. Notwithstanding the foregoing, I may disclose to any prospective employer
the fact and existence of this Agreement, and provide copies of this Agreement to such entity. The Company also has the right to apprise any
prospective employer or other entity or person of the terms of this Agreement and provide copies to any such persons or entities.
12. Other Terms of My Engagement.
Nothing in this Agreement alters the at-will nature of my employment or engagement with the Company. I acknowledge and agree that my
employment or engagement is at-will, which means that both I and the Company shall have the right to terminate such engagement at any
time, for any reason, with or without cause and with or without prior notice.
To the extent I am signing this Agreement in any capacity other than as an employee (e.g., consultant, independent contractor), the written
terms of my engagement supersede the terms of this Paragraph. Moreover, I acknowledge that my engagement with the Company requires
undivided attention and effort. Therefore, I will not, during my engagement with the Company, engage in any other employment or business,
other than for the Company, or assist in any manner any business that is competitive with the business or the future business plans of the
Company, unless I receive prior express written consent from the Company’s Global Ethics Team.
20

-- 114 of 121 --

I hereby acknowledge and accept the terms of this Agreement as of the Effective Date, by signature below.
/s/ Bradley Peterson 	Date: 6/22/22
Print Name: Bradley Peterson
21

-- 115 of 121 --

Exhibit B
Release of Claims
GENERAL RELEASE
WHEREAS, Bradley Peterson (hereinafter referred to as the "Executive") and Nasdaq, Inc. (hereinafter referred to
as "Employer") are parties to an Employment Agreement, dated October 1, 2020 (the "Employment Agreement"), which provided
for the Executive's employment with Employer on the terms and conditions specified therein; and
WHEREAS, the Executive has agreed to execute a release of the type and nature set forth herein as a condition to
his entitlement to certain payments and benefits upon his termination of employment with Employer.
NOW, THEREFORE, in consideration of the premises and mutual promises herein contained and for other good
and valuable consideration received or to be received by the Executive in accordance with the terms of the Employment
Agreement, it is agreed as follows:
1. 	Excluding enforcement of the covenants, promises and/or rights reserved herein, the Executive hereby
irrevocably and unconditionally releases, acquits and forever discharges Employer and each of Employer's owners, stockholders,
predecessors, successors, assigns, directors, officers, employees, divisions, subsidiaries, affiliates (and directors, officers and
employees of such companies, divisions, subsidiaries and affiliates) and all persons acting by, through, under or in concert with
any of them (collectively "Releasees"), or any of them, from any and all charges, complaints, claims, liabilities, obligations,
promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands, costs, losses, debts and expenses
(including attorneys' fees and costs actually incurred) of any nature whatsoever, known or unknown, suspected or unsuspected,
including, but not limited to, rights arising out of alleged violations of any contracts, express or implied, any covenant of good
faith and fair dealing, express or implied, or any tort or any legal restrictions on Employer's right to terminate employees, or any
Federal, state or other governmental statute, regulation or ordinance, including, without limitation, Title VII of the Civil Rights
Act of 1964, as amended, the Federal Age Discrimination In Employment Act of 1967 ("ADEA"), as amended, the Employee
Retirement Income Security Act ("ERISA"), as amended, the Civil Rights Act of 1991, as amended, the Rehabilitation Act of
1973, as amended, the Older Workers Benefit Protection Act ("OWBPA"), as amended, the Worker Adjustment Retraining and
Notification Act ("WARN"), as amended, the Fair Labor Standards Act ("FLSA"), as amended, the Occupational Safety and
Health Act of 1970 ("OSHA"), the New York State Human Rights Law, as amended, the New York Labor Act, as amended, the
New York Equal Pay Law, as amended, the New York Civil Rights Law, as amended, the New York Rights of Persons With
Disabilities Law, as amended, and the New York Equal Rights Law, as amended, that the Executive now has, or has ever had, or
ever will have, against each or any of the Releasees, by reason of any and all acts, omissions, events, circumstances or facts
existing or occurring up through the date of the Executive's execution hereof that directly or indirectly arise out of, relate to, or
are connected with, the Executive's services to, or employment by Employer (any of the foregoing being a "Claim" or,
collectively, the "Claims"); provided, however, that this release shall not apply to any of the obligations of Employer or any other
Releasee under the Employment Agreement, or under any agreements, plans, contracts, documents or programs described or
referenced in the Employment Agreement; and provided, further, that this release shall not apply to any rights the Executive may
have to obtain contribution or indemnity against Employer or any other Releasee pursuant to contract, Employer's certificate of
incorporation and by-laws or otherwise.
22

-- 116 of 121 --

2. 	The Executive expressly waives and relinquishes all rights and benefits afforded by California Civil Code
Section 1542 and does so understanding and acknowledging the significance of such specific waiver of Section 1542. Section
1542 states as follows:
"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR
DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF
EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE
MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR."
Thus, notwithstanding the provisions of Section 1542, and for the purpose of implementing a full and complete release and
discharge of the Releasees, the Executive expressly acknowledges that this Agreement is intended to include in its effect, without
limitation, all Claims that the Executive does not know or suspect to exist in the Executive's favor at the time of execution hereof,
and that this Agreement contemplates the extinguishment of any such Claim or Claims.
3. 	The Executive understands that she has been given a period of 21 days to review and consider this General
Release before signing it pursuant to the Age Discrimination In Employment Act of 1967, as amended. The Executive further
understands that she may use as much of this 21-day period as the Executive wishes prior to signing.
4. 	The Executive acknowledges and represents that she understands that she may revoke the waiver of his
rights under the Age Discrimination In Employment Act of 1967, as amended, effectuated in this Agreement within 7 days of
signing this Agreement. Revocation can be made by delivering a written notice of revocation to Office of the General Counsel,
Nasdaq, Inc., 151 West 42 Street, New York, New York 10036. For this revocation to be effective, written notice must be
received by the General Counsel no later than the close of business on the seventh day after the Executive signs this Agreement.
If the Executive revokes the waiver of his rights under the Age Discrimination In Employment Act of 1967, as amended,
Employer shall have no obligations to the Executive under Section 8 (other than the Base Obligations) of the Employment
Agreement.
5. 	The Executive and Employer respectively represent and acknowledge that in executing this Agreement
neither of them is relying upon, and has not relied upon, any representation or statement not set forth herein made by any of the
agents, representatives or attorneys of the Releasees with regard to the subject matter, basis or effect of this Agreement or
otherwise.
6. 	This Agreement shall not in any way be construed as an admission by any of the Releasees that any
Releasee has acted wrongfully or that the Executive has any rights whatsoever against any of the Releasees except as specifically
set forth herein, and each of the Releasees specifically disclaims any liability to any party for any wrongful acts.
7. 	It is the desire and intent of the parties hereto that the provisions of this Agreement be enforced to the
fullest extent permissible under law. Should there be any conflict between any provision hereof and any present or future law,
such law will prevail, but the provisions affected thereby will be curtailed and limited only to the extent necessary to bring them
within the requirements of law, and the remaining provisions of this Agreement will remain in full force and effect and be fully
valid and enforceable.
nd
23

-- 117 of 121 --

8. 	The Executive represents and agrees (a) that the Executive has to the extent she desires discussed all
aspects of this Agreement with his attorney, (b) that the Executive has carefully read and fully understands all of the provisions of
this Agreement, and (c) that the Executive is voluntarily entering into this Agreement.
9. 	This General Release shall be governed by, and construed in accordance with, the laws of the State of New
York, without giving effect to the conflicts of laws principles thereof or to those of any other jurisdiction which, in either case,
could cause the application of the laws of any jurisdiction other than the State of New York. This General Release is binding on
the successors and assigns of, and sets forth the entire agreement between, the parties hereto; fully supersedes any and all prior
agreements or understandings between the parties hereto pertaining to the subject matter hereof; and may not be changed except
by explicit written agreement to that effect subscribed by the parties hereto.
PLEASE READ CAREFULLY. THIS GENERAL RELEASE INCLUDES A RELEASE OF
ALL KNOWN AND UNKNOWN CLAIMS.
This General Release is executed by the Executive and Employer as of the 22nd day of June 2022.
/s/ Bradley Peterson___________________
Bradley Peterson
Nasdaq, Inc.
By: /s/ Bryan E. Smith
Name: Bryan E. Smith
Title: EVP and Chief People Officer
24

-- 118 of 121 --

Exhibit 31.1
CERTIFICATION
I, Adena T. Friedman, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Nasdaq, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most
recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal
control over financial reporting.
/s/ Adena T. Friedman
Name: 	Adena T. Friedman
Title: 	President and Chief Executive Officer
Date: August 3, 2022

-- 119 of 121 --

Exhibit 31.2
CERTIFICATION
I, Ann M. Dennison, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Nasdaq, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most
recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal
control over financial reporting.
/s/ Ann M. Dennison
Name: 	Ann M. Dennison
Title: 	Executive Vice President and Chief Financial Officer
Date: August 3, 2022

-- 120 of 121 --

Exhibit 32.1
Certification of CEO and CFO Pursuant to
18 U.S.C. Section 1350
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report on Form 10-Q of Nasdaq, Inc. (the “Company”) for the period ended June 30, 2022 as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), Adena T. Friedman, as President and Chief Executive Officer of the Company, and
Ann M. Dennison, as Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of her knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the
Company.
/s/ Adena T. Friedman
Name: 	Adena T. Friedman
Title: 	President and Chief Executive Officer
Date: 	August 3, 2022
/s/ Ann M. Dennison
Name: 	Ann M. Dennison
Title: 	Executive Vice President and Chief Financial Officer
Date: 	August 3, 2022
This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-
Oxley Act of 2002, be deemed filed by the Company for purposes of § 18 of the Securities Exchange Act of 1934, as amended.

-- 121 of 121 --